Pocket Guide - ARVO

ARVO.org/AM

ARVO Annual MeetingApril 28 – May 2Vancouver Convention CentreVancouver, B.C.

Pocket Guide

Creating possibilities for Non-infectious Uveitis

Find out more at Booth 1527

©2019 AbbVie Inc. North Chicago, IL 60064 US-IMMU-180247 January 2019

Cole Eye Institute Chair Daniel F. Martin, MD, invites

you to meet our presenters for lively discussions at

the Cole Eye Institute booth (#713).

Sunday, April 28, 201910-11 a.m. | Rishi Singh, MD

Advancements in the Diagnosis and Treatment for AMD

12-1 p.m. | George Hoppe, PhDHIF-1ɑ Stabilization for the Prevention of Retinopathy of Prematurity

2-3 p.m. | Alex Yuan, MD, PhDArgus II Retinal Prosthesis Experience at Cole Eye Institute

Monday, April 29, 201910-11 a.m. | Bela Anand-Apte, MD, PhD

Research Training Programs at Cole Eye Institute

12-1 p.m. | Rachel Chen, MDOphthalmology Residency Training at Cole Eye Institute

2-3 p.m. | Fatema Ghasia, MDPredicting Treatment Response to Occlusion Therapy: Insights from Fixation Eye Movements

Tuesday, April 30, 201910-11 a.m. | Connie Tam, PhD

Innate Immune Functions of Keratin Proteins in the Cornea

12-1 p.m. | Sujata Rao, PhDSignaling Pathways Regulating Cone Degeneration

2-3 p.m. | Vera Bonilha, PhDOxidative Stress and Degeneration in the RPE and Retina: Role of DJ-1 and Aging

COLE EYE INSTITUTE

#ARVO2019

2 Complete meeting information is available at ARVO.org/AM

Program Overview

†Separate registration/tickets required *All Posters — all first authors must be present at their poster.

Sunday, April 28 Location Time

Registration/Badge Printing Main Lobby 7am–6pm

ARVO Central Exhibit Hall 7am–6pm

Basic Clinical Lecture East Ballroom B 8–10am

Symposia See program listing 8–10am

Posters See program listing 8–9:45am | 1–2:45pm | 3–4:45pm | 5–6pm*

Exhibits Exhibit Hall 8:30am–5pm

ARVO/Alcon Keynote Session ARVO Ballroom 10:15–11:45am

Proctor Award Lecture ARVO Ballroom 12noon – 12:45pm

China-ARVO Networking Forum West 301 1–2:30pm

SIGs/Workshops See program listing 1–2:30pm

Low Vision Group West 223/224 1–2:30pm

Papers See program listing 3–4:45pm

Sunday Social † Vancouver Aquarium 7–10pm

Monday, April 29Registration/Badge Printing Main Lobby 7am–6pm


NAEVR Defense Briefing West 109/110 7–8am

Posters See program listing 8:15–10am | 11:15am–1pm | 4–5:45pm | 6–7pm*

Papers/Minisymposia See program listing 8:15–10am | 11:15am –1pm | 4–5:45pm


Section Business Meetings See program listing 10:15–11am

Workshops See program listing 1:15–2:45pm

SIGs See program listing 1:15–2:45pm | 7:30–9pm

MOI Group East Ballroom B 1:15–2:45pm

WEAVR Luncheon † Harbour Ballroom 1:15–2:45pm

Friedenwald Award Lecture ARVO Ballroom 3–3:45pm

Special Sessions See program listing 7:30–9pm

Student/Trainee Social Harbour Ballroom Foyer 7:30–9pm

Tuesday, April 30Registration/Badge Printing Main Lobby 7am–6pm


Breakfast with the Experts† Harbour Ballroom 7–8:30am


Posters See program listing 8:45–10:30am | 11:45–1:30pm | 2:45–4:30pm | 4:45–5:45pm*

Papers/Minisymposia See program listing 8:45–10:30am | 11:45–1:30pm | 2:45–4:30pm

General Business Meeting West 211 10:45–11:30am

Weisenfeld Award Lecture ARVO Ballroom 1:45–2:30pm

MIT Poster Award Competition Exhibit Hall 4:15–5:45pm

ARVO/Champalimaud Lecture ARVO Ballroom 5:45–6:45pm

Wednesday, May 1

Registration/Badge Printing Main Lobby 7am–6pm


Posters See program listing 8:15–10am | 10:15–12noon | 3–4:45pm | 5–6pm*

Papers/Minisymposia See program listing 8:15–10am | 10:15–12noon | 3–4:45pm


Workshops See program listing 12:15–1:45pm

Genetics Group East Ballroom B 12:15–1:45pm

SIGs See program listing 12:15–1:45pm | 6:15–7:45pm

Cogan Award Lecture ARVO Ballroom 2–2:45pm

Special Sessions See program listing 6:15–7:45pm

Classical Concert West 301 8–10pm

Karaoke Night † Blackbird Public House 9pm –12midnight

Thursday, May 2Registration Main Lobby 7am–4:30pm


Symposia See program listing 8–10am

Posters See program listing 8–9:45am | 10:15am–12noon | 2–3pm*

Papers See program listing 10:15am–12noon

SIGs/Workshops See program listing 12:15–1:45pm

ARVO 2020 Kickoff Reception Exhibit Hall 2–3pm

Beckman Argyros Award Lecture ARVO Ballroom 3:15–4:15pm

ARVO/Alcon Keynote Session ARVO Ballroom 4:30–6pm

Complete meeting information is available at ARVO.org/AM 3

Table of Contents

Program Overview ............................................................................ 2Policies .............................................................................................. 6Convention Center Maps ................................................................... 8How to Connect ............................................................................... 16Safety and Security ......................................................................... 16 Presenter Guidelines ....................................................................... 18Services Cash Machine/ATM .................................................................... 20 Mother’s Lounge ........................................................................ 20 Coat and Luggage Check .......................................................... 20 First-Aid or Medical Needs ........................................................ 20 Lost and Found .......................................................................... 20 Prayer and Meditation Room ..................................................... 20 Recycling ................................................................................... 20 Tourism Vancouver Information Desks ...................................... 21 Security Services ....................................................................... 21 Water Coolers ............................................................................ 21NAEVR Booth/DoD Session Information ......................................... 22Meeting Information Meeting Management Office...................................................... 24 Press Activities/Press Registration ............................................ 24 Registration ................................................................................ 24 Registration/Badge Printing Hours (convention center) ............. 25 Badge Printing (downtown hotels) ............................................. 25 ARVO Fellows ............................................................................ 25 ARVO Members-in-Training ....................................................... 25 Travel Grant Recipients .............................................................. 25Dowling Society Members ............................................................... 26ARVO Awards and Award Lectures ARVO/Alcon Keynote Series ...................................................... 28 Proctor Award and Lecture ........................................................ 30 Friedenwald Award and Lecture ................................................ 30 Weisenfeld Award and Lecture .................................................. 30 Cogan Award and Lecture ......................................................... 30 ARVO/Champalimaud Award Lecture ........................................ 31 Beckman-Argyros Award Lecture .............................................. 31General Business Meeting General Business Meeting agenda ............................................ 32 ARVO Distinguished Service Awards ........................................ 32 Joanne G. Angle Service Award ................................................ 33Fellows Class of 2019 ...................................................................... 34Exhibits Exhibit Hall Hours ...................................................................... 35 Exhibit Hall Floor Plan ............................................................... 36 Exhibits A-Z ............................................................................... 38 Exhibitor Descriptions ................................................................ 43 Exhibitor Education Lounge ....................................................... 86


Table of Contents

Daily Program Schedules Sunday ....................................................................................... 89 Monday ...................................................................................... 93 Tuesday ...................................................................................... 98 Wednesday .............................................................................. 103 Thursday .................................................................................. 108CME/CPD Information Physician Accreditation Statement .......................................... 113 Physician Credit Designation ................................................... 113 Instructions to Receive Credits ................................................ 114 CME Credits and Certificate Fee ............................................. 115 Disclosures of Conflicts of Interest — AMPC Committee/CME Committee......................................... 116 CME Sessions ......................................................................... 121Social Events ................................................................................. 137Section Business Meetings ........................................................... 138Transportation Airport Transportation .............................................................. 140 Other Transportation Options ................................................... 140ARVO 2020 Hotel Information ....................................................... 142Future Meetings ............................................................................. 142Visit Baltimore Activities/Giveaways .............................................. 143Travel Grant Supporters ................................................................. 144

DisclaimerThe Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting online program materials and print publications aim to promote vision research and scientific discourse for educational purposes. ARVO accepts no responsibility for any products, presentations, opinions, statements or positions expressed; and inclusion of such material within the meeting, the publications or posted online does not constitute an endorsement by ARVO.

Photography ReleaseBy attending the ARVO Annual Meeting, attendees agree to allow their names, likenesses and images either in audio, photographic or video format recorded onsite to be used by ARVO and the ARVO Foundation for Eye Research for educational and promotional purposes.

© 2019 by the Association for Research in Vision and Ophthalmology, Inc. All rights reserved. Permission to republish any part of this book must be obtained in writing from the ARVO Director of Communications, prior to publication. Contact Marisa Lavine at [email protected].

The Association for Research in Vision and Ophthalmology1801 Rockville Pike, Suite 400 | Rockville, MD 20852-5622

Tel: +1.240.221.2900 | [email protected] | ARVO.org


Policies

Section Business MeetingsARVO PoliciesUse of recording/photography/audiotape/video equipment: Recording by any means (photographing, audiotaping, videotaping) of any presentations or sessions at any ARVO meeting is prohibited, except by an ARVO-authorized agent for official purposes or by First Authors who want to photograph their own poster presentations. Violators risk confiscation of their equipment and/or dismissal from the Annual Meeting as deemed appropriate by ARVO.

Commercial Relationships Policy: Presenters must state and display all applicable commercial relationships. For more information on this important policy, refer to the Commercial Relationships Index at ARVO.org/Program-Summary.

Clinical Trials Registration Policy: All clinical trials that will be reported in ARVO Annual Meeting abstracts must be registered on a publicly available database. The required acknowledgement of the First Author, acting as the authorized agent for all authors, certifies that any research presented in the abstract that reports on a clinical trial is registered, and the registration location and number are included on the abstract, in compliance with the ARVO Statement on Registering Clinical Trials, ARVO.org/About/Policies/Statement-on-Registering-Clinical-Trials. For more information on this policy, refer to the Clinical Trials Registration Index at ARVO.org/Program-Summary.

Children in the convention center: Children under 18 years old must be accompanied by a parent or guardian at all times. Parents/guardians who bring children into paper sessions must remove them immediately if they become disruptive. Children are not allowed to accompany parents/guardians in sessions/events where tickets are required or food is provided, except events for which children’s tickets are available for purchase. Under no circumstances are children permitted in the exhibit hall during set-up or dismantle times.

Continuing Medical EducationARVO is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

ARVO designates this live activity for a maximum of 29.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Please refer to the CME information on page 113.


Connect with ARVO on your favorite social media site to stay up-to-date on the latest news and information on eye and vision research.

twitter.com/ARVOinfo or include #ARVO2019

facebook.com/ARVOinfo

linkedin.com/company/arvoinfo

arvoconnect.arvo.org

5th Assembly of Ocular Inflammation Societies8th Annual Meeting of Taiwan Retina Society

15th

INTERNATIONAL OCULAR INFLAMMATION SOCIETY

CONGRESS

www.iois.info

in conjunction with

KAOHSIUNGTAIWAN

13 - 16NOVEMBER

2019

Exchanging scientific and clinical informations globally.


Convention Center

WATERFRONT ROAD

SHOWOFFICE

LOBBY

BURRARD INLET

Vancouver Convention Centre (West Building)Lower Level — West Exhibition

Exhibit HallExhibitsARVO CentralARVO 2020 Baltimore HotelsARVO 2020 Baltimore KickoffNAEVR CentralExhibitor Education LoungeConcessions

Poster Area A


Convention Center

WATERFRONT ROAD

SHOWOFFICE

LOBBY

BURRARD INLET

Poster Area B

Exhibitor Education

Lounge

MITPosters


Convention Center

BALLROOMFOYER

WEST PACIFICTERRACE

THURLOW STREET ENTRANCE

BURRARDSTREETENTRANCE

LEVEL 1 OCEAN FOYER

BALLROOM LOBBY

PARKADE ENTRANCE

LEVEL 1BURRARD

FOYER

FIRSTAID

ENTRANCELOBBY

109

110

113

114 115 116 117

118

021 911

121122

112 111

BURRARD INLET

101 102 103 104 105 106 107 108

ENTRANCELOBBY

UNDERGROUND CONNECTOR

TO EAST BUILDING

Vancouver Convention Centre (West Building) West Level 1

Ballroom FoyerStudent/Trainee SocialPresident’s Reception

ARVO BallroomARVO/Alcon Keynote SessionsAward Lectures

Harbour BallroomARVO Foundation GalaWEAVR LuncheonBreakfast with the Experts

West 101ARVO Foundation Office

First Aid


Convention Center

BALLROOMFOYER

WEST PACIFICTERRACE

THURLOW STREET ENTRANCE

BURRARDSTREETENTRANCE

LEVEL 1 OCEAN FOYER

BALLROOM LOBBY

PARKADE ENTRANCE

LEVEL 1BURRARD

FOYER

FIRSTAID

ENTRANCELOBBY

109

110

113

114 115 116 117

118

021 911

121122

112 111

BURRARD INLET

101 102 103 104 105 106 107 108

ENTRANCELOBBY

UNDERGROUND CONNECTOR

TO EAST BUILDING

Ballroom LobbyRegistration

West 105ARVO MeetingManagement

West 107/108MIT Lounge

First TimersLounge

West 112Press Office

West 116Speaker Ready


Convention Center


222

223224

220

221

512 612 712 812 912

214 213

211

212

210202

201

203 204 205 206 207209

208

BURRARD INLETLEVEL 2 OCEAN TERRACE

224 223

222 221

220

219218217216215

214 213 212

211

210209

208207206205204203202

201

OCEAN FOYER

BURRARDFOYER

CITY FOYER

OPEN TO LEVEL 1

West 204FARVO Lounge


Convention Center

222

223224

220

221

512 612 712 812 912

214 213

211

212

210202

201

203 204 205 206 207209

208

BURRARD INLETLEVEL 2 OCEAN TERRACE

224 223

222 221

220

219218217216215

214 213 212

211

210209

208207206205204203202

201

OCEAN FOYER

BURRARDFOYER

CITY FOYER

OPEN TO LEVEL 1


BURRARD INLET

LIVING ROOF

306305 304 303 302

301

SUMMIT FOYER

SUMMITTERRACE

TERRACE

West 301Classical Concert


Convention Center

Vancouver Convention Centre (East Building) East Level 2

Vancouver Convention Centre (East Building) East Level 1

TO/FROMCONVENTION

LEVEL & LOBBY

TO/FROM HOTELTO/FROMCONVENTIONLEVEL & LOBBY

TO/FROMGROUND LEVEL

SOUTHFOYER

2019 18 17

1516

14

13

12

11

10

987

654

3

2

1

TERRACE

OUTDOOR PUBLIC PROMENADE

WATERFRONT RD

OUTDOOR PROMENADETO/FROMGROUND LEVEL

UNDERGROUNDCONNECTOR

TO WEST BUILDING

RAMP DOWNTO PARKADE

EXHIBITION HALL

MAINENTRANCE

TOTEMPOLES

BALLROOM

CBALLROOM

BBALLROOM

LOBBY

TO/FROM MEETINGLEVEL & HOTEL

TO/FROMFOOD COURT & HOTEL

TO/FROM WESTBUILDING CONNECTOR


T & HOTEL

A


Convention Center


TO WEST BUILDING

RAMP DOWNTO PARKADE

EXHIBITION HALL

MAINENTRANCE

TOTEMPOLES

BALLROOM

CBALLROOM

BBALLROOM

LOBBY

TO/FROM MEETINGLEVEL & HOTEL

TO/FROMFOOD COURT & HOTEL

TO/FROM WESTBUILDING CONNECTOR


T & HOTEL

A

TO/FROMCONVENTION

LEVEL & LOBBY

TO/FROM HOTELTO/FROMCONVENTIONLEVEL & LOBBY

TO/FROMGROUND LEVEL

SOUTHFOYER

2019 18 17

1516

14

13

12

11

10

987

654

3

2

1

TERRACE

OUTDOOR PUBLIC PROMENADE

WATERFRONT RD

OUTDOOR PROMENADETO/FROMGROUND LEVEL

East Ballroom Imaging Conference


How to Connect

Wireless Internet Complimentary wireless Internet access will be available

in designated areas throughout the Vancouver Convention Centre. Connect to the “ARVO” network on your device, and then open your browser. No password is needed.

Wi-Fi provided by ARVO is used by all attendees and ARVO asks that attendees limit their web use with regards to live streaming and downloading. The ARVO wireless network is an “open” network and does not use any encryption or security measures. We recommend that you avoid making online purchases or accessing personal information over the wireless network.

Safety/Security Tips■■ Carry with you the name, address, phone numbers

and email of an individual to contact in case of emergency. If you have a mobile phone, enter the emergency contact phone number in your contacts list under the heading “ICE” (In Case of Emergency).

■■ Be sure to carry a card describing any medical conditions or allergies you may have, or wear a medical alert tag.

■■ Do not wear your meeting name badge out and about in Vancouver.

■■ Avoid poorly lit streets and always walk with another person when sightseeing or shopping, particularly at night.

■■ Do not display large amounts of cash when paying for taxis or other purchases.

■■ Do not leave unsecured valuables in your hotel room; lock them in your in-room safe. Hotels are not responsible for items left in your room.

■■ At the meeting, check items at the coat and luggage check area located on the Exhibits Level of the Vancouver Convention Centre.


Vladimir J. Kefalov, PhDWashington University School of Medicine

recipient of the

2019 Bressler Prizefor his contributions to

the field of retinal physiology

and

Tiffany M. Schmidt, PhDNorthwestern University

recipient of the

2019 Pisart Awardfor her work in the field

of visual system neuroscience

Lighthouse Guildcongratulates

The Bressler Prize recognizes a mid-career vision

clinicians or scientist whose leadership, research and

service have led to substantive advancements in the

understanding of vision loss, treatment of eye disease, or

the rehabilitation of people with vision loss.

For both the Bressler Prize and the Pisart Award,

non-clinicians may be eligible if their work has direct, immediate and readily translatable clinical relevance.

Call for nominations is now open for the 2020 Awards, visit lighthouseguild.org/awards

lighthouseguild.org


Presenter Guidelines

Section Business MeetingsPresenters All speakers scheduled in session rooms are required to check into the Speaker Ready Room, West 116/117, preferably 24 hours, but no later than four hours before their presentations.

■■ Previously uploaded presentations must be reviewed and approved.

■■ All presentation slides and other files must be uploaded in advance of your presentation.

■■ Presenters will not be allowed to load PowerPoint slides or other files directly to the computer in the session room.

■■ Personal laptops cannot be used for presentations in the session rooms.

■■ Do not bring your laptop or other media devices to the session. There are no exceptions to this policy.If you are unavoidably delayed, you must still go directly to

the Speaker Ready Room.

Speaker Ready Room — West 116/117Fri., April 26 ...................................................................4 – 9pm Sat., April 27 .............................................................7am – 6pm Sun., April 28 ............................................................7am – 6pm Mon., April 29 ..........................................................7am – 6pm Tues., April 30 ...........................................................7am – 6pm Wed., May 1 ............................................................. 7am – 6pm Thurs., May 2 ............................................................7am – 2pm

For details see ARVO.org/AM/Abstracts then go to Paper, Invited Speaker, SIG Presentation Guidelines.

Poster Presenters ■■ Sunday poster presenters are strongly encouraged to

register and print their badges on Saturday. ■■ All posters must be placed by 8am on the day of

presentation and remain on display the entire day until after the All Posters session.

■■ Posters may not be displayed prior to the day of presentation.

■■ Presenters must be present at their poster boards during their scheduled presentation times. The poster area will be monitored and “no show” presenters will be recorded and will be ineligible for 2020 abstract submission as First Author.


Presenter Guidelines

■■ Posters should be removed immediately after the All Posters session for that day. All Posters ends at 6pm on Sunday, 7pm on on Monday, 5:30pm on Tuesday, 6pm on Wednesday, and 3pm on Thursday.

■■ ARVO is not responsible for poster materials left at the end of day. Posters remaining on the poster boards will be removed and discarded.

■■ For details see Poster Presentation Guidelines at ARVO.org/AM/Abstracts.

Abstract Withdrawals and Substitute Presenters If the First Author cannot attend and present, he or she must submit an online withdrawal or an online request for approval of a co-author as substitute presenter. Withdrawals and substitute presenter requests must be received by 2pm (U.S. PDT) the day before the scheduled presentation. Failure to comply will result in rejection of the First Author’s abstract submission to the 2020 Annual Meeting.

For details see Abstract Withdrawal and Substitute Presenter Policy at ARVO.org/AM/Abstracts.

Untitled-1 1 3/4/19 9:32 AM


Services

Cash Machine/ATM There are two ATM Machines in the Vancouver Convention Centre: one in the East Building lobby and one in the West Building lobby.

Mother’s Lounge There is a mother’s lounge located in both the East Building and the West Building. In the West Building, the mother’s lounge is located on the first floor near the ARVO Ballroom. In the East Building, the mother’s lounge is located on the meeting level near the south foyer. Please call the phone number posted outside the rooms for access.

Coat and Luggage Check (Exhibits Level)

Check your coat, luggage, and other items. Sat., April 27 ..................................................6:30am – 6:30pm Sun., April 28 .................................................6:30am – 6:30pm Mon., April 29 ................................................6:30am – 9:30pm Tues., April 30 ................................................6:30am – 7:30pm Wed., May 1 ...................................................6:30am – 8:30pm Thurs., May 2 .................................................6:30am – 6:30pm ARVO is not responsible for items left at the end of the meeting.

First-Aid or Medical Needs The First Aid office is located on Level 1 of the West Building of the Vancouver Convention Centre near the ARVO Ballroom.

Lost and Found All lost items are taken to Meeting Management Office, West 105. Please stop by this office or email [email protected] to see if your item has been found. Prayer/Meditation Room The Prayer/Meditation Room is in West 120 of the Vancouver Convention Centre.

Recycling Recycling and compost bins are located throughout the Vancouver Convention Centre. Help ARVO in our efforts to be environmentally friendly and put your trash in the appropriate receptacle.


Services

Tourism Vancouver Information Desks (VCC East and West Lobbies) Information is available on local attractions and activities as well as city maps, restaurant reservations and much more.

Security Services If you need assistance while at the Vancouver Convention Centre contact the Information Desk in ARVO Central, Exhibit/Poster Hall or Meeting Management in West 105.

Water Coolers Water coolers are available throughout the Vancouver Convention Centre.

2019 Annual Meeting SurveyWe want to hear from you! Following the Annual Meeting, all attendees will receive a link to the Online Annual Meeting Survey. Please respond and send us your thoughts about how ARVO can continue to improve the Annual Meeting. We appreciate your attendance and look forward to receiving your comments. Survey participants will be entered into a drawing for an Amazon gift card.

Visit the Gift Shop in ARVO Central to pick up the ARVO 2019 t-shirt


Visit NAEVR Central in the Exhibit Hall Hours: Sun. – Wed. 8:30am – 5pmHosted by NAEVR’s James Jorkasky and David Epstein■ Contact Congress to support vision research funding in-

creases ■■■ Learn about research funding resources, such as multiple

Department of Defense (DoD) funding opportunities to meet critical vision research gaps

NAEVR’s Defense-Related Vision Research Opportunities SessionMon., April 29, 7 – 8am | West 109/110NAEVR has invited DoD representatives to speak about funding opportunities and past DoD awardees to offer insights into how researchers can be most responsive to the funding Program Announcement

EyeResearch.org

European Association for Vision and Eye Research

EVER

2019October 17-19 in Nice, France

REGISTER NOW! EARLY REGISTRATION

within July 15, 2019

CALL FOR ABSTRACTApril 10, 2019


1. Full 360o image captured with posterior/anterior imaging capabilities of the Triton. Composite image made with 3rd party imaging software.

©2019 Topcon Medical Systems, Inc. MCA #3695

Come see why the multimodal Triton Swept Source OCT is the most comprehensive imaging device on the market today.1

Tomorrow’s OCT, today!ARVO Booth #803

DRI OCT Triton™ SeriesA Multimodal Swept Source OCT

See the Whole Picture with Triton™

19077_ARVO Pocket Guide Ad_0321.indd 1 3/21/19 1:45 PM


Meeting Information

Meeting Management Office Email: [email protected]. Staff will be available in West 105 throughout the week to assist with meeting services.Sat., April 27 ...................................................... 7am – 5:30pm Sun., April 28 ..........................................................7am – 6pmMon., April 29 .........................................................7am – 8pmTues., April 30 ..........................................................7am – 6pmWed., May 1 ............................................................7am – 7pmThurs., May 2 ...........................................................7am – 6pm

Press Activities/Press Registration ARVO invites members of the press to cover paper and poster sessions at the meeting. Pre-registered press should bring their email confirmation to West 111/112 to pick up their badges. Other press may apply for press credentials in West 111/112. Please note that research presented at the meeting may be proprietary or submitted for publication.

Annual Meeting Registration (Vancouver Convention Centre)ARVO 2019 registration is on the first floor of the West Building Vancouver Convention Centre. Registration includes: ■ Badge Printing Bring your email confirmation with the QR code to an

ExpressPass badge printing kiosk. Simply scan the QR code and receive your badges and/or tickets. QR codes can also be scanned from your smartphone.

■■■ Onsite Registration Complete the onsite registration form and submit payment

at the onsite registration desk. ■■■ Onsite Guest Complete the appropriate registration form and submit

payment at the onsite registration desk. ■■■ Name badge replacement Replace a lost or forgotten name badge at the Badge

Replacement desk for a $50 fee. Corrections to the badges are free.

■■■ Exhibitor registration All pre-registered exhibitors should print their confirmation and

bring it with them to the convention center. Simply scan the QR code at the Exhibitor registration desk. All non-registered exhibitors may register onsite at the Exhibitor registration desk.


Meeting Information

Registration and Badge Printing (Vancouver Convention Centre) Sat., April 27 ........................................................... 7am – 6pm Sun., April 28 ...........................................................7am – 6pm Mon., April 29 ..........................................................7am – 6pm Tues., April 30 ..........................................................7am – 6pm Wed., May 1 ............................................................7am – 6pm Thurs., May 2 ...........................................................7am – 2pm

Note: Sunday presenters are strongly encouraged to register and/or print their badges on Saturday.

Badge Printing(Satellite Badge Printing — downtown hotels) Bring your email confirmation with the QR code to an ARVO kiosk at the following hotels:■■■ Hyatt Regency Vancouver

655 Burrard Street, Vancouver, BC■■■ Vancouver Marriott Pinnacle Downtown (4th floor) 1128 W. Hastings Street, Vancouver, BC

Sat., April 27 .............................................................7am – 9pmSun., April 28 ............................................................7am – 3pm

ARVO Fellows ARVO Fellows in the Class of 2019 may pick up their materials at the FARVO Lounge in West 204 of the Vancouver Convention Centre during registration hours. Please note: enter through West 203 to gain access to West 204. Ribbons for prior year Fellows will also be available.

ARVO Members-in-TrainingMembers-in-Training (MIT) are invited to network and relax together in the MIT lounge. Sunday-Wednesday, 8am-5pm, West 107/108.

Travel Grant Recipients Pick up your Travel Grant packet during registration hours at the Travel Grants/Awards Desk on Saturday in the registration area on the First Floor of the West Building and Sunday – Thursday at ARVO Central in the Exhibit Hall.


Dowling Society

Former ARVO Foundation chair John Dowling, PhD, FARVO; current chair Paul Sternberg, Jr., MD, FARVO; and former chairs Gary Abrams, MD, FARVO; Nicolas Bazan, MD, PhD, FARVO; and Mark Petrash, PhD, FARVO; present Alice McPherson, MD, with a Dowling Society medal in recognition of her 2018 pledge to the Foundation.

Dowling SocietyThe prestigious Dowling Society recognizes individuals for their significant support for eye and vision research. The society is named for vision researcher and first Chairman of the ARVO Foundation Board of Governors, John E. Dowling, PhD, FARVO, in honor of his accomplishments within the ARVO Foundation, ARVO and the vision research community.

Members of the Dowling Society have made a pledge or donation to the Foundation for $10,000 or more. Members have the option of adding a spouse/partner for an additional contribution of $5,000. Pledges may be paid over five years. Below are members of the Dowling Society that we wish to recognize for their contributions:

Gary W. Abrams, MD, FARVO and Jane C. Werner, MD

Jayakrishna Ambati, MD, FARVORobert E. Anderson, MD, PhD,

FARVOJoanne Angle*, MLS, MPASally S. Atherton, PhD, FARVO

and Robert AthertonRobert B. Barlow*, PhD, FARVO

and Patricia BarlowHaydee E. P. Bazan, PhD, FARVO

and Nicolas G. Bazan, MD, PhD, FARVO

Bernard Becker*, MD, FARVODavid C. Beebe*, PhD, FARVO

and Mrs. Betsy Beebe, PA-CPaul S. Bernstein, MD, PhD,

FARVO

Eliot L. Berson*, MD, FARVO and Kyra Kaplan-Berson

Roger W. Beuerman, PhD, FARVO

Laszlo Z. Bito, PhDJanet C. Blanks, PhD, FARVOJeffrey H. Boatright, PhD, FARVOWilliam J. Brunken, PhD, FARVO

and Dale D. Hunter, PhD, JDClaude F. Burgoyne, MD, FARVO

and Vicki SmithPatrick Burke, MD, PhDStanley Chang, MD, FARVOSteve T. Charles, MD, FACS, FICSEmily Y. Chew, MD, FARVO and

Robert P. Murphy, MDBruce E. Cohan, MDLancey B. Cowan, JD, CAE


Dowling Society

To become a member of the Dowling Society, please contact the ARVO Foundation at +1.240.221.2950 or [email protected]

Cheryl M. Craft, PhD, FARVOPatricia A. D’Amore, MBA, PhD,

FARVOPaulus T. V. M. de Jong, MD, PhD,

FARVO, FEBOphth, FRCOphth and Marij de Jong

John E. Dowling, PhD, FARVO and Judith F. Dowling

Joseph L. Dowling, MDMelinda K. Duncan, PhD, FARVODavid L. Epstein*, MD, FARVO and

Susan M. Epstein, RN, JD Rafal Farjo, PhDSteven J. Fliesler, PhD, FARVORobert N. Frank, MD, FARVORonald E. P. Frenkel, MDJuan E. Gallo, MD, PhD, FARVORonnie Glaser and Bert M.

Glaser*, MD, FARVOIsrael A. Goldberg, PhD and

Diane GoldbergEvangelos S. Gragoudas, MD,

FARVOHans E. Grossniklaus, MD, FARVOJulia A. Haller, MD, FARVO and

John D. Gottsch, MD, FARVOMary Elizabeth Hartnett, MD,

FARVOLinda D. Hazlett, PhD, FARVOJohn R. Heckenlively, MD, FARVOJohn A. Hoepner, MDDavid Huang, MD, PhD, FARVOMartine J. Jager, MD, PhD, FARVOMurray A. Johnstone, MD, and

Jeanie JohnstoneDimitrios Karamichos, PhDPaul L. Kaufman, MD, FARVO and

Margaret KaufmanJohn L. Keltner, MD and

Nancy KeltnerShigeru Kinoshita, MD, PhD,

FARVOIngrid Kreissig, MDPaul P. Lee, MD, JD, FARVO and

Jennifer LeeMarmor Foundation/

Michael F. Marmor, MD, FARVO

Alice R. McPherson, MDJennifer J. Kang-Mieler, PhD,

FARVO and William F. Mieler, MD, FARVO

Ann H. Milam, PhD, FARVOJoan W. Miller, MD, FARVORobert F. Miller, MD, FARVOAlan R. Morse, PhDJanice OlivaSamir C. Patel, MDChristopher A. Paterson*, PhD,

DSc, FARVODavid R. Pepperberg*, PhD, FARVOJ. Mark Petrash, PhD, FARVO and

Kelly Cope PetrashRobert Ritch, MD, FARVOStella M. Robertson, PhD and

James D. Robertson, PhDFrances J. Rucker, PhD, MCOptomIris M. Rush, CAEStephen J. Ryan*, Jr., MD, FARVODavid E. SafferJose Alain Sahel, Jr., MD, FARVO Joel S. Schuman, MD, FARVO and

Carole Miner SchumanLawrence J. Singerman, MD, FACSGregory L. Skuta, MDAlfred Sommer, MD, MHSRichard F. Spaide, MD, FARVOWilliam Eric Sponsel, MDW. Daniel Stamer, PhD, FARVO and

Catherine Bowes Rickman, PhDPaul Sternberg, Jr., MD, FARVO

and Gloria SternbergJoyce Tombran-Tink, PhD, FARVO

and Colin J. Barnstable, DPhil, FARVO

Carol B. Toris, PhD, FARVO Erik J. van Kuijk, MD, PhD and

Virginia Brooke, RN, PhDDavid R. Williams, PhD, FARVO

and Inger M. Williams, PhDTerri L. Young, MD, MBA, FARVOThomas Yorio, PhD, FARVO and

Elena Yorio*deceased


ARVO/Alcon Keynote Series

The ARVO/Alcon Keynote Series is sponsored by the ARVO Foundation through the generous support of Alcon.

ARVO/Alcon Opening KeynoteSun., April 28, 10:15 – 11:45am | ARVO Ballroom

Randy W. Schekman, PhDNobel Laureate

Investigator, Howard Hughes Medical Institute

Professor of Cell and Developmental Biology, University of California at

Berkeley

How cells export proteins and RNA — applications to the treatment of disease

Dr. Schekman has studied how cells transport proteins from their site of synthesis in the endoplasmic reticulum to their various ultimate destinations inside or outside the cell, using membrane vesicles as a vehicle. Using yeast as a model organism, his work has harnessed the power of yeast genetics to understand this fundamental biological process of intracellular vesicular trafficking.

Martin Gleave, CM, MD, FRCSC, FACS

Director, The Vancouver Prostate Centre

Professor and Vice Chair, Department of Urological Sciences, University of

British Columbia, Vancouver

Models of translational science to span innovation gaps in academia

Dr. Gleave’s studies have characterized molecular mechanisms that mediate treatment resistance in cancer, focusing on stress-activated adaptive responses that drive acquired treatment resistance. By designing rational combination co-targeting strategies to abrogate the stress response, conditional lethality improved cancer control. He has patented several anti-cancer drugs and, in 2001, founded OncoGenex Technologies, for which he serves as chief scientific officer.

ARVO/Alcon Closing KeynoteThurs., May 2, 4:30 - 6pm | ARVO Ballroom

ARVO


200 FIFTH AVENUE NEW YORK, NY 10010

LEGAL RELEASE STATUS

AD APPROVAL

Release has been obtained Legal Coord:

Acct Mgmt: Print Prod:

Art Director: Proofreader:

Copywriter: Studio:

JOB #: SAICOR-Q90014_Journal PROOF: 5

CLIENT: SANTEN INC. OP: RS, CV, KS

SPACE/SIZE: B: 4.25” x 8.875” T: 4” x 8.5” S: 3.5” x 8”

DATE:

THIS ADVERTISEMENT PREPARED BY TOWNHOUSE

CLIENT: SANTEN INC. SIZE, SPACE: 4” x 8.5”, 4C

PRODUCT: CORPORATE PUBS: MAGAZINE

JOB#: SAICOR-Q90014_Journal ISSUE: 2019

ART DIRECTOR: None COPYWRITER: None

A Clear Vision For Life®

With an aging population, we recognize the increasing pressure of managing glaucoma for patients who are living longer and want to maintain independence. At SANTEN, we’re committed to developing novel therapeutic solutions that will advance your approach to glaucoma management and help you preserve your patients’ vision.

Learn more about our pipeline and our mission to preserve eyesight at www.SantenUSA.com

Visit us at ARVO, booth #1203.

SANTEN – TURNING THE PRESSURE OF GLAUCOMA INTO PROGRESS

© 2019 Santen Inc. All rights reserved.

S:3.5”S:8”

T:4”T:8.5”

B:4.25”B:8.875”


ARVO Awards and Awards Lectures

Friedenwald Award and LectureMon., April 29, 3 – 3:45pm | ARVO Ballroom

Donald Zack, MD, PhD, FARVOWilmer Eye Institute, Johns Hopkins UniversityBaltimore, Md.

From transcription to drug discovery, and from photoreceptors to RGCs, a fun journey

Cogan Award and LectureWed., May 1, 2 – 2:45pm | ARVO Ballroom

Przemyslaw Mike Sapieha, PhDMaisonneuve-Rosemont Hospital Research CentreMontreal, QC

Neurovascular and neuroimmune communication in retinal vascular disease

Mildred Weisenfeld Award and LectureTues., April 30, 1:45 – 2:30pm | ARVO Ballroom

Sheila West, PhD, FARVOWilmer Eye Institute, Johns Hopkins UniversityBaltimore, Md.

Toward the elimination of disease

Proctor Award and LectureSun., April 28, 12noon – 12:45pm | ARVO Ballroom

Jerry Niederkorn, PhD, FARVOUniversity of Southwestern Texas Medical CenterDallas, Texas

The eye sees eye to eye with the immune system


ARVO Awards and Awards Lectures

The 2018 António Champalimaud Vision Award was given to seven scientists recognized for the first successful gene-therapy treatment of an inherited disease that caused childhood blindness — a version of Leber Congenital Amaurosis. Their research demonstrated the potential for gene therapy to cure other inherited diseases.

2018 AwardeesJean Bennett, MD, PhD, and Albert M. Maguire, MD, University of Pennsylvania School of Medicine and Children’s Hospital of Philadelphia

Robin Ali, PhD and James Bainbridge MD, PhD, University College London and Moorfields Eye Hospital

Samuel G. Jacobson, MD, PhD, and William W. Hauswirth, PhD, University of Pennsylvania School of Medicine and University of Florida College of Medicine

Michael Redmond, PhD, NIH/National Eye Institute

Dr. Bennett and Dr. Ali will discuss their groundbreaking research on behalf of the awardees.

ARVO/Champalimaud Award LectureTues., April 30, 5:45 – 6:45pm ARVO Ballroom

Beckman–Argyros AwardMark F. Bear, PhDMassachusetts Institute of Technology/Howard Hughes Medical InstituteCambridge, Mass.

Thurs., May 2, 3:15 – 4:15pm, ARVO Ballroom

Synaptic plasticity and amblyopiaThe Beckman-Argyros Award in Vision Research funds potentially high-impact work that lacks the full suite of data necessary to secure government funding. This year’s recipient is Mark F. Bear, PhD, a Picower Professor of Neuroscience in The Picower Institute for Learning and Memory and the Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology.

Bear’s work is particularly focused on understanding developmental plasticity in the visual cortex and hippocampus. He has described novel forms of procedural learning in the visual system, and investigated synaptic function in models of fragile X syndrome and other autism spectrum disorders.


General Business Meeting

ARVO Distinguished Service AwardsDistinguished Service Award recipients will be recognized at the General Business Meeting (Tues., April 30, 10:45 – 11:30am | West 211).

Claude F. Burgoyne, MD, FARVODevers Eye Institute, Portland, Ore.2018 Immediate Past President GL Section Trustee 2013-2018

Raymond A. Applegate, OD, PhD, FARVOUniversity of Houston, Houston, TX2018 ARVO Vice PresidentVI Section Trustee, 2014-2019

Andrew D. Dick, MBBS, MD, FMedSci, FARVOUniversity of Bristol/Bristol Eye HospitalBristol, UK2018 ARVO Vice PresidentIM Section Trustee, 2014-2019

General Business MeetingWest 211 | Tues., April 30, 10:45 – 11:30am■ Welcome — ARVO President, Steven J. Fliesler, PhD,

FARVO

■■■ Presentation of ARVO Distinguished Service Awards

■ Claude F. Burgoyne, MD, FARVO

■■ Raymond A. Applegate, OD, PhD, FARVO

■■ Andrew D. Dick, MBBS, MD, FMedSci, FARVO

■■■ Presentation of the Joanne G. Angle Award to Thomas Yorio, PhD, FARVO

■■■ Presentation of Membership Update and Election Results

■■ Membership and Annual Meeting attendance update

■■ Introduction of Incoming Officers

■■■ Recognition of the 2019 Achievement Award recipients

■■■ Announcment of the 2020 Achievement Award recipients

■■■ Conclude Meeting


General Business Meeting

A TRULY COMPREHENSIVE OPHTHALMOLOGY MEETING FOR ALL OPHTHALMOLOGISTS

SOE 2019CONGRESS

SEE YOU IN NICE

www.SOE2019.org

RegisterNOW!

SOE2019 ARVO PP advert 79x92.qxp_Layout 1 20/02/2019 15:10 P

Joanne G. Angle Service Award The Joanne G. Angle Service Award is the highest service honor to a volunteer professional bestowed by ARVO. The 2019 award is presented to Thomas Yorio, PhD, FARVO, of the North Texas Eye Research Institute, University of North Texas Health Science Center, in Fort Worth.

Dr. Yorio joined the North Texas Eye Research Institute in 1977, later becoming Provost, and then Provost Emeritus when he stepped down from the position. Within ARVO, Yorio served as VP of the Board of Trustees, Chair of the Physiology and Pharmacology section within the Annual Meeting Program Committee and the Chair of the Finance Committee. He served as an Editorial Board Member, an Associate Editor and the Editor-in-Chief of IOVS. He is a Dowling Society member, and, as a North Texas Eye Research Institute member, he participates in evaluating the eyes of over 2,400 local school children a year.

The award will be presented to Dr. Yorio at the General Business Meeting (Tues., April 30, 10:45 – 11:30am, West 211).


ARVO Fellows

Fellows of ARVOARVO will induct the Fellows Class of 2019 at the opening ARVO/Alcon Keynote Lecture to recognize and honor these members for their leadership, dedication and contributions to the Association.

Gold FellowsHaydee BazanClaudio BucoloAnne ColemanAles CveklFrancois DeloriAdriana Di PoloBrad FortuneJuana GallarHaiyan GongJane GwiazdaJennifer Kang-MielerMary KelleyPaul KnepperDavid LeeJennifer LimFrank LovicuGoldis MalekMaureen McCallDebora NicklaT. Michael RedmondAustin RoordaLeopold SchmettererNaj SharifSteven ShevellCynthia TothRussell Van GelderGadi Wollstein

Silver FellowsAlistair BarberStefano BoniniChing-Kang ChenDong Feng Chen

Nathan CongdonJonathan CrowstonMarc De SmetDusanka DereticJ. Crawford DownsJacque DuncanSilvia FinnemannJ. Peter GierowFarhad HafeziSarah Hamm-AlvarezChristopher HammondNoriko KoizumiJudy KimJan KremersMarlyn LangfordAlfred LewinRichard LibbyAllison McKendrickThomas MillarIan MorganSteven Nusinowitz Darryl OverbyLuminita ParaoanEli PeliNancy PhilpBaerbel RohrerHendrik SchollMahnaz ShahidiSangly SrinivasAlan StittAngela SuburoGeeta VemugantiManuel Vidal-Sanz

Exhibit Hours


Exhibit Hall Hours Sun., April 28 8:30am – 5pm Mon., April 29 8:30am – 5pm Tues., April 30 8:30am – 5pm Wed., May 1 8:30am – 5pm

The Association for Research in Vision and Ophthalmology gratefully acknowledges the support of exhibiting companies and Annual Meeting supporters.


Exhibit Hall

Poster Area B

Poster Area A

ExhibitorPresentation

ARVO Central1127

NAEVR

1002 1003

1006 1007

1012 1013

1016

1018 1019

1026 1027

1029

1030 1031

1032 1033

1036 1037

1040 1041

1042 1043

1102 1103

1106

1108 1109

1117

1126

1130

1132

1136 1137

1138

1140 1141

1142 1143

1203

1209

1219

1236

1238

1240 1241

1249

1251

1253

1255

1303

1307

1311

1317

1337

1340

1342 1343

1348 1349

1350 1351

1352 1353

1354 1355

1402 1403

20'

1404

1406 1407

1411

1417

1427

1436 1437

1438 1439

1440 1441

1442

1448 1449

1450 1451

1452 1453

1454 1455

1502

20'

1503

1505

1506

1509

1517

1526 1527

1528

1530

1536 1537

1538 1539

1540 1541

1542 1543

1548

1550

1552

1554

1602 1603

1604 1605

1607

1608

1610 1611

1615

1616

1618 1619

1621

1636 1637

1639

1640 1641

1642 1643

1702

1704

1706

1708

1710

1714

1718

1736

1738

1740

1742

703

705

707

713

719

721

727

729

731

733

737

739

741

743

802 803

806

809

813

815

818 819

820

826 827

828

830

833

836 837

838

840 841

842

902 903

906 907

909

912 913

914 915

917

919

921

926 927

928

931

932 933

936 937

941

946

Entrance

Meeting Suites

Vancouver Convention CentreExhibit Hall

Exhibit Hall


Poster Area B

Poster Area A

ExhibitorPresentation

ARVO Central1127

NAEVR

1002 1003

1006 1007

1012 1013

1016

1018 1019

1026 1027

1029

1030 1031

1032 1033

1036 1037

1040 1041

1042 1043

1102 1103

1106

1108 1109

1117

1126

1130

1132

1136 1137

1138

1140 1141

1142 1143

1203

1209

1219

1236

1238

1240 1241

1249

1251

1253

1255

1303

1307

1311

1317

1337

1340

1342 1343

1348 1349

1350 1351

1352 1353

1354 1355

1402 1403

20'

1404

1406 1407

1411

1417

1427

1436 1437

1438 1439

1440 1441

1442

1448 1449

1450 1451

1452 1453

1454 1455

1502

20'

1503

1505

1506

1509

1517

1526 1527

1528

1530

1536 1537

1538 1539

1540 1541

1542 1543

1548

1550

1552

1554

1602 1603

1604 1605

1607

1608

1610 1611

1615

1616

1618 1619

1621

1636 1637

1639

1640 1641

1642 1643

1702

1704

1706

1708

1710

1714

1718

1736

1738

1740

1742

703

705

707

713

719

721

727

729

731

733

737

739

741

743

802 803

806

809

813

815

818 819

820

826 827

828

830

833

836 837

838

840 841

842

902 903

906 907

909

912 913

914 915

917

919

921

926 927

928

931

932 933

936 937

941

946

Entrance

MIT Poster Area


Exhibits A–Z

Exhibits current as of March 30, 2019 MS Meeting Suite location

AAbbVie ................................................................................................................1527 Absorption Systems ...........................................................................................1436 Abyss Processing .................................................................................................919 AcuiSee ...............................................................................................................1241 Aeon Imaging LLC ................................................................................................ 931 Aequus Pharmaceuticals ....................................................................................1538Aerie Pharmaceuticals ....................................................................................... 1503 Aero Pump GmbH .............................................................................................. 1736 Alcon ................................................................................................................... 1417 Allergan ...............................................................................................................1102 Allergan Medical Affairs ......................................................................................1006 Alpha Independent Review Board, Inc. ............................................................... 1608 American Academy of Ophthalmology ...............................................................1714 Aptar Pharma ....................................................................................................... 928 AYOXXA Biosystems Inc. ...................................................................................... 705

BB. Braun CeGaT, LLC ......................................................................................... 1506 Bio-Concept Laboratories, Inc. .............................................................................703 Biocytogen .......................................................................................................... 1554 BioTime ..............................................................................................................MS14 Blueprint Genetics .............................................................................................. 1718 Boston Micromachines Corp. ................................................................................ 828 BrightFocus Foundation ........................................................................................ 913

CCalvert Laboratories, Inc. ...................................................................................... 914 Cambridge Research Systems ...........................................................................1621 Canon ................................................................................................................. 1539 CenterVue, Inc .................................................................................................... .1537 Cerebral Mechanics, Inc. ...................................................................................... 739 Charles River ...................................................................................................... 1219 Chengdu Kanghong Biotechnology Co., Ltd. ...................................................... 1351 CiToxLAB North America .................................................................................... 1030 Clearside Biomedical, Inc. .................................................................................. 1353 Cleveland Clinic Cole Eye Institute ....................................................................... 713 Clinical Edge, Inc. ................................................................................................1541 Comparative Biosciences, Inc. .............................................................................1016 Congressionally Directed Medical Research Programs (CDMRP) .................... MS13 Congruence Medical Solutions ...........................................................................1639 Covance, Inc. .......................................................................................................1348 Custom coILABorators Buffalo Innovations ........................................................ 1450 Cylite ................................................................................................................... 1619

DDiagnosys LLC ................................................................................................... 1517 Doheny Eye Institute (DIRC) ................................................................................ 707 Dompé Medical Affairs.......................................................................................... 840 Dove Medical Press ............................................................................................ 1706

Exhibits A–Z



EEllex .....................................................................................................................1502 Elsevier Inc. .........................................................................................................1108 Emmes .................................................................................................................826 Encompass Pharmaceutical Services, Inc. ........................................................ 1407 Epsilon .................................................................................................................. 936 European Association Vision Eye Research (EVER) ........................................... 731 Eversight .............................................................................................................. MS6Eversight ............................................................................................................... 727Excalibur Pathology ............................................................................................ 1440 Experimentica Ltd. ..............................................................................................1354 Exsera BioLabs .................................................................................................. 1704 Eye Pharma S.P.A. .............................................................................................. 1708 EyeCRO.............................................................................................................. 1337 EyeKor, Inc. ......................................................................................................... 1311 Eyenuk, Inc. ........................................................................................................ 1637 EyePoint Pharmaceuticals .................................................................................. 1542 EyeQue Corp. ..................................................................................................... 1742 EyeTech Digital Systems ......................................................................................837

FFareva ................................................................................................................. 1607 Foster Delivery Science ...................................................................................... 1536 Foundation Fighting Blindness .......................................................................... MS10

GGenentech, Inc. ..................................................................................................1103 Geuder AG ...........................................................................................................733 Gilead Sciences .................................................................................................. 1740 Glauconix Biosciences, Inc. ................................................................................ 1253 Gooch & Housego .............................................................................................. 1540 Good-Lite Company ............................................................................................. 802 Greenlight Clinical ...............................................................................................1552 Guardion Health Sciences ...................................................................................1509 Gyros, Inc. ...........................................................................................................1255 Gyroscope Therapeutics ......................................................................................1641

HHAI Laboratories, Inc. ............................................................................................909 Hamamatsu Pharma Research USA, Inc. ...........................................................1352 Hamilton Eye Institute/University of Tennessee Health Science Center ..............1710 He University .......................................................................................................1502 Heidelberg Engineering, Inc. .............................................................................. 1117Heidelberg Engineering, Inc. ................................................................. MS11, MS12

Iicare USA ...........................................................................................................1449Imagine Eyes .......................................................................................................1403 Imedos Systems GmbH ........................................................................................ 721


Exhibits A–Z


INCYTO Co., Ltd. ................................................................................................ 1349Innova Systems, Inc. ............................................................................................. 820 Integral BioSystems, LLC ..................................................................................... 813 International Society for Eye Research .............................................................. 1130 Iris Pharma ......................................................................................................... 1002

JJAMA Network .................................................................................................... 1406 Joinn Laboratories Co., Ltd. ................................................................................ 1442 Jorvec Corp. ....................................................................................................... 1041

KKeeler Instruments ............................................................................................... 903 Knight Therapeutics, Inc. ....................................................................................1548 Konan Medical USA, Inc. .................................................................................... 1007 Kugler Publications ............................................................................................. 1029

LLeica Microsystems .............................................................................................. 937 Lexitas Pharma Services, Inc. ............................................................................1618 Lions Eye Institute for Transplant and Research .................................................1136 Lions Gift of Sight ............................................................................................... 1437 Lions VisionGift .....................................................................................................815 LIV Medical Technoloty Inc. .................................................................................1141 LKC Technologies, Inc. ....................................................................................... 1003 LumiThera .......................................................................................................... 1142

MM&S Technologies ................................................................................................ 926 MacuLogix, Inc. ................................................................................................... 1143 Mallinckrodt Pharmaceuticals ............................................................................. 1251 Mary Ann Liebert Inc. ..........................................................................................1504 MedGenome, Inc. ............................................................................................... 1603 Medical Innovation Partners International (RE-ONE) ......................................... 1238 Medmont International ........................................................................................1615 Metrovision ......................................................................................................... 1236 MUHC-McGill University Eye Pathology & Translational Research Laboratory ..................................................................... 1543

NNational Disease Research Interchange ............................................................ 1140 National Eye Institute .......................................................................................... 1427 Natus Medical Incorporated ................................................................................. 912 Nemera ............................................................................................................... 1611 Nidek .................................................................................................................. 1019 NKT Photonics ...................................................................................................... 836 NOF America Corporation .................................................................................. 1036 Novartis .............................................................................................................. 1411 Novartis ............................................................................................................... MS2

OOakwood Labs .................................................................................................... 1343 Ocular Instruments ............................................................................................. 1026

Exhibits A–Z



Oculos ................................................................................................................1455 Oculus, Inc. ..........................................................................................................1032 OcuMetrics, Inc. .................................................................................................... 915 OcuScience ........................................................................................................ 1018 Ophthalmology Times ......................................................................................... 1042 Optoprobe Science Ltd. ........................................................................................809Optos Inc. ............................................................................................................. 906 Optovue, Inc. .........................................................................................................819 Optronics ............................................................................................................1610 Ora, Inc. ..............................................................................................................1303 Orbit Biomedical, Inc. ...........................................................................................MS5 OSOD, LLC ......................................................................................................... 1311 Oxymap ehf .......................................................................................................... 743

PPharmOptima, LLC ..............................................................................................1137PhenoSys GmbH ...................................................................................................921 Phoenix Technology Group ................................................................................. 1013 Powered Research ............................................................................................. 1530 Precision Vision .................................................................................................. 1126 PreventionGenetics ............................................................................................ 1640 Promedica International ..................................................................................... 1012 ProQR .................................................................................................................. MS7 ProQR ................................................................................................................. 1340

RRegeneron Pharmaceuticals .............................................................................. 1209 Reichert, Inc. .......................................................................................................1132 Remidio Innovative Solutions PVT LTD. .............................................................. 1342 RetinAi Medical GmbH ....................................................................................... 1043 Review of Ophthalmology/Jobson Publishing ..................................................... 1106 Roland Consult ................................................................................................... 1027 RxGen, Inc. ........................................................................................................... 806

SSanten ................................................................................................................ 1203 Saving Sight ......................................................................................................... 842 SDC .................................................................................................................... 1307 Second Sight Medical Products ............................................................................ 841 Shenyang Xingqi Pharmaceutical Co., Ltd. .......................................................... 933 Shin Nippon Biomedical Laboratories, Ltd. .........................................................1643 Shire (Medical Affairs) ......................................................................................... MS8 Shire (Medical Affairs) .......................................................................................... 827 Sichuan Primed Shines Bio-tech Co., Ltd. ..........................................................1441 Silgan Dispensing Systems .................................................................................1249 Singapore Eye Research Institute (SERI) .......................................................... 1033 Slack, Incorporated ............................................................................................... 917 Softcare Ltd. ......................................................................................................... 741 Spark Therapeutics ............................................................................................. 1109 STEMCELL Technologies, Inc. ........................................................................... 1642


Exhibits A–Z


Sterling IRB ........................................................................................................ 1402 Striata Technologies ............................................................................................1636 Studylog Systems, Inc. ..........................................................................................729 Syneos Health .......................................................................................................830

TTaylor & Francis Group ........................................................................................1404 Teledyne e2v .......................................................................................................1528 Topcon ..................................................................................................................MS1 Topcon ...................................................................................................................803 tpm taberna pro medicum GMbH ........................................................................1138 Translational Imaging Innovations........................................................................1448Trial Runners LLC ..................................................................................................927

UUnither Pharmaceuticals .....................................................................................1438

VVanrx Pharmasystems ...........................................................................................907 Vasoptic Medical ...................................................................................................941 Viewpoint Life Sciences, Inc. .................................................................................737 Vision Tiffany Inc. ...................................................................................................719 Visionix- Luneau Technology ...............................................................................1702 VO-CRO ..............................................................................................................1240 Volk Optical, Inc. ....................................................................................................902 Voxeleron LLC .......................................................................................................932

W Wasatch Photonics ..............................................................................................1037 WCCT Global Ophthalmology Research Center .................................................1550 Welch Allyn ............................................................................................................818 West China-Frontier PhamaTech Co.,Ltd. ............................................................1738 Wicab, Inc. ...........................................................................................................1605 Wolters Kluwer Health ..........................................................................................833 World Glaucoma Association ..............................................................................1031 World Health Organization .................................................................................1350 World Precision Instruments ................................................................................1526 WuXi AppTec – Laboratory Testing Division ........................................................1439

YYuYu Pharma ........................................................................................................MS4

ZZeiss ....................................................................................................................1317 Zilia ........................................................................................................................838

Exhibitor Descriptions


A

AbbVie ....................................................................................................... 1527Alexandra Wendt1 North Waukegan Rd.North Chicago, Ill. 60064847-935-8658; [email protected]; abbvie.com

AbbVie is a global, research-based biopharmaceutical company which combines the focus of a leading-edge biotech with the expertise and structure of a long-established pharmaceutical leader. AbbVie is committed to using unique approaches to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases.

Absorption Systems ................................................................................. 1436Tawny Britton436 Creamery Way, #600Exton, Pa. 19341610-280-7300; [email protected]; absorption.com

Absorption Systems is a Nonclinical CRO developing innovative services and solutions for the pharmaceutical, biotech, medical device and regenerative medicine industry. With over 80 years of combined experience in ocular research our team is dedicated to optimizing ocular models focused on improving outcomes. Our models include in vivo & ex vivo options for implants, small & large molecules, specialized tissue-based ADME models, disease models and more. Learn more: absorption.com/ocular

Abyss Processing....................................................................................... 919Michael Girard2 Jurong East St., 21Singapore 609601Singapore+65 910-10-541; [email protected]; abyssprocessing.com

Glaucoma is a complex disease affecting the 3D structures of the eye. Our team is dedicated to provide clinicians with companion software tools that will help them reduce blindness from glaucoma.

AcuiSee ..................................................................................................... 1241Jeff Jamison5512 Bob White Ave.Kalamazoo, Mich. 49009858-736-1359; [email protected]; acuisee.com

Acuisee offers an innovative method to measure true visual acuity in rodents. Our unique blend of hardware and software utilizes operant conditioning to train animals to a visual task and once trained, visual acuity and contrast sensitivity can be easily and quickly measured. The system requires little technician intervention and is free from user bias. Our devices are ideal for users new to visual testing as well as experienced users looking for an easier unbiased method to measure VA.

Aeon Imaging LLC ...................................................................................... 931Matthew Muller501 S. Madison St., Ste 103Bloomington, Ind. 47403812-822-2048; [email protected]; aeonimaging.com

Aeon Imaging develops NIR confocal retinal cameras for vision research and retinal disease screening. The unique line-scan technology of Aeon’s Digital Light Ophthalmoscope (DLO) rapidly reveals drusen and other RPE/photoreceptor defects, which are normally hidden in standard retinal images. Users can present custom visual stimuli at high resolution while monitoring the position of the retina.



Aequus Pharmaceuticals ......................................................................... 1538Natalie Bourre2820-200 Granville St.Vancouver, B.C. V6C 1S4Canada647-871-4628; [email protected]; aequuspharma.ca

Aequus is focused on bringing specialized therapeutics and devices to physicians and patients in Canada. Adding to our ophthalmic portfolio of Vistitan (bimatoprost 0.03%) for glaucoma, Aequus is thrilled to be the exclusive distributor for the Zepto® Precision Pulse Capsulotomy System in Canada. Please join us at the Aequus booth to speak with us directly, or for more information, visit aequuspharma.ca. Follow us on LinkedIn (aequus-pharmaceuticals/) and on Twitter (AequusPharma).

Aerie Pharmaceuticals ............................................................................. 1503Storm Charbonneau2030 Main St.Suite 1500Irvine, Calif. 92614949-526-8700; [email protected]; aeriepharma.com

Aerie is an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma and other diseases of the eye. Aerie’s first product, Rhopressa(r) (netarsudil ophthalmic solution) 0.02%, for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension, was recently FDA approved.

Aero Pump GmbH ......................................................................................1736 Rouven KrausDr.-Ruben-Rausing-Str. 5Hochheim am Main 65239Germany+49 6146603-115; [email protected]; aeropump.de

AERO PUMP GmbH is a leading manufacturer of high precision application systems for the pharmaceutical and healthcare industry with a state-of-the-art production facility. Our sophisticated Ophthalmic Multidose System is widely established in the OTC and prescription drugs market. Its modular design allows a maximum level of flexibility to meet the individual requirements of our customers.

Alcon ......................................................................................................... 1417Erin Moore6201 South Freeway, TC-33Fort Worth, Texas 76134817-568-6077; [email protected]; alcon.com

Alcon, a global leader in eye care, offers the broadest portfolio of products to enhance sight and improve people’s lives. Our products touch the lives of more than 285 million people each year living with conditions like cataracts, glaucoma, retinal diseases, dry eye and refractive errors, and there are millions more who are waiting for solutions to meet their eye care needs. For more information, visit alcon.com.

Allergan ..................................................................................................... 1102Mary Mikels2525 Dupont Dr.Irvine, Calif. 92612714-246-4500; [email protected]; allergan.com

Allergan plc (NYSE: AGN), is a bold, global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. For more information, visit Allergan’s website at Allergan.com.



Allergan Medical Affairs ........................................................................... 1006Mary Mikels2525 Dupont Dr.Irvine, Calif. 92612714-246-4500; [email protected]; allergan.com

Allergan plc (NYSE: AGN), is a bold, global pharmaceutical company focused on developing, manufacturing and commercializing branded pharmaceuticals, devices and biologic products for patients around the world. For more information, visit Allergan’s website at Allergan.com.

Alpha Independent Review Board, Inc. ................................................... 1608Marianne Thornton1001 Avenida Pico, Suite C 497San Clemente, Calif. 92673949-542-3882; [email protected];alphairb.com

American Academy of Ophthalmology................................................... 1714Customer Service655 Beach St.San Francisco, Calif. 94109415-561-8540; [email protected]; aao.org

The American Academy of Ophthalmology is a global community of eye physicians and surgeons who are dedicated to protecting sight and empowering lives. As the leader in ophthalmic education, we offer a wealth of innovative resources, such as the ONE® Network, EyeWiki® and IRIS® Registry. Join us for AAO 2019 in San Francisco, Oct. 12 – 15.

Aptar Pharma .............................................................................................. 928Pamela Moran250 North Route 303Congers, N.Y. 10920845-639-3700; [email protected]; aptar.com

At Aptar Pharma, we have been setting the standard for the drug delivery industry for decades and continue to break new ground in innovative healthcare technologies. Respected for our proven regulatory expertise, we simplify and accelerate our partners’ path through approval and compliance processes. We harness healthcare trends to continuously offer innovative, convenient and safe products for all customers.

AYOXXA Biosystems Inc. ........................................................................... 705Santiago Fadul1 Broadway, 14th FloorCambridge, Mass. 02142760-277-3280; [email protected]; ayoxxa.com

AYOXXA’s offers LUNARIS™ Multiplex Ophthalmology Kits for human and mouse samples optimized to run on AYOXXA’s platform that is specifically designed for multiple protein analysis of highly precious and scarce samples. Offering optimized preparation protocols for ocular fluids (vitreous and aqueous humor) requiring less than 5 ?L sample volume, AYOXXA enable researchers to study eye disease underlying molecular mechanisms.



B

B. Braun CeGaT, LLC ................................................................................ 1506 Dawn Brooke824 Twelfth Ave. Bethlehem, Pa. 18018-3524773-255-3611; [email protected]; bbrauncegat.com

Our genetic diagnostic laboratory offers a wide range of services for the sequencing and analysis of genetic information. We have expertise in the genetic causes of eye disease having analyzed thousands of patients with these diseases. Our Panel for Eye Diseases covers 24 subpanels with 384 genes known to be associated with retinal and related disorders, our sequencing is at a high coverage (800-1000x) in order to increase the probability of finding causative variants in a patient’s DNA.

Bio-Concept Laboratories, Inc................................................................... 703Francis Smith13 Industrial WaySalem, N.H. 03079603-734-4990, ext. 2001; [email protected]; bioconcept.com

We offer a full range of formulation development, microbiology, analytical chemistry, process development, stability programs and aseptic clinical manufacturing in ophthalmic plastic bottles and IVT serum glass vials. Stop by our booth at space 703

Biocytogen ................................................................................................ 1554Yanan Li50 C Audubon Rd.Wakefield, Mass. 01880781-587-3558; [email protected]; biocytogen.com

Bioctogen Boston Corporation is a Biotech CRO offering custom gene targeting services, featuring CRISPR-based EGE® technology, which increases large fragment knockin efficiency by 10-20-fold. Biocytogen also offers Immuno-Oncology drug validation services that rely on independently-developed humanized immune-checkpoint mouse models (e.g. B-hPD-1 mice) and immune-deficient, human immune system-reconstituted mice (B-NDG model).

BioTime ....................................................................................................MS14Rachel Klass1010 Atlantic Ave.,#102Alameda, Calif. 94501860-554-8806; [email protected]; biotimeinc.com

BioTime is leading the next revolution in medicine – regenerative medicine. BioTime is a late stage clinical biotechnology company focused on developing and commercializing products addressing degenerative diseases. Our Company’s current clinical programs are targeting three primary sectors: Aesthetics, Ophthalmology, Cell/drug delivery. Together with our subsidiaries, we have a strong focus on improving patients’ lives, and we are advancing clinical trials and a robust pipeline.

Blueprint Genetics .................................................................................... 1718Heidi Silander1268 Missouri St.San Francisco, Calif. 94107630-229-8325; [email protected]; blueprintgenetics.com

Blueprint Genetics delivers quality genetics testing to the global clinical community. We provide clinicians, and their patients, with comprehensive and high-quality tools and resources for diagnostics of genetic conditions. Through our innovative laboratory process, latest sequencing technology with AI empowered data-crunching tools, and world-class professionals, we are advancing mainstream healthcare.



Boston Micromachines Corp. .................................................................... 828Michael Feinberg30 Spinelli Place, Suite 103Cambridge, Mass. 02138617-868-4178; [email protected]; bostonmicromachines.com

Founded in 1999, Boston Micromachines Corporation (BMC) is a designer of advanced retinal imaging instrumentation and is the leading provider of microelectromechanical systems (MEMS) - based mirror products. BMC’s customizable Apaeros Retinal Imaging Systems are adaptive optics scanning laser ophthalmoscopes (AOSLO). This family of instruments is designed for best-in-class performance and has the ability to add the latest features developed by leaders in retinal imaging instrument development.

BrightFocus Foundation ............................................................................ 913Kara Summers22512 Gateway Center Dr.Clarksburg, Md. 20871301-948-3244; [email protected]; brightfocus.org

BrightFocus Foundation is a donor-supported charity that funds research seeking cures for age-related macular degeneration, glaucoma, and Alzheimer’s disease and provides the public with information about risk factors, preventative lifestyles, available treatments and coping strategies. Since inception, BrightFocus has committed more than $190 million in support of its research aims. For more information, visit brightfocus.org.

C

Calvert Laboratories, Inc. ........................................................................... 914Joe Winslow130 Discovery Dr.Scott Technology ParkScott Township, Pa. 18447570-586-2411; [email protected]; calvertlabs.com

Calvert Labs is a collaborative preclinical CRO bringing extensive experience, an innovative, solutions-oriented approach and unsurpassed performance to your drug development program. We offer a range of lead identification and optimization services and a wide array of preclinical services in most therapeutic areas to meet your R&D needs, helping you navigate your GLP testing needs prior to advancing to clinical trials.

Cambridge Research Systems ................................................................ 1621Carol Luscombe80 Riverside EstateSir Thomas Longley Rd.Rochester, Kent ME2 4BHU.K.+44 1634-720707; [email protected]; psychophysics.uk

Precise psychophysical assessment of visual function. Ready-to-run tests for measuring visual acuity and spatial, temporal, colour, and depth discrimination in individuals of all ages with normal or defective vision. Sufficiently sensitive to examine small changes in visual function used to monitor the progression or remission of disease quantitatively over time. Ideal for detecting subtle changes in contrast sensitivity at scotopic and mesopic levels as a biomarker of early onset of AMD.



Canon ........................................................................................................ 1539Jasbir Banwait8000 Mississauga Rd.Brampton, ON. L6Y 5Z7Canada905-863-8309; [email protected]; canon.ca

Canon’s extensive line of ophthalmic diagnostic equipment spans cutting-edge digital retinal imaging systems, optical coherence tomography systems featuring Angiography, fully automatic Ref-Keratometers and Tonometers, as well as associated intuitive control software to enhance patient care.

CenterVue, Inc. .......................................................................................... 1537Keshia Sanchez979 Corporate WayFremont, Calif. 95439408-988-8404; [email protected]; centervue.com

CenterVue develops highly advanced and easy to use diagnostic systems for early detection and management of sight-threatening pathologies such as Diabetic Retinopathy, Glaucoma and Macular Degeneration. Our innovative devices employ imaging principles and fluid functionality that aid in precise diagnosis and efficient workflow. The CenterVue portfolio includes the DRS Automated Fundus Camera, the EIDON Wide-Field Confocal Scanner, the MAIA Microperimeter and the new COMPASS Fundus Perimeter.

Cerebral Mechanics, Inc. ............................................................................ 739Shauna Pringle16 East Glen Place, SEMedicine Hat, AB. T1B 2X1Canada403-360-3195; [email protected]; cerebralmechanics.com

CerebralMechanics Inc. develops, markets, and supports software, instruments, and integrated systems for behavioural neuroscience.

Charles River ............................................................................................ 1219Shannon Spiliotis251 Ballardvale St.Wilmington, Mass. 01887-1000781-222-7319; [email protected]; criver.com

Charles River offers an integrated approach to ophthalmology research to guide new drugs from bench to market. Compounds or implantable devices intended for ocular treatment can be assessed for efficacy and safety. Ocular effects of compounds targeted to non-ocular conditions can also be characterized. GLP studies either as stand-alone studies or as part of general and specialty toxicology programs as well as Non-GLP pilot or proof-of-concept studies can also be conducted.

Chengdu Kanghong Biotechnology Co., Ltd. ........................................ 1351Anna Oughton100 Enterprise Dr., Suite 301Rockaway, N.J. 07866215-353-6621; [email protected]; cnkh.com

Kanghong Pharmaceutical Group is a modern pharmaceutical enterprise group dedicated to the R&D, production, sales and after-sales service of proprietary Chinese medicines, chemical medicines and biologic products. We believe our company purpose is to fundamentally improve patients lives and promote the progress of human health. We hold offices in both the US and China with the company headquarters being located in Chengdu in the Sichuan Province.



CiToxLAB North America ......................................................................... 1030Sophie Dubois445 Boulevard Armand FrappierLaval, QC.H7V 4B3Canada450-973-2240; [email protected]; citoxlab.com/en

Citoxlab is a full-service non-clinical CRO, serving the Pharma/Biotech and Chemical/Agrochemical/Cosmetic industries through nine state-of-the-art GLP facilities in North America and Europe. Our service portfolio includes general and specialty toxicology (reproductive, juvenile, infusion, inhalation, carcinogenicity, transgenics), safety pharmacology (including EEGs and CV/CNS electrophysiology), genomics, biomarkers, bioanalysis, immunology, ecotoxicology, medical device and radiation safety.

Clearside Biomedical, Inc. ....................................................................... 1353900 Northpoint ParkwayAlpharetta, Ga. 30005678-270-3631; [email protected]; clearsidebio.com

Cleveland Clinic Cole Eye Institute ........................................................... 713Alan Steinberger9500 Euclid Ave.Cleveland, Ohio 44195216-444-5832;[email protected]; ccf.org

Cole Eye Institute is one of the few dedicated, comprehensive eye institutes in the world. Our internationally recognized staff diagnoses and treats the entire spectrum of eye conditions, managing over 310,000 clinical visits, performing more than 16,000 surgeries and 1,300 refractive surgical cases annually. It is one of 26 clinical and special expertise institutes at Cleveland Clinic, a nonprofit academic medical center ranked No. 2 hospital in the country by U.S. News & World Report.

Clinical Edge, Inc. ..................................................................................... 1541Lisa Laskowski939 West North Ave., Suite 750Chicago, Ill. 60642773-218-6449; [email protected]; clinicaledgeinc.com

Clinical Edge, Inc. provides certification in all areas of visual function including BCVA, low luminance, reading tests and IOP in order to assure a high level of quality and consistency amongst clinical sites participating in the conduct of ophthalmology drug, biologic, and device trials. Our Certifiers are licensed optometrists and ophthalmologists, with added experience in serving patients with low-vision. Our Team of professionals has an unparalleled level of expertise and experience.

Comparative Biosciences, Inc. ............................................................... 1016Rachel Stainton786 Lucerne Dr.Sunnyvale, Calif.94085408-738-8074; [email protected]; compbio.com

CBI provides the best resources and quality service to all sectors of the biomedical community. With a multitude of expertise, we are able to serve pharmaceutical and biotech companies as well as academic, industrial and governmental organizations. CBI’s extensive experience performing ocular GLP and non-GLP preclinical toxicology, efficacy, pharmacology, pharmacokinetics-pharmacodynamics, histopathology, and safety studies make us the ideal collaborator for your next scientific breakthrough.



Congressionally Directed Medical Research Programs (CDMRP) ................................................................MS13Tian Wang1053 Patchel St.Fort Detrick, Md. 21702301-619-3693; [email protected]; cdmrp.army.mil

CDMRP originated in 1992 via a Congressional appropriation to foster novel approaches to biomedical research. Today, CDMRP manages 30 programs totaling >$1B in annual appropriation for the Department of Defense and U. S. Army Medical Research & Materiel Command. The VRP (https://cdmrp.army.mil/vrp/default) was established in 2009 to fund impactful military-relevant vision research. Between FY09-17, the VRP has funded 83 awards ranging from hypothesis development to clinical trials.

Congruence Medical Solutions ............................................................... 1639Gautam Shetty3000 Falls Rd., 200ABaltimore, Md. 21211216-272-5521; [email protected]; congruencemed.com

Congruence Medical Solutions, LLC is a developer of injection devices for intraocular drug delivery. We have devices for accurate, precise injections for use in animals (as low as 0.5 microliter) and for use in human applications (5 microliters and above). All our systems use standard hypodermic needles and can be provided sterile, ready to use.

Covance, Inc. ............................................................................................ 1348Terri Leigh Rhody3301 Kinsman Blvd.Madison, Wis. 53704608-245-7084;[email protected]; covance.com

Covance Inc., the drug development business of Laboratory Corporation of America Holdings (LabCorp) headquartered in Princeton, New Jersey, USA, is the world’s most comprehensive drug development company, dedicated to advancing healthcare and delivering Solutions Made Real®. Information on Covance’s solutions can be obtained through its website at covance.com.

Custom coILABorators Buffalo Innovations .......................................... 1450Mark Butler6880 Heise Rd.Clarence Center, N.Y. 14032716-725-5781; [email protected]; buffaloinnovations.com

Cylite .......................................................................................................... 1619Steve Frisken7/45 Normanby Rd,Nottinghill, Vic. 3168Australia+61 4-0128-7047; [email protected]; cyliteoptics.com

Cylite’s Hyperparallel OCT (HP-OCT) technology can acquire over 1000 simultaneous A-scans in one millisecond, freezing eye movement and allowing, for the first time in a commercial instrument, accurate in-vivo measurements of anterior ocular surface topography using OCT. Based on fully-automated image acquisition, Cylite’s HP-OCT instrument also provides axial length measurement, high resolution volumetric imaging and volumetric retinal imaging.



D

Diagnosys LLC ......................................................................................... 1517Anne Doran55 Technology Dr., Suite 100Lowell, Mass. 01851978-458-1600;[email protected]; diagnosysllc.com

Celeris high-throughput ERG + VEP solution for disease research, drug discovery, gene and stem cell therapy in rodent and small animals models lets you can examine the entire visual system from photoreceptor to visual cortex. Clinical ERG, VEP, and Pyschophysicial testing including Full-Field Scotopic Threshold (FST) and Dark Adaptometry (DA) are useful for functional examination and monitoring of disease progression in Clinics, Operating Rooms, Pediatrics, Private Practices, and beyond.

Doheny Eye Institute (DIRC) ...................................................................... 707Cecilia Zamudio1355 San Pablo St.Los Angeles, Calif. 90033323-342-7101; [email protected]; doheny.org

Doheny Eye Institute, affiliated with UCLA Stein Eye Institute, is a global leader in vision research. Our physician-scientists lead the quest to improve vision—from precise diagnostic and analytic capacities of optical coherence tomography to history-making gene therapy that treats Leber’s hereditary optic neuropathy, to new methodologies for tracking aqueous fluid outflow in patients with glaucoma, and much, much more. Visit our booth to learn about our research programs and meet the team.

Dompé Medical Affairs ............................................................................... 840Elena MuttoniVia Santa Lucia,6Milan 20122Italy+39 063-750-1035; [email protected]; dompe.com

Dove Medical Press .................................................................................. 1706Sandra LeBeechfield House Winterton WayMacclesfield, SK11 0LPU.K.+44 1626-509-130; [email protected]; dovepress.com

Dove Medical Press (dovepress.com) is an open access Publisher of 90+ peer reviewed biomedical and scientific journals, which focus on medicine, drug treatment, clinical risk management, outcomes research and adherence across a breadth of disease states and technologies, biology and basic sciences. The benefits of publishing in our open access journals include wider dissemination, increased visibility, better impact and increased downloads of your articles. Come visit us at booth 1706.

E

Ellex ........................................................................................................... 1502Kylie Brown7138 Shady Oak Rd.Minneapolis, Minn. 55344800-824-7444; [email protected]; ellex.com

Ellex Medical provides a comprehensive range of laser and imaging products for the diagnosis and treatment of cataract, glaucoma and retinal conditions. With our head office and manufacturing based in Adelaide, Australia, Ellex has sold more than 25,000 Ellex-branded laser and ultrasound systems worldwide.



Elsevier Inc. ............................................................................................... 1108Jillian Ruggieri1600 JFK Blvd., Suite 1800Philadelphia, Pa. 19103215-239-3900; [email protected]; elsevierhealth.com

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, and deliver better care.

Emmes ......................................................................................................... 826Kimberly Dawkins401 North Washington St., Suite 700Rockville, Md. 20850301-251-1161, ext. 236; [email protected]; emmes.com

Emmes clinical trials and research studies make a difference in developing new and improved treatment options and preventing threats to public health. A collaboration with Emmes is your assurance of excellence in the important areas of public health, quality visual function certification services, and electronic visual acuity assessment. Please stop by our booth, meet our representatives, and find out what a research collaboration with Emmes is all about.

Encompass Pharmaceutical Services, Inc. ............................................ 1407Rick Coulon150 Technology Parkway, N.W.Norcross, Ga. 30092770-248-4501, ext. 260; [email protected]; encompass-pharma.com

We offer a full range of ophthalmic drug development and formulation services from pre-formulation through manufacturing scale-up including: -Preclinical Support -Consulting -Drug Formulation -Drug Delivery -Analytical Support -Manufacturing Process Development -Clinical Supplies Manufacturing We have proprietary in-vitro models & drug delivery technologies to assist our clients in the efficient evaluation, & selection formulations. Our PROLOC delivery technology offers a 8 hour drug release profile.

Epsilon ......................................................................................................... 936Mohammed Ibrahim13851 Roswell Ave. Suite IChino, Calif. 91710909-984-4614; [email protected]; epsilonusa.com

Epsilon USA is a custom manufacturer of hand held surgical instruments and aluminum surgical trays. Innovation is our specialty. New instrument designs and ideas are welcomed. Thank You.

European Association Vision Eye Research (EVER) ............................... 731Giuliana Giardina Viale Matteotti, 7 - 50121 Florence, Italy +39 055 5035343; ever.be

EVER, the European Association for Vision and Eye Research, is currently the leading ophthalmological research association in Europe which covers all areas of ophthalmology and the visual sciences. Membership is open to individuals of any nationality engaging in or with an interest in ophthalmic and vision research. The EVER 2019 congress will be held in France at the Nice Acropolis Convention Center from October 17-19, 2019.



Eversight ....................................................................................................MS6Colleen Vrba4889 Venture Dr.Ann Arbor, Mich. 48108312-469-5552; [email protected]; eversightvision.org

Eversight is a global network of eye banks restoring sight and preventing blindness through donation, transplantation and research. We accelerate discoveries in vision research by delivering human ocular tissue and critical funding to scientists seeking cures for eye diseases. The Eversight Vision Research Registry & Biorepository, launching in 2018, will connect researchers with well-characterized ocular tissue accompanied by detailed medical records.

Eversight ..................................................................................................... 727Colleen Vrba4889 Venture Dr.Ann Arbor, Mich. 48108312-469-5552; [email protected]; eversightvision.org

Eversight is a global network of eye banks restoring sight and preventing blindness through donation, transplantation and research. We accelerate discoveries in vision research by delivering human ocular tissue and critical funding to scientists seeking cures for eye diseases. The Eversight Vision Research Registry & Biorepository, launching in 2018, will connect researchers with well-characterized ocular tissue accompanied by detailed medical records.

Excalibur Pathology ................................................................................. 1440Paula Pierce5830 N. Blue Lake Dr.Norman, Okla. 73069-8057405-570-6679; [email protected]; excaliburpathology.com

Ophthalmic Histology Service All Species

Experimentica Ltd..................................................................................... 1354Giedrius KalesnykasMicrokatu 1, P.O. Box 1188Kuopio, Finland 8122+358-40-930-7087; [email protected]; experimentica.com

Experimentica Ltd. is a contract research organization dedicated to developing and offering preclinical ocular models and services to clients in the pharmaceutical, biotech and academic sectors.

Exsera BioLabs ......................................................................................... 1704Julie Misayvanh1775 N. Aurora Court, Mail Stop B115, Room 3105Aurora, Colo. 80045303-724-6602; [email protected]; exserabiolabs.org

Let us introduce Exsera BioLabs, your source for complement testing. While our name may not be familiar, our expertise is evident. Our Director has written >100 Principal Investigator reports and has overseen many more studies. Combine that with a team with decades of experience in complement testing, Exsera BioLabs has the experience to exceed your expectations. We have a commitment to providing quality and timely results with the insight and expertise that makes a difference.



Eye Pharma S.P.A. .................................................................................... 1708Elena MeloniVia Francesca Saverio Borghero 916148 Genova, Italy786-218-7339; [email protected]; eyepharma.com

Thanks to advance technology and research we develop products and formulas from natural extracts. Our products are clinically studied and tested. We collaborate with several of the most important international research centers to create products that improve patients quality of life. Our objective is to slow down diseases progression with the correct intake of food supplements. Health and well-being are the cornerstones of the company’s commitment.

EyeCRO ..................................................................................................... 1337Rafal Farjo5301 N. Beverly Dr.Oklahoma City, Okla. 73105405-604-8954; [email protected]; eyecro.com

Our team has decades of experience utilizing ophthalmic animal models for drug development. We specialize in preclinical ophthalmic studies of pharmacology/efficacy, PK/tox, and eyedrop formulation development. Efficacy models include dry eye, optic nerve crush, allergic conjunctivitis, corneal NV, laser-induced CNV, STZ-induced diabetes, ischemia/reperfusion, inherited retinal degenerations, quantification of A2E/retinoids, light-induced retinal degeneration, OIR, and autoimmune uveitis.

EyeKor, Inc. ................................................................................................ 1311Yijun Huang6527 Normandy Ln., Suite 100Madison, Wis. 53719608-206-3614; [email protected]; eyekor.com

EyeKor provides image management and analysis services for ophthalmic clinical and preclinical studies through an innovative technology platform - EXCELSIOR™. From site certification through grading data export, EyeKor manages each step of clinical trial imaging. Data and images are easily shared between clinical sites, reading centers, CROs and sponsors. Ease of access and workflow control makes managing global ophthalmic trials with multiple reading centers not only feasible, but practical.

Eyenuk, Inc. ............................................................................................... 1637Alejandro Quinones5850 Canoga Ave.Woodland Hills, Calif. 91367818-835-3585; [email protected];

Eyenuk Inc., is a global artificial intelligence (AI) medical technology company and the leader in real-world AI Eye Screening™ for autonomous disease detection and AI Predictive Biomarkers™ for risk assessment and disease surveillance. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life- and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk, and Alzheimer’s disease.

EyePoint Pharmaceuticals ....................................................................... 1542Don Manser110 Allen Rd., 2nd FlrBasking Ridge, N.J. 07920856-287-5858; [email protected]

EyePoint Pharmaceuticals, Inc. is a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products in indications with high unmet medical need to help improve the lives of patients with serious eye disorders.



EyeQue Corp. ............................................................................................ 1742Jamiee Neal39608 Eureka Dr.Newark, Calif. 94560415-624-7672; [email protected]

EyeQue is on a global mission to elevate eye care. Based on revolutionary patented technology, EyeQue is bringing self-administered eye tests to billions of people around the world, many of whom may not have had the opportunity to test their eyes and correct their vision without access to these low cost, convenient solutions. Our at home vision testing solutions include the award-winning Personal Vision Tracker, The EyeQue Insight, the award-winning VisionCheck, PDCheck, and The EyeQue Eye.

EyeTech Digital Systems ........................................................................... 837Simon Prosser1128 East Barwick Dr., Suite 1Mesa, Ariz. 85203602-672-9315; [email protected]; eyetechds.com

EyeTech Digital Systems provides custom eye tracking solutions for both medical device and analytic/ research applications. Our dedicated and experienced team of engineers have been pioneering eye tracking technology for over 23 years. We pride ourselves in delivering innovative and cutting edge technology to meet our clients needs.

F

Fareva ........................................................................................................ 1607Robert Klehr24 West 57th St., Ste 505New York, N.Y. 10019908-813-8595; [email protected]; fareva.com/pharmaceuticalindustry.html

Fareva is a privately held, global CDMO developing and manufacturing OTC, prescription and cosmetic products. Fareva can develop and manufacture Ophthalmic products in conventional/preservative free bottles, blow, fill and seal (BFS) containers, and ophthalmic ointments and gels in tubes.To support our clients, our 40 sites are strategically located in the United States and Europe. We also produce injectable, tablets/capsules, creams, gels, oral liquids/suspensions, and food supplements.

Foster Delivery Science ........................................................................... 1536Amy Snow36 Ridge Rd.Putnam, Conn. 06260860-630-4524; [email protected]

Foster Delivery Science is a contract manufacturer of drug/polymer blends, specializing in cGMP hot melt extrusion for solid oral dose and implantable drug delivery products. Foster DS offers a comprehensive range of development & manufacturing services, from pre-formulation studies, to solubility screenings, and formulation/process development and scale. Downstream processing capabilities allow for custom shaping of drug delivery dosage forms; pellets, fibers, films, tubes and pressed tablets.



Foundation Fighting Blindness ..............................................................MS10Corrie Simkin-Brocato7168 Columbia Gateway Dr., Suite 100Columbia, Md. 21046410-423-0600; [email protected]; blindness.org

The Foundation Fighting Blindness is the world’s leading private funder of retinal disease research. On an annual basis, the Foundation Fighting Blindness funds more than 100 research grants. The research projects are conducted by more than 150 research investigators at institutions, eye hospitals, and universities in the Australia, England, France, Germany, The Netherlands, Italy, Israel, and Mexico.

Genentech, Inc. ......................................................................................... 1103Dan Imamoto1 DNA WaySouth San Francisco, Calif. 94080650-255-1000; [email protected]; gene.com

Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for over 40 years. Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions. We are among the world’s leading biotech companies, with multiple products on the market and a promising development pipeline.

Geuder AG ................................................................................................... 733Michaela WeisHertzstr. 4HeidelbergBaden-Wurttemberg, 69126Germany+49 6221-306-705; [email protected]; http: geuder.com

The Geuder Group represents innovation and research. Modern procedures cannot be performed without precise instruments, innovative systems, highly effective and well tolerated vitreoretinal fluids and vitreous substitutes. By providing such products, the Geuder Group aims to contribute to the success and ongoing development of the procedures in anterior and posterior eye segment surgeries.

Gilead Sciences ........................................................................................ 1740Chrissie Chew333 Lakeside Dr.Foster City, Calif.94404650-574-3000; [email protected]; gilead.com

Gilead’s research and development program identifies and evaluates investigational compounds that show potential to advance the treatment of life-threatening diseases in areas of unmet medical need. Gilead is advancing a pipeline of novel investigational agents for inflammatory diseases, addressing multiple targets with potential application across a broad range of disorders.

Glauconix Biosciences, Inc. .................................................................... 1253Feryan Ahmed257 Fuller Rd.Albany, N.Y.12203518-542-5815; [email protected]; glauconix-biosciences.com/

Glauconix Biosciences novel tissue models and proprietary physiologic testing platforms have been used from discovery through clinical efforts. These microphysiological systems can detect induced changes in intraocular pressure at physiologically relevant levels with direct translatable, species and clinically relevant results. The models provide long-term dynamic studies, combined with human-based healthy or disease models, and able to test diverse genetic populations.



Gooch & Housego .................................................................................... 1540Mark StevensDowlish FordIlminster, TA19 0PFU.K.+44 1460 256440; [email protected]; goochandhousego.com

Gooch & Housego researches, designs and manufactures high quality optical components and optical sub-systems for the biomedical imaging and laser surgery markets. Our acousto-optic and electro optic laser control devices are at the heart of many medical lasers systems including LASIK. We offer contract manufacturing of components, subsystems with FDA, CFDA, and CEA approval.

Good-Lite Company ................................................................................... 802Donovan Livingston1155 Jansen Farm Dr.Elgin, Ill. 60123847-841-1145; [email protected]; good-lite.com

Manufacturer of the Lea Test System including Lea Symbols and Lea Numbers. Complete range of vision testing products including the new self-calibrating ETDRS Standardized Viewer. Cortical Vision Assessment, high and low contrast, color vision, preferential looking tests will be on display at ARVO 2019

Greenlight Clinical .................................................................................... 1552Amy Nguyen134 William St.Woolloomooloo, N.S.W.02011Australia+61 2-9191-0640; [email protected]; greenlightclinical.com

GreenLight Clinical is a global, full-service CRO with headquarters in Australia and offices throughout the Americas, Asia and Europe. As an ophthalmology-focused CRO, GreenLight benefits from senior management who have taken candidates from discovery through preclinical and clinical phases of development onward to marketing approval. The people we hire are the best in the industry and all our services are tailored. greenlightclinical.com

Guardion Health Sciences ....................................................................... 1509Brian Wilson15150 Ave of Science, Suite 200San Diego, Calif. 92128858-999-5935; [email protected]

Guardion Health Sciences offers prescription medial nutrition and highly accurate measuring tools, to provide the first evidence based protocol designed to change the course of common eye diseases. Guardion has Lumega-Z, the only ocular health food on the market, providing the critical carotenoids needed to restore & maintain the macular pigment, alongside proprietary devices, the MapCat and VectorVision, to accurately measure macular pigment optical density and contrast sensitivity

Gyros, Inc. ................................................................................................. 1255Joy Concepcion30 Technology Dr., Suite 1FWarren, N.J. 07059650-755-0011; [email protected]; gyros.com

Gyros manufactures innovative laboratory platforms and kits that maximize productivity by miniaturizing and automating immunoassays at nanoliter-scale. Gyrolab open platforms accelerate assay development and bioanalysis for ocular research in R&D and preclinical tox. Its’ affinity flow-through format, eliminates incubations with shorter run times. Gyros’ technology ensures high reproducibility and productivity with Gyrolab platforms that process up to 112 data points per CD in an hour.



Gyroscope Therapeutics .......................................................................... 1641Kim SmithStevenage Bio-Science Catalyst, Gunnels Wood RoadStevenage Herts SG1 2FXU.K.+44 (0)1438-906770; [email protected]; gyroscopetx.com

H

HAI Laboratories, Inc. ................................................................................. 909Vivian Xue320 Massachusetts Ave.Lexington, Mass. 02420781-862-9884; [email protected]; hailabs.com

HAI Laboratories, the leading US manufacturer of ophthalmic equipment, specializes in clinical (non-contact and contact), eye bank and laboratory specular microscopes, digital video slit lamps, full exam-lane equipment, and microsurgical instruments. Our software features live sequence imaging, comprehensive analysis and image-data correlation. We offer custom manufacturing for research and studies. HAI Labs also supply best quality & affordable surgical instrument at the show.

Hamamatsu Pharma Research USA, Inc. ............................................... 1352Ikuo Hayashi4660 La Jolla Village Dr., Ste 100San Diego, Calif. 92122858-535-4819; [email protected]; hpharmausa.com

Hamamatsu Pharma Research is a Japan-based preclinical CRO specializing in pharmacological efficacy studies using nonhuman primate disease models including macular degeneration (wet- and dry-type) and glaucoma. As nonhuman primates are phylogenetically and physiologically more similar to humans than rodents, our NHP efficacy models will help you to obtain preclinical POC relevant to clinical efficacy. We support development of your novel therapeutics with our efficacy models!

Hamilton Eye Institute/ University of Tennessee Health Science Center .................................... 1710Monique Dailey930 Madison Ave., Suite 470Memphis, Tenn. 38163901-448-4133; [email protected]; uthsc.edu

The researchers at the Hamilton Eye Institute undertake research that will advance ophthalmic care for patients of all ages. Working together, researchers and clinicians collaborate on projects that address a variety of conditions, including dry eye disease, glaucoma, traumatic injuries, age-related macular degeneration, Keratoconus and diabetic retinopathy among other conditions. An engaging environment provides the optimum setting for research and education.

He University ............................................................................................. 1502Liang YangNo. 66 Sishui St, Hunnan DistrictShenyang, P.R. 110163China+86 15142071006; [email protected]



Heidelberg Engineering, Inc. ................................................................... 1117Marc Crosier10 Forge ParkwayFranklin, Mass. 02038508-530-7847; [email protected]; heidelbergengineering.com

Please visit Heidelberg Engineering at booth 1117

Heidelberg Engineering, Inc. ...................................................... MS11, MS12Marc Crosier10 Forge ParkwayFranklin, Mass. 02038508-530-7847; [email protected]; heidelbergengineering.com

Please visit Heidelberg Engineering at booth 1117

I

icare USA ................................................................................................... 1449John Floyd4700 Falls of Neuse Rd., Suite 245Raleigh, N.C. 27609888-422-7313; [email protected]; icare-usa.com

Icare® is an advanced medical technology company which manufactures Icare® tonometers. Our devices use patented rebound technology to measure intraocular pressure. A light-weight probe makes momentary contact with the cornea, and requires no drops, air or specialized skills for its use.

Imagine Eyes ............................................................................................. 1403Laurent Vabre18 Rue Charles de GaulleOrsay, 91400France+33 164-86-15-66; [email protected]; imagine-eyes.com

Imagine Eyes is a leading pioneer in ophthalmic imaging. Its rtx1 product enables examining patients’ retinas with an unprecedented level of detail: the cellular level. Thanks to adaptive optics technology, the rtx1 images individual cells, blood vessel walls and microscopic lesions in the retina with the highest resolution on the market. Imagine Eyes also offers software for driving quick examinations, tracking microscopic changes over time, and analyzing cellular and microvascular biomarkers.

Imedos Systems GmbH ............................................................................. 721Cornelia SchmidtAm Nasstal 4Jena Thuringia D-07751Germany 67552+49 3641-63960; [email protected]; imedos.de

Imedos – the Expert of Retinal Vessel Analysis. The retinal microcirculation is a perfect window to the body. Imedos is using ocular transparency to analyze the structure and function of retinal vessels both in humans and animal models. These results serve as valuable biomarkers in ophthalmology and in other medical disciplines. Important cohort studies could prove the relevance and clinical use of the biomarkers gained from Retinal Vessel Analysis. And there is great potential to discover more.



INCYTO Co., Ltd. ....................................................................................... 1349Yanni Yang 112 Seonggeo-gil, Seonggeo-eup, Seobuk-gu Cheonan-si, Chungnam-do31044 KoreaSouth Korea +82 41-550-9762-7; [email protected]; incyto.com

1. INCYTO Needles : An innovative hollow microneedles for Sub-retinal, Intravitreal, Retinal vein, etc. 2. OD/ID : 45?(50 Gauge) ~130?(38 Gauge) / 15?(50G) ~ 70?(38G) 3. Applicable for customers’ specification

Innova Systems, Inc. .................................................................................. 820Valerie Valentino8330 S. Madison St., Suite 60Burr Ridge, Ill. 60527630-920-8880; [email protected]; innovasysi.com

Our product line ranges from visual acuity to quality of vision tests including Rabin Cone Test, contrast sensitivity and night vision. Innova Systems’ Rabin Cone Test is quickly becoming known as the functional disease detection & management device. The Rabin Cone Test has been chosen for clinical trials by Duke University, UCSF and Shiga University for disease studies including Dry AMD, Glaucoma and MS. Stop by our booth to see how the Rabin Cone Test may be used in your practice or research!

Integral BioSystems, LLC .......................................................................... 813Dave Karasic23 Crosby Dr., Suite 100ABedford, Mass. 01730781-275-8059; [email protected]; integralbiosystems.com

Bedford, MA-based CRO Integral BioSystems specializes in ophthalmic delivery, partnering with pharmaceutical companies in formulation R&D, dissolution testing, corneal permeability, analytical methods, stability and process development. Dose Forms: Microspheres, Eye-drops, Hydrogels, CMC writing for INDs for 505b1/2, ANDA. Drugs: Small Molecules, Biologics. The company has also developed a proprietary licensable emulsion, OcuSurf, designed for high bioavailability and efficient drug absorption.

International Society for Eye Research .................................................. 1130Erik Rosales655 Beach St.San Francisco, Calif. 94109415-561-8569; [email protected]; iser.org

The International Society for Eye Research (ISER) was founded in 1968 to establish an international organization to support eye & vision research and is comprised of vision research scientists from more than 34 countries. The ISER Biennial Meeting is held in some of the world’s most distinctive and exciting cities. Research topics covered at these meeting vary from year to year, and include the most current areas of eye & vision research. ISER’s official journal is Experimental Eye Research.

Iris Pharma ................................................................................................ 1002Yann QuentricAllee Hector PintusLa Gaude 06610France33-493-594-959; [email protected]; iris-pharma.com

Iris Pharma is a world-class Contract Research Organization (CRO) totally dedicated to ophthalmology. Since 1989, Iris Pharma has helped bring nearly 70 ocular drugs and medical devices to the American and European markets. Iris Pharma is your ideal partner to carry out proof of concept and GLP preclinical studies (tolerance, PK, efficacy), Phase I to IV clinical trials, bioanalysis and preclinical formulation development as well as to provide you with an on-hand specialist consulting service.



J

JAMA Network .......................................................................................... 1406Millette Jackson-Bates330 N. Wabash Ave., Suite 39300Chicago, Ill. 60611312-464-4868; [email protected]; jamanetwork.com

JAMA Network brings JAMA together with JAMA Network Open and eleven specialty journals to offer enhanced access to the research, reviews, and opinions shaping the future of medicine. JAMA Oncology has an Impact Factor of 20.9.

Joinn Laboratories Co., Ltd. .................................................................... 1442Bo Wei2600 Hilltop Dr.Richmond, Calif. 94806510-408-7722; [email protected]; joinnlabs.com

JOINN Labs is a leading CRO, conducting all spectrum of drug pre-/clinical studies in China. Our ophthalmology lab is fully equipped with advanced instruments. The team has demonstrated extensive expertise in full range of ocular studies. We provide services tailored to clients’ specific needs for drug and device development, including efficacy, safety, PK/TK, clinical trials, in a GLP/GCP compliant environment, which allow us to obtain reliable data in supporting global IND/NDA submissions.

Jorvec Corp. .............................................................................................. 1041Edward Miskiel6860 SW 81st St.Miami, Fla. 33143305-668-6102; [email protected]; jorvec.com

See our advanced visual evoked potential VEP systems and our innovative pattern electroretinogram PERG system with its unique display tablets for high rate visual stimulation and our integrated rodent holder. Learn how our technologies can facilitate earlier detection and monitoring of glaucoma, LHON, and other optic neuropathies. We look forward to the opportunity to discuss how our instruments and services can meet your specific research needs.

K

Keeler Instruments ..................................................................................... 903Liliana A. Gamba3222 Phoenixville Pike, Bldg. 50Malvern, Pa. 19355610-353-4350; [email protected]; keelerusa.com

Keeler Instruments, long known for their superior optics, will be exhibiting our wide range of optometric and ophthalmic instruments, including the Vantage Indirect Ophthalmoscopes Wired, Wireless and Digital Video systems, slit lamps, loupes, and Non Contact Tonometers. Keeler Instruments is also proud to showcase its line of ultrasound diagnostic and imaging devices, including the A-scan Connect, B-scan Plus, UBM Plus, 4Sight combination unit, AccuPen tonometer, and PachPen pachymeter.



Knight Therapeutics, Inc. ......................................................................... 1548Corey Richardson3400 de Maisonneuve W., Suite 1055Montreal, QC. H3Z 3B8Canada514-484-4483; gud-knight.com

Knight Therapeutics Inc. is a publicly-traded, specialty pharmaceutical company focused on acquiring, in-licensing, out-licensing, marketing and distributing innovative prescription pharmaceuticals, consumer health products and medical devices in Canada and select international markets. Knight has acquired or in-licensed a portfolio of over 20 products that are marketed, under regulatory review or in various stages of development.

Konan Medical USA, Inc. .......................................................................... 1007Ian McMillan15770 Laguna Canyon Rd., Suite 150Irvine, Calif. 92618949-576-2200; [email protected]; konanmedical.com

Committed to advancing healthcare by developing diagnostic ophthalmic devices that are best in class, innovative and unique. Visual Function Diagnostics Robotic Retinal Imaging Specular Microscopy Clinical Trials people| vision | inspiration | innovation | dedication

Kugler Publications .................................................................................. 1029Simon BakkerP.O. Box 205381001 NM Amsterdam The Netherlands+31 20-68-45-700; [email protected];kuglerpublications.com

Kugler Publications (est. 1974) is an independent publishing company specialized in Ophthalmology, Otorhinolaryngology and related fields. Kugler Publications has built a rich experience and solid reputation in publishing books, journals, proceedings and congress program and abstracts books, both in print and electronic. Drop by our booth to for our newest publications or to discuss your publication ideas.

L

Leica Microsystems ................................................................................... 937Vicky Thoene1700 Leider LaneBuffalo Grove, Ill. 60089847-405-7039; [email protected]; leica-microsystems.com

Leica Microsystems develops and manufactures microscopes and scientific instruments for the analysis of microstructures and nanostructures. The company is one of the market leaders in compound and stereo microscopy, digital microscopy, confocal laser scanning microscopy, electron microscopy sample preparation, optical coherence tomography, and surgical microscopes.

Lexitas Pharma Services, Inc. ................................................................. 1618Kim Morris313 Foster St. Durham, N.C. 27701919-280-9167; [email protected]; lexitas.com

Lexitas is a full-service contract research organization specializing in ophthalmology. We are focused on providing both technical expertise and exceptional service to our sponsors. Lexitas is your clinical trial partner expert for clinical trial operations, study design, project management, clinical and medical monitoring, and site relations and training.



Lions Eye Institute for Transplant and Research ................................... 1136Dana Caggia1410 N. 21st St.Tampa, Fla. 33605813-289-1200; [email protected]; lionseyeinstitute.org

LEITR specializes in providing ocular tissues with a rapid death -to-preservation time, most globes in under 8 hours. We typically supply tissues with the following criteria - High quality, low death-to-preservation Age, race and gender-specific criteria Control and pathologically graded diseased tissue including Glaucoma, Age-Related Macular Degeneration We also offer custom on-site experiments, dissection of fresh eye tissues, fixation, flash-freezing, or RNAlater and histological processing,

Lions Gift of Sight .................................................................................... 1437Sung Lee1000 Westgate Drive St., Suite 260St. Paul, Minn. 55114612-626-2682; [email protected]; lionsgiftofsight.org

Lions Gift of Sight (formerly Minnesota Lions Eye Bank) serves a critical role in vision research. One of the largest providers of research tissue with 58 years of experience, we have completed more than 30,000 ocular research tissue distributions. Serving industry and academic research initiatives, we offer stringent donor screening, tissue evaluation, custom recovery, and preservation in fulfilling heredity, disease-specific, and specialized tissue requests.

Lions VisionGift .......................................................................................... 815Corrina Patzer2201 SE 11th Ave.Portland, Ore. 97214-5303503-808-7004; [email protected]; visiongift.org

Lions VisionGift has proudly provided ocular tissue for research initiatives across the nation and around the world for more than 40 years. Our world-renowned Vision Research Laboratory is equipped to meet your unique research tissue requests both now and in the future, with both east and west coast locations. Our extensive donor referral network allows us to quickly recover more tissue to supply all of your research initiatives.

LIV Medical Technoloty Inc. ..................................................................... 1141Hyunchul Kim301 West 29th St., Suite 2004Baltimore, Md. 21211443-915-6706; [email protected]

LIV Medical Technology Inc. offers a solution for subretinal injection using an OCT sensor guided SMART micro-injector. Our innovative device employs optical coherence tomography imaging and sensing technology to enhance the surgeon’s ability to identify delicate transparent tissue and maintain safe surgical positions in the retinal space. We also develop, build and commercialize various optical sensor guided surgical tools to assist clinicians perform the most demanding micro-surgical tasks.



LKC Technologies, Inc. ............................................................................. 1003James Datovech2 Professional Dr., Suite 222Gaithersburg, Md. 20879301-840-1992; [email protected]; lkc.com

When vision issues impact your everyday life, LKC Technologies is here to help. Building on over 40 years of experience in the visual electrophysiology space, LKC’s flagship product, the RETeval™ device, brings comprehensive electrophysiology technology to any office or clinical setting. LKC Technologies is committed to developing innovative products that lead to the preservation and treatment of sight. Visit LKC.com and visit us at booth #1003.

LumiThera ................................................................................................. 1142Tracy Puckett19332 Powder Hill Place NEPoulsbo, Wash. 98370844-342-3333; [email protected]; lumithera.com

LumiThera is a commercial-stage medical device company focused on treating people affected by ocular disorders and diseases including dry AMD, a leading cause of blindness in adults over 65. The Company is a leader in the use of photobiomodulation for the treatment of acute and chronic ocular diseases and disorders. The Company is developing the office-based Valeda™ Light Delivery System to be used by eye care specialists as medical treatments.

M

M&S Technologies ...................................................................................... 926Susan Tanaka5715 W. Howard St.Niles, Ill. 60714847-763-0500; [email protected]; mstech-eyes.com/products/category/clinical-trial-suite

M&S Technologies is pleased to release version 2.18 of our Clinical Trial Suite (CTS), which is comprised of a variety of automated, comprehensive, easy-to-use computerized protocols that ensure any phase of clinical trial testing maintains precision, accuracy and efficiency, at any distance. Customize the Suite based on your trial needs!

MacuLogix, Inc. ......................................................................................... 1143Ted Newill1801 Oberlin Rd., Suite 301Middletown, Pa. 17057717-914-4067; [email protected]; maculogix.com

MacuLogix is a pioneer in the early detection and tracking of retinal diseases. We are introducing the AdaptDx, the first practical measurement tool for dark adaptation. Dark adaptation is known to be significantly impaired in macular diseases such as AMD and other macular dystrophies. Based on scientific advances, the AdaptDx provides doctors with an easy-to-use functional test similar to routine perimetry testing for glaucoma.

Mallinckrodt Pharmaceuticals ................................................................. 1251Lida Clark1425 Route 206Bedminster, N.J. 07921908-238-6321; [email protected]; mallinckrodt.com

Mallinckrodt Pharmaceuticals is a global specialty biopharmaceutical and medical imaging company. The company’s Autoimmune and Rare Diseases business includes H.P. Acthar® Gel (repository corticotropin injection), indicated for use in multiple specialties. To learn more, visit Acthar.com.



Mary Ann Liebert, Inc. .............................................................................. 1504Nilda Rivera140 Huguenot St., Floor 3New Rochelle, N.Y. 10801-5215914-740-2100; [email protected]; liebertpub.com

Journal of Ocular Pharmacology and Therapeutics is the only peer-reviewed journal that combines the fields of ophthalmology and pharmacology to enable optimal treatment and prevention of ocular diseases and disorders. The Journal delivers the latest discoveries in the pharmacokinetics and pharmacodynamics of therapeutics for the treatment of ophthalmic disorders.

MedGenome, Inc. ...................................................................................... 1603Hiran Govindamangalam348 Hatch Dr.Foster City, Calif. 94404888-440-0954; [email protected]; medgenome.com

MedGenome is a global genomics research company headquartered in California. We offer the most comprehensive phenotype knowledgebase (300,000+ patient records) for ophthalmological disease research. The knowledgebase offers an aggregate of sample access, phenotype/ treatment information and family pedigree data for researchers to dive deep into the underlying cause of the disease. Our Next Generation Sequencing labs are located in Singapore and India.

Medical Innovation Partners International (RE-ONE) ............................ 1238Jolie Slaton2101 Cedar Springs Rd., Suite 1050Dallas, Texas 75201214-347-0563; [email protected]; medicalinnovationpartners.international

We support the needs of vision research by providing devices to facilitate and enhance the delicate work of the researcher.

Medmont International ............................................................................. 1615John BondUnit 5 56 Norcal RoadNunawading, VC. 3131Australia+61 3 9259 0800; [email protected]; medmont.com

Medmont has been a leader in providing high quality, high value ophthalmic instruments for the worldwide eye care market for over 20 years. Medmont is continuing to expand on its bespoke line of products and proprietary software. Medmont’s current portfolio of products and software is used by ophthalmic and researchers professionals worldwide. Medmont International Pty Ltd is proud to have had, and continues to have, its equipment used in numerous unsponsored peer review studies.

Metrovision................................................................................................ 1236Jacques Charlier4 rue des PlatanesPerenchies 59840France+33 32-017-1956; [email protected]; metrovision.fr

MonCvONE, a full field projection perimeter available in 3 versions: -SAP for Standard Automated Perimetry, -PRO for SAP, Goldmann perimetry and video imaging, -CR for advanced clinical research MonPackONE, a multifunction instrument combining several tests in one compact unit: Psychophysics: visual field perimetry, contrast sensitivity, dark adaptation Electrophysiology: ganzfeld flash, pattern and multifocal ERG and VEP Eye movements: video oculography, scan path analysis, pupillometry.



McGill University Eye Pathology & Translational Research Laboratory (MUHC) .......................................... 1543Miguel N Burnier, Jr, MD, PhD1001 Boul Decarie, Block E, E02.2389Montreal, QC. H4A 3J1Canada514-934-1934, ext. 76129; [email protected]; ocularpathlab.com

The MUHC/McGill University Eye Pathology & Translational Research Lab is the largest ocular pathology research & training center in Canada. As a global referral center for oncologists, pathologists & ophthalmologists, this unit offers a unique graduate program, which has trained more than 200 residents, MSc, PhD, Postdocs, medical students & fellows from 25 countries. In 2010, our trainees founded BIOPSY (Burnier International Ocular Pathology Society), which hosts biannual meetings.

N

National Disease Research Interchange ................................................ 1140Sara Zakarewsky1628 John F. Kennedy Blvd., 8th Floor8 Penn CenterPhiladelphia, Pa. 19103215-577-7361-290; [email protected]; ndriresource.org

The National Disease Research Interchange (NDRI) is a 501(c)(3) not-for-profit, NIH-funded organization that provides project-driven human biospecimen service to academic and corporate scientists. NDRI has over 30 years of experience globally distributing human biospecimens for research. Our extensive recovery network has the expertise to provide anatomical structures, organs, and tissues with annotated data.

National Eye Institute ............................................................................... 1427Kerry Goetz10 Center Dr., Room 10N109Bethesda, Md. 20892-1860301-443-7835; [email protected]; nei.nih.gov

The National Eye Institute supports basic, clinical, and translational research to increase understanding of the eye & visual system and promote prevention, treatment and rehabilitation of disease conditions. NEI is redesigning our website to more easily find eye health information, funding opportunities & other resources. Stop by our booth to get a sneak peek & share your feedback about the new design. We’ll also be giving away Google Cardboard headsets, so come try our new virtual reality app!

Natus Medical, Inc....................................................................................... 912Carol Stone1501 Industrial Rd.San Carlos, Calif. 94070847-573-5421; [email protected]; natus.com

RETCAM Pediatric Eye Imaging is a fully integrated wide-field digital imaging system for the hospital and clinic. This state-of-the-art system provides ophthalmic visualization and photo documentation with features that help assure the capture of pediatric ocular images. natus.com



Nemera ...................................................................................................... 1611Manuela Basso20 Avenue de la GareLa Verpillière 38290France+33 04-74-94-06-54; [email protected]; nemera.net

Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics industries. The use of preservatives can cause irritations, allergies and other side effects to the eye, thus jeopardizing adherence to treatments and damaging patients’ eyes. The multidose closing tip system Novelia® avoids the need for preservatives in the drug and prevents bacterial contamination over the duration of treatment.

Nidek .......................................................................................................... 1019Alicia Johnson47651 Westinghouse Dr.Fremont, Calif.94539-7474415-994-1758; [email protected]; usa.nidek.com

NIDEK offers a wide array of diagnostic and surgical equipment designed with simplicity, functionality and reliability to assist you with your patients having anterior and posterior disorders or diseases, including glaucoma, AMD, Visual function and other vision-impairing afflictions.

NKT Photonics ............................................................................................ 836Nanda Sturm3514 N Vancouver Ave., Suite 310Portland, Ore. 97227503-444-8404; [email protected]; nktphotonics.com

NKT Photonics is the leading supplier of high performance fiber lasers, fiber optic sensing systems, and photonic crystal fibers. Our main markets are within imaging, sensing and material processing. Our products include ultrafast lasers, supercontinuum white light lasers, low noise fiber lasers, distributed temperature sensing systems and a wide range of specialty fibers. NKT Photonics has its headquarters in Denmark with sales and service worldwide.

NOF America Corporation ....................................................................... 1036Kentaro MiyakeOne North Broadway, Suite 912White Plains, N.Y. 10601914-682-9790; [email protected]; nofamerica.com

We, NOF CORPORATION, are fine chemical company providing novel and unique materials for life science and pharmaceutical final products and their developments. We exhibit the phosphorylcholine polymer which helps to ease dry eye symptom and protect eye cornea for eye-care application. Also, we introduce new, novel silicone monomers for second generation of silicone hydrogel contact lenses and surface modifier for contact lenses for higher hydrophilicity.

Novartis ......................................................................................................MS2Sarah Urben9 Rue Du Pre-Bouvier1242 SatignyGeneva, Switzerland+41 22 33 99 [email protected]; mci-group.com

Medical Engagement Suite - upon invitation



Novartis ..................................................................................................... 1411Grace HoddyOne Health PlazaEast Hanover, N.J. 07936862-778-1759; [email protected]; pharma.us.novartis.com

Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, preventive vaccines and diagnostic tools, over-the-counter and animal health products. For more information, please visit novartis.com.

O

Oakwood Labs .......................................................................................... 1343Mark Ilhan7670 First Place, Suite AOakwood Village, Ohio 44146440-703-3615; [email protected]

Oakwood is focused on the design, development, and aseptic manufacturing of sustained-release injectable microsphere products through the use of our patented Chroniject technology. In addition we have an FDA approved aseptic manufacturing facility to support clinical and commercial manufacturing. Oakwood partners with companies worldwide to ensure a one-stop shop from formulation development through commercial supply.

Ocular Instruments ................................................................................... 1026Customer Service2255 116th Ave., NEBellevue, Wash. 98004425-455-5200; [email protected]; ocularinc.com

Established in 1966, Ocular Instruments has been creating solutions to save sight. Our line of ophthalmic lenses for research are designed especially for use on small eyes of laboratory animals. Whether for examination, laser, surgery, or scientific research, Ocular makes the lenses you need. We invite to share your new product ideas with Ocular’s R & D department. Who knows – your name could be the next to appear on an Ocular product!

Oculos ....................................................................................................... 1455Ben Burton7500 W. Henrietta Rd.Rush, N.Y. 14543585-533-1672; [email protected]; iuvobioscience.com

Oculus, Inc................................................................................................. 1032Jennifer Conway17721 59th Ave. NEArlington, Wash. 98223425-670-9977; [email protected]; oculususa.com

OCULUS has been setting milestones in the eye care industry since 1895. In addition to the Pentacam®, we offer visual field perimeters, corneal topographers, slit-lamp cameras, pachymeters, autorefractors, keratometers, trial frames and loupes. OCULUS products are 100% made in Germany and fully supported in the United States and Canada.



OcuMetrics, Inc. .......................................................................................... 915Bruce Ishimoto2224-C Old Middlefield WayMountain View, Calif. 94043-2421650-960-3955; [email protected]; ocumetrics.com

Supplying instruments for ophthalmic research: Fluorotron(TM) Master ocular fluorophotometer for assessing the integrity of the blood-retinal and blood-aqueous barriers and measuring aqueous flow, cornea epithelial and endothelial permeability, tear flow, cornea pH, and ocular pharmacokinetics.

OcuScience ............................................................................................... 1018Daniel Lindgren2764 North Green Valley Parkway, Suite 262Henderson, Nev. 89014866-250-3937; [email protected]; Ocu-Science.com

OcuScience® is advancing eye research and veterinary care for multi-species electroretinography by providing the means to capture unprecedented data. Our iVivo imaging systems provide versatility to meet the requirements of your laboratory. Come learn about our new products such as our intravitreal lenses for mice, rats, and rabbits. Our human retina biosensor is a revolutionary service to test and screen drugs on actual human retina tissue. Visit the OcuScience booth #1018.

Ophthalmology Times .............................................................................. 1042Melissa Devlin485 F Route One South, Suite 210Iselin, N.J. 08830203-523-7067; [email protected]; ophthalmologytimes.com

Ophthalmology Times, winner of six Jesse H. Neal National Business Journalism Awards, is a physician-driven media brand that presents cutting-edge advancements from around the world in surgery, clinical diagnosis, drug therapy, and technology to elevate the delivery of progressive eye health from physician to patient. Find out more at OphthalmologyTimes.com.

Optoprobe Science Ltd. ............................................................................. 809Junqiang LiangRoom 352, Langguang yunding Majiapu Rd., No.180F engtai DistrictBeijing, China+86 17718471267; [email protected]; optoprobe.com

Optoprobe Science Ltd., founded in 2015, specializes in imaging and functional testing equipment for small animals. We have a series of scientific research instruments such as optical coherence tomography, adaptive optics optical coherence tomography, fundus camera, confocal fluorescein angiography, visual electrophysiology. We also provide experiment protocols and experiment analysis method.

Optos, Inc. ................................................................................................... 906Emily Vieira500 Nickerson Rd.Suite 500-201Marlborough, Mass. 01752508-787-1585; optos.com

Optos develops retinal imaging and analysis tools for ophthalmologists. More than 400 peer reviewed studies confirm that optomap ultra-widefield imaging helps doctors more effectively detect and treat retinal pathology. optomap is revolutionizing ophthalmic practice flow and helping doctors save sight and save lives.



Optovue, Inc. ............................................................................................... 819Kellie Archer2800 Bayview Dr.Fremont, Calif. 94538510-623-8868; [email protected]; optovue.com

Optovue is dedicated to the advancement of high-speed OCT and OCTA technology. Since our founding in 2003, we have installed over 12,000 systems worldwide. Optovue was the first to develop and commercialize the pioneering OCTA technology. The AngioVue® OCTA system is now used in more than 1,700 clinics and has been featured in over 400 peer-reviewed publications.

Optronics ................................................................................................... 1610Matthew Bartos1 S. Los Carneros Rd.Goleta, Calif. 93117805-968-3568; [email protected]; optronics.com

OPTRONICS Booth #1610 OPTRONICS offers 4K & HD microscope imaging solutions designed for the ophthalmic surgeon and clinical investigator. Our MICROCAST® 4K PRO & MICROCAST® HD PRO camera systems are compatible with all leading brands of microscopes and offer unrivaled performance surgical procedures. New: MICROCAST PRODUCER, personalized 1:1 online microsurgical video editing sessions.

Ora, Inc....................................................................................................... 1303Jeanne Hecht300 Brickstone SquareAndover, Mass. 01810919-601-8139; [email protected]; oraclinical.com

Ora is the world’s leading full-service ophthalmic-only CRO and product development firm, with offices in the United States, Europe and Japan. Over the past 40 years, we have proudly helped our clients earn 46 product approvals. Let Ora be your partner, whether you are at the preclinical, clinical, or post-approval stage of product development. Our disease models and site management organization will accelerate your timelines. Learn more at oraclinical.com

Orbit Biomedical, Inc. ................................................................................MS5Eileen Edginton300 Brookside Ave., Bldg 18, Suite 180Ambler, Pa. 19002267-523-2106; [email protected]

OSOD, LLC ................................................................................................ 1311Gary Leatherberry455 Science Dr., Suite 120Madison, Wisc. 53711608-206-3614; [email protected] ocularservices.com

OSOD is a consortium of internationally recognized experts specializing in the delivery of world-class services to accelerate identification and development of leading therapeutic compounds and ophthalmic devices. OSOD has expertise in discovery, establishing proof of concept, accelerating drug/device development, and assessment of ocular toxicities. OSOD has an exclusive relationship with Covance, Inc. that allows us to provide our clients with a fully-integrated preclinical service.



Oxymap ehf ................................................................................................. 743Arni Thor ArnasonVatnsmyrarvegur 16Reykjavik 101Iceland+354 897-0531; [email protected]; oxymap.com

The Oxymap T1 allows metabolic imaging of the retina for investigation of the pathophysiology of common eye diseases. It measures retinal vessel oxygen saturation as well as the vessel diameter. In addition it automatically evaluates the quality of the retinal images. The Oxymap T1 is a CE marked medical devise which has been used in more than 30 research centres and hospitals on 4 continents.

PharmOptima, LLC ................................................................................... 1137Stephanie Thompson6710 Quality WayPortage, Mich. 49002269-492-3872; [email protected]; pharmoptima.com

PharmOptima™ is a member of Genesis Drug Discovery and Development (GD3), a preclinical CRO offering a comprehensive portfolio of services for drug discovery and development. PharmOptima specializes in ADME and ocular models by using bioanalytical tandem mass spectrometry (MS/MS) method development, validation, sample analysis, and custom in vivo research models. We have expertise in micro-dissection of ocular tissues and development of cell lines for HTS and target validation.

PhenoSys GmbH ........................................................................................ 921Gerd BehmeSchumannstr. 1810117 Berlin Germany+49 030 28 87 98 67; [email protected]; phenosys.com

PhenoSys is a technology company based in Berlin providing innovative solutions for animal behavior research. We offer several systems of interactive Virtual Reality for rodents. Furthermore, PhenoSys provides the first system for the automated measurement of the optomotor response in mice. Our experimental systems are used for behavioral phenotyping, brain research, experimental psychology, and the diagnostic characterization of animal models.

Phoenix Technology Group ..................................................................... 1013Stuart Watts6630 Owens Dr.Pleasanton, Calif. 94588925-485-1100; [email protected]; phoenixtech.com

For 10+ yrs the Phoenix MICRON in-vivo retinal imaging system has been the standard of quality in eye research. Today 10 out of 12 of the top research institutions employ Phoenix MICRON for their research. The Phoenix MICRON system offers the most essential modalities needed to power the best ophthalmic research-in a single imaging system. Modalities include a retinal microscope, FA, OCT, CNV & ERG in a modular system that makes capturing and processing high quality data easy to do.



Powered Research .................................................................................... 1530Chris BrasfieldP.O. Box 14466Research Triangle Park, N.C. 27709919-213-6035; [email protected]; poweredresearch.com

Powered Research, LLC is a North Carolina based preclinical CRO specializing in ophthalmic models. Led by a Board Certified Veterinary Ophthalmologist & Toxicologist and our Director of Research, we have proven expertise in multiple models for the ocular space including Ophthalmic Examinations, Models of Disease, and Biocompatibility / Toxicity / PK studies. Our standard IACUC protocol review occurs within 3-4 days and we typically can begin a study within 2 weeks of protocol submission.

Precision Vision ........................................................................................ 1126Jessica Kopidlansky1725 Kilkenny Ct.Woodstock, Ill. 60098815-223-2022; [email protected]; precision-vision.com

Precision Vision has been the leading producer of vision testing and visual acuity products worldwide for decades. They have been at the forefront of numerous milestones in the field and are still recognized as the premier manufacturer for standard and custom products.

PreventionGenetics .................................................................................. 1640Danielle Krohn3800 South Business Park Ave.Marshfield, Wisc.54449715-387-0484; [email protected]; preventiongenetics.com/index.php

Founded in 2004 and located in Marshfield, Wisconsin, PreventionGenetics is a CLIA and ISO 15189:2012 accredited clinical DNA testing laboratory. PreventionGenetics provides patients with sequencing and deletion/duplication tests for nearly all clinically relevant genes. These tests include our powerful and comprehensive whole exome sequencing test, PGxome®. PreventionGenetics also offers DNA Banking (PGDNABank), a long-term storage of a person’s DNA. DNA Banking is available direct-to-consumer.

Promedica International ........................................................................... 1012Terrie Hopton3100 Bristol St., Suite 250Costa Mesa, Calif. 92626714-460-7363; [email protected]; promedica-intl.com

Promedica International is a privately held, full-service, ISO-certified CRO providing clinical trial services for the medical device, biotechnology and pharmaceutical industries. Founded in 1985, we are a woman-owned corporation headquartered in Orange County, California. We have successfully provided exceptional value to our clients in clinical trial project management, site recruitment and management, clinical study monitoring, data management, biostatistics, medical writing and GCP auditing.

ProQR .........................................................................................................MS7Megan Sessa245 Main St.Cambridge, Mass. 02142575-587-6389; [email protected]; proqr.com

ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases such as Leber’s congenital amaurosis 10, Usher syndrome type 2 and dystrophic epidermolysis bullosa. Based on our unique proprietary RNA repair platform technologies we are growing our pipeline with patients and loved ones in mind.



ProQR ........................................................................................................ 1340Megan Sessa245 Main St.Cambridge, Mass. 02142575-587-6389; [email protected]; proqr.com

ProQR Therapeutics is dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe genetic rare diseases such as Leber’s congenital amaurosis 10, Usher syndrome type 2 and dystrophic epidermolysis bullosa. Based on our unique proprietary RNA repair platform technologies we are growing our pipeline with patients and loved ones in mind.

R

Regeneron Pharmaceuticals ................................................................... 1209777 Old Saw Mill River Rd.Tarrytown, N.Y. 10591914-847-7000; [email protected]; regeneron.com

Regeneron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases. Founded and led for 30 years by physician-scientists, our unique ability to consistently translate science into medicine has led to six FDA-approved treatments and numerous product candidates in development, all of which were homegrown in our laboratories.

Reichert, Inc. ............................................................................................. 1132Linda Hauser3362 Walden Ave.Buffalo, N.Y. 14043716-686-4500; [email protected]; reichert.com

Reichert Technologies of Buffalo, NY (unit of AMETEK, Inc.) is a global leader in the design and manufacture of diagnostic devices for optometry, ophthalmology, and retail eye centers. Inventors of the Phoroptor® and Non-Contact Tonometer, Reichert continues its American-made tradition by providing industry defining products, including the digital Phoroptor® VRx, Tono-Pen® Tonometer, the break-through Ocular Response Analyzer® featuring Corneal Hysteresis, and ClearChart Digital Acuity Systems.

Remidio Innovative Solutions, PVT, LTD ................................................ 1342Adeeb Ulla BaigNo. 1-51-2/12, (II Floor), Vacuum Techniques CompoundOpp Volvo Factory, Peenya Industrial Area, Phase-IBangalore, Karnataka 560 058India+91 9008298004; [email protected]; remidio.com

Remidio is an innovative medical device company that seeks to create Healthcare Access by combining simplicity of product design with technology & sustainable business models. Remidio’s retinal imaging devices have helped screen and impact more than 7.5 million patients in 15 countries globally, as a result of increased access provided by the ease of use and affordability of Remidio’s patented optics on the smartphone platform.

RetinAi Medical GmbH ............................................................................. 1043Carlos CillerSpitalgasse 243011 Bern, Switzerland+41 764643141; [email protected]; retinai.com

RetinAI Medical develops healthcare solutions to protect patients from vision loss using artificial intelligence (AI). To achieve this goal, we build tools to collect, analyze and to organize health data, empowering healthcare professionals and patients with automatic image and data analysis supported by advanced machine learning.



Review of Ophthalmology/Jobson Publishing ...................................... 1106Casey Foster11 Campus Blvd., Suite 100Newton Square, Pa. 19073610-492-1007; [email protected]; reviewofophthalmology.com

Review of Ophthalmology® features clinically relevant information on surgical technique, new technologies, disease diagnosis and management. Review presents timely articles on ophthalmic subspecialties such as glaucoma, retina, refractive surgery, cornea and external disease, pediatric ophthalmology, and oculoplastics. The Review Group is your resource for continuing medical education and promotional meetings, conferences, webinars, teleconferences, and events.

Roland Consult ......................................................................................... 1027Joachim FingerFriedrich Franz St. 1914770 BrandenburgGermany+49 3381 890 1034; [email protected]; roland-consult.com

Expert Roland-Consult is globally recognized for a tradition of innovation, developing high-quality Electrophysiological Diagnostics Systems for Vision which include; ERG, VEP, EOG, mfERG, mfVEP, Visual Acuity, Pupillometry, DARK adaptation. Please visit the Roland Consult booth to experience the all NEW RETImap, an ALL in One system combining Infrared Fundus Imaging cSLO, Focal and Multifocal ERG, OCT, FA and Auto Fluorescence diagnostic tool for animal and human research.

RxGen, Inc. .................................................................................................. 806Christopher Stanley4 Science ParkNew Haven, Conn. 06511203-498-9706; [email protected]; rx-gen.com

RxGen is a specialty translational research company developing and providing innovative in vivo disease modeling and related preclinical research and development services to meet preclinical and translational research needs of the global pharmaceutical, biotechnology, and life sciences industry. Our translational research platform is designed to accelerate the evaluation, selection, and development of candidate therapeutics while reducing the cost and risk of clinical failure.

S

Santen ........................................................................................................ 1203Victor Chan6401 Hollis St., Suite 125Emeryville, Calif. 94608510-390-2989; [email protected]; santenUSA.com

As a global ophthalmology company, Santen specializes in the research, development and commercialization of pharmaceutical, surgical, and OTC eye care products. With over 3,600 employees and its worldwide headquarters in Japan, Santen continues to provide innovative solutions in glaucoma, retina, uveitis, dry eye, ocular allergy and infection to patients around the world. Santen is the market leader in Japan for prescription ophthalmic pharmaceuticals and sells products in over 60 countries.



Saving Sight ................................................................................................ 842Patrick Gore10560 N Ambassador Dr., Suite 210Kansas City, Mo. 64153813-753-4487; [email protected]; saving-sight.org

Saving Sight is a nonprofit eye bank with a mission to change lives by saving sight. Saving Sight has grown to become one of the nation’s leading eye banks and is focused on providing innovative solutions to its clinical and research partners. Headquartered in Kansas City, Mo., Saving Sight facilitates eye donation in Missouri, Kansas, and Illinois, serving transplantation and research specialists locally and around the world.

SDC ............................................................................................................ 1307Jim Townsend63 South Rockford Dr., Suite 240Tempe, Ariz. 85281480-632-5468; [email protected]; sdcclinical.com

SDC delivers top-tier clinical trial services to pharma, biologic, & device/diagnostic companies. With strategic scientific consulting & clinical data services (statistics, data management/EDC, & IRT/IWRS) expertise at our core, our services are scalable via our strategic partnerships to provide full service clinical trial solutions. With extensive experience on 200+ ocular trials since 2005, speak with us today to see why SDC is The Right Fit for your ophthalmic study needs. sdcclinical.com

Second Sight Medical Products ................................................................ 841Duane Tsutsui12744 San Fernando Rd., Suite 400Sylmar, Calif. 91342818-833-5060; [email protected]; secondsight.com

Second Sight Medical Products is the developer and manufacturer of the Argus II® Retinal Prosthesis System - the first and only approved long-term device therapy for people living with advanced Retinitis Pigmentosa in the U.S. Argus II is designed to provide artificial vision to people who are profoundly blind and provide them with increases in orientation and mobility skills and is intended to increase their independence and quality of life by restoring their ability to see objects and motion.

Shenyang Xingqi Pharmaceutical Co., Ltd. .............................................. 933Qiang YangNo.68 Sishui St., Dongling District110163 Shenyang China400-613-5599; [email protected]; sinqi.com

Shenyang Xingqi Pharmaceutical Co., Ltd. is a state-level new and high-tech enterprise specializing in R&D, production and sales of ophthalmic drugs. With an eye on the rejuvenation of China’s national pharmaceutical industry, it is committing itself to the ophthalmology.

Shin Nippon Biomedical Laboratories, Ltd. ........................................... 1643Jenn Fukuyama2438 Miyanoura Kagoshima891 1394 Japan+81 99-294-2600; [email protected]; snbljapan.com/

Shin Nippon Biomedical Laboratories, Ltd. (SNBL) is a full-service pre-clinical CRO that offers toxicology and efficacy services to bring your drug or device to market sooner. Founded in Japan in 1957, SNBL has expanded to offer services to clients all over the world. Our ocular services appeal to those who want quality data and attention to detail. We leverage our experience with a variety of imaging modalities to find just the right ocular solution for your drug or device development program.



Shire (Medical Affairs) ...............................................................................MS8Jennifer Tyma5 Riverwalk, Citywest Business CampusDublin 2Ireland800 83-7470; [email protected]; shire.com

Shire (Medical Affairs) ................................................................................ 827Jennifer Tyma5 Riverwalk, Citywest Business CampusDublin 2Ireland800 83-7470; [email protected]; shire.com

Sichuan Primed Shines Bio-tech Co., Ltd. ............................................ 1441Mingling WuB4-501, Tianfu Science Technology Park, No.88, Keyuan South Road, Hi-tech ZoneChengdu, Sichuan China 610041+86 28-8592 1823; [email protected]; primed.com.cn

Primed Shines has a large Non-Human Primate (NHP) population (n= ~3000) with both spontaneous and induced ocular disease models include DR, DME, AMD, Dry eye, Glaucoma, BRVO, RP. We provide pharmacology/efficacy, PK/toxicology services for the drug development of ocular, metabolic, cardiovascular, NASH, bone, kidney and CNS diseases. Our strong imaging and other biomarker research capabilities enable us to build the best platform with translatable NHP models to facilitate new drug development.

Silgan Dispensing Systems ..................................................................... 1249Gwynne Teass501 South 5th St.Richmond, Va. 23219804-923-1971; [email protected]; silgandispensing.com

Silgan Dispensing is a leading global supplier of highly engineered triggers, pumps, sprayers and dispensing closure solutions to major branded consumer goods product companies in the home, health and beauty markets. With several cGmp certified facilities around the world, approved medical device facility with ISO 7&8 clean room, consumer insights and manufacturing expertise, Silgan Dispensing provides innovative and customizable solutions that meet Brand owners’ needs

Singapore Eye Research Institute (SERI) ............................................... 1033Serene HoThe Academia, 20 College RoadDiscovery Tower Level 6Singapore 169856Singapore+65 6576 7318; [email protected]; seri.com.sg

Singapore Eye Research Institute, SERI is Singapore’s national eye research institute. SERI has played key strategic roles in the conceptualization of research ideas & technologies with local & international institutions that has ensured a high level of research competency & skills transfer. Critically, SERI’s research has translated to tangible outcomes, actual patient benefit, & success stories. Today, SERI is recognized as a preeminent pacesetters of eye research in Asia and globally.



Slack, Inc. .................................................................................................... 917Ashley Seigfried6900 Grove Rd.Thorofare, N.J. 08086856-848-1000; healio.com/OSN

SLACK Incorporated invites you to pick up your free issue of OCULAR SURGERY NEWS U.S. Edition and OSLI RETINA. Sign up for the free News Wire at Healio.com/OSN and digital Editions of OSN Europe, OSN APAO and OSN Latin America. Stop by for show specials on SLACK Incorporated books.

Softcare Ltd. ................................................................................................ 741Takeshi Shirakawa243-5 Yatsunami Fukutsu, Fukuoka 811-3201 Japan+81 940-36-9693; [email protected]; softcare-ltd.co.jp

Softcare’s Laser Speckle Flowgraphy (LSFG-NAVI or Lite) visualizes the distribution of blood flow in the retina with a series of 2-D color coded maps and observes changes in retinal and choroidal blood flow in real time. Demonstrations of the latest version of LSFG-NAVI’s value to the study of ocular blood circulation will be conducted at the exhibition. We can provide the equipment (LSFG-Micro and etc..) to observe blood flow of animal eye ground as laboratory mice, rats, rabbit, pig or monkey.

Spark Therapeutics ................................................................................... 1109Desiree Skipworth3737 Market St., Suite 1300Philadelphia, Pa. 19104215-220-6300; [email protected]; sparktx.com

Spark Therapeutics, a fully integrated company, strives to challenge the inevitability of genetic disease by discovering, developing, and delivering gene therapies that address inherited retinal diseases (IRDs), neurodegenerative diseases, as well as diseases that can be addressed by targeting the liver. To learn more about us, visit sparktx.com.

STEMCELL Technologies, Inc. ................................................................. 1642Briana Liau Chan-Kent1618 Station St.Vancouver, B.C. V6A 1B6Canada604-668-1812; [email protected]; stemcell.com

STEMCELL Technologies Inc. is committed to providing specialized cell isolation products, standardized cell culture media and accessory tools for your cell biology research. Driven by science and a passion for quality, STEMCELL supports the advancement of scientific research around the world with our catalog of more than 2000 cell biology research tools. To learn more, visit STEMCELL.com.

Sterling IRB ............................................................................................... 1402Kathye Richards5500 Interstate North Parkway, Suite 515Atlanta, Ga.30328678-501-7806; [email protected]; sterlingirb.com

For over 29 years, Sterling IRB has been overseeing clinical research trials for pharmaceutical and medical device companies specializing in treatments for eye diseases and vision correction. Our Board membership includes experts in ophthalmology and optometry. We are proud of our role in protecting those research participants who play such a vital part in the development of new medicines and medical technologies.



Striata Technologies ................................................................................. 1636Thomas MuenchOtfried-Müller-Str. 2572076 TübingenBaden-WürttembergGermany+49 1520-98-99380; [email protected]: striata-tech.com

The OptoDrum system from StriataTechnologies quantifies the visual abilities in mice based on their optomotor reflex. Mice (like other animals and humans) compensate for global image drift in the visual environment with reflexive eye and head movements. This behavior can be used to characterize the visual abilities of the animal, thus gaining information about its spatial acuity or contrast sensitivity. With our OptoDrum system, this is done in a fully automated way.

Studylog Systems, Inc. ............................................................................... 729Eric Ibsen101-A Hickey Blvd., Suite 301So. San Francisco, Calif. 94080650-290-7540; [email protected]; studylog.com

Studylog’s Animal Study Workflow Software® is designed for biomedical animal research and provides features for the design, planning, execution, analysis, and reporting of animal studies in a standardized, highly efficient manner, while protecting data integrity. Reducing many labs’ study-related labor by half, Studylog automates and streamlines the entire animal study process, making it easier, faster and cheaper, so researchers have more time and resources to get their job done.

Syneos Health ............................................................................................. 8301030 Sync. St.Morrisville, N.C. 27560919-876-9300; [email protected]; syneoshealth.com

Syneos Health (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. Created through the merger of two industry leading companies, INC Research and inVentiv Health, we bring together 21,000+ clinical and commercial minds with the ability to support customers in 110+ countries

T

Taylor & Francis Group ............................................................................ 1404Kayla Daniel530 Walnut St., Suite 850Philadelphia, Pa.19106215-606-4239; [email protected]; tandfonline.com

Taylor & Francis Group partners with researchers, scholarly societies, universities and libraries worldwide to bring knowledge to life. Our scholarly journals cover a wide variety of ophthalmology hot topic areas. Visit Taylor & Francis booth #1404 to learn more about our journals and to take advantage of special offers.



Teledyne e2v ............................................................................................. 1528Lynn Todd765 SycamoreMilpitas, Calif. 95035949-212-3000; [email protected]

Teledyne e2v’s CMOS, CCD and EM image sensors and subsystems deliver high performance across many applications. Teledyne e2v’s unique approach involves listening to the market and application challenges of customers and partnering with them to provide innovative standard, semi-custom or fully custom imaging solutions.

Topcon ........................................................................................................MS1Christina Peccini111 Bauer Dr.Oakland, N.J. 07436201-599-5100; [email protected]; topconmedical.com

Topcon presents a wide range of ophthalmic instruments and software solutions, including the Triton Swept Source OCT and the new Harmony Data Management System. Stop by our booth #803 or visit our website at topconmedical.com to learn more.

Topcon ......................................................................................................... 803Christina Peccini111 Bauer Dr.Oakland, N.J. 07436201-599-5100; [email protected]; topconmedical.com

Topcon presents a wide range of ophthalmic instruments and software solutions, including the Triton Swept Source OCT and the new Harmony Data Management System. Stop by our booth #803 or visit our website at topconmedical.com to learn more.

tpm taberna pro medicum GMbH ............................................................ 1138Sven ScharenbergIm Dorf 15aDE 21335 LueneburgGermany+49 4131-40-15-55; [email protected];tpm.eu

tpm is launching the new Ocular Pressure Blood Flow Analyzer. Non-invasive diagnostic procedure to measure and record pulsatile ocular perfusion in support of the early detection of glaucoma and other circulatory irregularities. tpm is the global leader in high frequency ultrasound diagnostic for the skin, developed from the inspiration of Ophthalmology systems in 1983. tpm has always been active in Ophthalmology and Dermatology for new and inovative diagnostic products.

Translational Imaging Innovations .......................................................... 1448Eric BucklandPO 1569Hickory, N.C.28603919-827-1200;[email protected]; tiinnovations.com

TII integrates your imaging science workflows to shorten the timeline of ocular innovations. Lattice is a living subjects workflow manager designed for the R&D environment, combining protocols, consents, exam tracking, and image and biospecimen data collection into one interface. Mosaic is a flexible platform for the exploration, validation, and application of image processing and AI algorithms. Lattice and Mosaic interface to our Image Repository to accelerate your image-driven breakthroughs.



Trial Runners LLC ....................................................................................... 927Emily Murphy116 W. Villard St.Dickinson, N.D. 58601701-483-3599; [email protected]; trialrunners.com

Trial Runners is a global, niche ophthalmology CRO shaping the future of clinical trials to help others see the world. Founded in 2006, Trial Runners has worked as a partner on over 70 trials and helped over 10,000 patients on the mission to help improve the quality of life of those suffering from ophthalmology-related conditions around the globe. Utilizing customized strategies, Trial Runners is able to help the pharmaceutical community by providing unique value, innovation, and expertise.

U

Unither Pharmaceuticals ......................................................................... 1438Stacy McDonald-Mickey755 Jefferson Blvd.New York, N.Y. 14623585-507-1302; [email protected]; unither-pharm.com

Unither Pharmaceuticals is a global leader in developing and manufacturing unit dose pharmaceutical products, using sterile blow-fill-seal (BFS) and stick pack technologies. Our unit dose solutions enable line extensions and product differentiation that support on-the-go lifestyles, with the potential to improve medication dosing safety and adherence. With our experience and technology, we can assist our customers at every stage of the development process to help ensure their product’s success.

V

Vanrx Pharmasystems ............................................................................... 907Greg Speakman#200-3811 North Fraser WayBumaby, B.C. V5J 5J2Canada604-453-8660, Ext. 752; [email protected]

Vasoptic Medical ......................................................................................... 941Amit Guruprasad1215 East Fort Ave., Suite 304Baltimore, Md. 21230443-961-3591; [email protected]; vasoptic.com

Vasoptic Medical developed the XyCAM Retinal Imager for estimating blood flow in the retina with high spatio-temporal resolution. The XyCAM is portable and affordable, making it suitable for research involving collection of retinal blood flow data in point-of-care settings. Robust elucidation of blood flow is emerging as a frontier for retinal imaging. The XyCAM enables assessment of flow-derived trends and parameters that may lead to improved diagnostics and disease management.



Viewpoint Life Sciences, Inc. ..................................................................... 737Eric BATUT2550 Bates - Suite 404MONTREAL, QC. H3S 1A7Canada514-343-5003; [email protected]; vplsi.com

ViewPoint offers various solutions with applications in the field of Vision The VisioBox system can accurately analyse movements of the zebrafish eyes subject to visual stimuli surrounding the larvae. Addionnally ViewPoint has a patented technology to evaluate discomfort and eye irritation using worms. This easy to use and HTS solution can be used to evaluate quality of compounds used in shampoo or cream but its sensitivity is so high that we can also discriminate products such as eyewash.

Vision Tiffany Inc. ....................................................................................... 719Tiffany Wang2345 Wentworth Ave., 2nd FloorChicago, Ill. 60606847-287-6688; [email protected]; visiontiffany.com

Vision Tiffany Inc. Is a dedicated eye surgical instrument company • Titanium Instrument & Stainless Instrument reusable and disposables • Surgical Trays • I phone Adapter • Vision Chart and • Portable slit lamps • Slit lamp Digital Adapters Lens Meter

Visionix- Luneau Technology .................................................................. 1702Claire Rzonca224 James St.Bensenville, Ill. 60106800-729-1959, ext. 135; [email protected]; luneautechusa.com

Visionix, a brand of the Luneau Technology Group, is a worldwide leader in wavefront technology for the optical industry. Known for technological innovation, Visionix has set the industry standard for high tech instrumentation utilizing wavefront technology with fully automated operational functionality, offering efficient and affordable technology for eye care professionals.

VO-CRO ..................................................................................................... 1240Taylor Smith1161 21st Avenue S, B3321 MCNNashville, Tenn. 37232-2569443-617-8678; [email protected]; vumc.org/vo-cro

The Vanderbilt Ophthalmic Contract Research Organization (VO-CRO) is a research enterprise dedicated to producing the highest quality pre-clinical data using state-of-the-art technology in ophthalmic disease models. VO-CRO specializes in animal models of oxygen-induced retinopathy, diabetic retinopathy, and laser-induced choroidal neovascularization, along with numerous tissue-based and cell culture techniques. Our team is poised to offer consultation on selecting pre-clinical testing methods.

Volk Optical, Inc. ........................................................................................ 902Carmella Cadusale7893 Enterprise Dr.Mentor, Ohio 44060440-742-9888; [email protected]; volk.com

Volk Optical is the premier manufacturer of ophthalmic lenses for use in diagnosis, laser therapy and surgery. More recently we have diversified our product offering with an addition of diagnostic imaging equipment. * Pictor Plus a 2 lb portable fundus and anterior segment camera * Volk InView a 1lb portable fundus camera that works with your iPhone (5/6/6S) or iTouch * Single-use lenses, great for use on animals



Voxeleron LLC ............................................................................................ 932Jonathan Oakley4695 Chabot Dr., Suite 200Pleasanton, Calif. 94588925-558-2755; [email protected]; voxeleron.com

Voxeleron’s mission is to be the leader in delivering state-of-the-art artificial intelligence and computer vision software for applications in medicine, biology, and beyond. Voxeleron was the first to develop and commercially release platform-independent OCT analysis software in support of clinical and pharmaceutical research. At ARVO we will be demonstrating Orion, our advanced OCT retinal analysis software; and InSight, our animal OCT analysis software.

W

Wasatch Photonics ................................................................................... 1037David Freihofer808 Aviation Parkway., Suite 1400Morrisville, N.C. 27560919-544-7785;[email protected]; wasatchphotonics.com

Wasatch Photonics provides high-resolution, high-sensitivity optical coherence tomography (OCT) solutions. We provide all the tools needed to obtain world class OCT images, including full plug and play systems for a variety of applications. Our OCT solutions are specifically developed for research and OEM applications. We also manufacture spectrometers for Hyperspectral Imaging, NIR, UV-VIS, and Raman spectroscopy. NEW! Software drivers to speed your acquisition, control, and image processing.

WCCT Global Ophthalmology Research Center .................................... 1550Talia Hight5630 Cerritos Ave.Cypress, Calif. 90630714-793-3100; [email protected]; wcct.com

WCCT Global is a multisite, full-service, early phase contract research organization (CRO) for pharmaceutical, biotechnology, and medical device industries. We are specialized regulatory and clinical development professionals who offer an innovative, agile and collaborative approach to every program we deliver.

Welch Allyn ................................................................................................. 818Mary Hart4341 State Street Rd., P.O. Box 220Skaneateles Falls, N.Y. 13153315-685-4100;[email protected]; welchallyn.com

At ARVO, Welch Allyn is featuring the RetinaVue® care delivery model. A proven, turnkey teleretinal solution, RetinaVue is simple and affordable enough for individual practices and scalable for nationwide health programs. RetinaVue Imagers are the world’s most advanced handheld fundus cameras and designed for ease of use allowing any clinician to capture and transmit high-quality retina images. Welch Allyn is a leading medical diagnostic device company and a division of Hill-Rom (NYSE: HRC).



West China-Frontier PhamaTech Co.,Ltd ............................................... 1738Fengruitang28 GaoPeng St., Hi-Tech DistrictChengdu, Sichuan 610041China+86 28-8515 4334, ext. 167; [email protected]; glpcd.com

As a first-class professional organization in China specializing in the evaluation of non-clinical research, Chengdu WestChina-Frontier PharmaTech (National Chengdu New Drug Safety Evaluation Center) is established on international standards and dedicated to providing high-quality pharmacodynamics, toxicology, pharmacokinetics and biological analysis and evaluation, supporting the global applications and registration of drugs in China, North America, Europe, and Australia.

Wicab, Inc. ................................................................................................. 1605Bill Conn8313 Greenway Blvd., Suite 100Middleton, Wisc. 53562608-829-4504; [email protected]; wicab.com

Wicab, Inc. developed and sells the FDA approved BrainPort® Vision Pro vision aid that provides electro-tactile stimulation to aid profoundly blind users in orientation, mobility, and object recognition as an adjunctive device to other assistive methods such as the white cane or a guide dog. BrainPort V100 translates digital information from a wearable video camera into electrical stimulation patterns on the surface of the tongue. Some have described it as seeing with your tongue.

Wolters Kluwer Health ................................................................................ 833Joey-Rose JesterTwo Commerce Sq., 2001 Market St.Philadelphia, Pa. 19103215-521-8300; [email protected]; shop.lww.com

Wolters Kluwer Health is a leading global provider of information and point of care solutions for the healthcare industry. Our solutions are designed to help professionals build clinical competency and improve practice and patient care. We offer evidence-based medical, nursing and allied health content and clinical decision support tools.

World Glaucoma Association .................................................................. 1031Marije de GraafSchipluidenlaan 41062HE AmsterdamThe Netherlands+31 20 570 9600; [email protected]; wga.one/wga

The World Glaucoma Association (WGA) is an amalgamation of glaucoma societies throughout the world. In addition, the association has industry members as well as a patient organization. The WGA membership covers about 12,000 individuals involved in glaucoma in some aspect or another and touches many more glaucoma patients. Its core purpose is to eliminate glaucoma-related disability worldwide.



World Health Organization ....................................................................... 1350Jean Westcott22883 Quicksilver Dr.Sterling, Va. 20166703-661-1541; [email protected]; who.int

Stylus Publishing is the North American distributor for The WHO. The WHO is a Specialized Agency of the United Nations, charged to act as the world’s directing and coordinating authority on questions of human health. It is responsible for providing leadership on global health matters, shaping the health research agenda, setting norms and standards, articulating evidence-based policy options, providing technical support to countries and monitoring and assessing health trends.

World Precision Instruments ................................................................... 1526Carmen Raymond175 Sarasota Center Blvd.Sarasota, Fla. 34240941-371-1003; [email protected]; wpiinc.com

WPI is a leading global laboratory product manufacturer focused on providing scientists with cutting edge laboratory instruments at cost-effective prices. Our popular ARVO display items will feature: surgical / microdissection instrumentation, surgical accessories, loupes and our UltraMicroPump (UMP3) with Nanofil for microinjection.

WuXi AppTec - Laboratory Testing Division ........................................... 1439Lindsey Schwenk101 Morgan LanePlainsboro, N.J. 08536609-917-0047; [email protected]; labtesting.wuxiapptec.com

WuXi AppTec Laboratory Testing Division, Toxicology department has established a professional ophthalmology laboratory so as to provide various services for ophthalmological studies. The provided services include comparative ophthalmologic examination in varieties of toxicity studies, eye irritation, new ocular drug toxicity and toxicokinetics, pharmacodynamics and pharmacokinetics.

Y

YuYu Pharma ..............................................................................................MS4Robert Wonsang YuYuyu Building, 197 Dongho-Ro, Jung-guSeoul, Republic of South Korea+82 2-2253-6600; [email protected]; yuyu.co.kr

Z

Zeiss .......................................................................................................... 1317Varsha Balachandran5160 Hacienda Dr.Dublin, Calif. 94568925-640-5108; [email protected]; zeiss.com/us

Uncovering the undiscovered relies on collaboration. At ZEISS, a new era in open collaboration is bringing clinicians, researchers and scientists together to explore the future of Swept-Source OCT Angiography and multimodality imaging solutions , to better support vision care around the world, today and into the future.



Zilia .............................................................................................................. 838Joannie Desroches050-475 Grande-Allée EQuebec, QC. G1R 2J5Canada833-501-6996; [email protected]; ziliahealth.com

Zilia has developed Zilia Ocular, the first and only ocular oximeter to provide non-invasive, continuous, quantitative and accurate measurements of oxygenation in targeted regions of the retina. Since oxygen supply is proving to be an important factor in multiple ocular diseases, its versatility and high precision make it a powerful tool for researchers and eye care professionals involved in ocular diseases, physiological and metabolic mechanisms, and oxygen regulation.


Exhibitor Education Lounge


Visit the Exhibitor Education Lounge in the Exhibit Hall

Mon., April 29 9amEyeFind Demonstration W. Daniel Stamer, PhD, FARVO, President-Elect, ARVO, and Joseph A.C. Wadsworth Professor of Ophthalmology, Professor of Biomedical Engineering, Duke UniversityKevin Corcoran, CAE. President/CEO, Eye Bank Association of America

11am A Future Outlook at Transforming Patient Care: From Advanced Intelligence to Advanced CollaborationAngelo Rago, Head of Ophthalmic Diagnostics, Carl Zeiss Meditec, Inc.

1pm Rodent ElectrophysiologyDiagnosys LLC

Tues., April 3010am Microvascular biomarkers of Retinal Vessel Analysis and Ophthalmodynamometry Cornelia Schmidt, Benedikt Krauss, Imedos Systems GmbHL

2pm NEI 3-D Retina Organoid Challenge 2020: Eligibility, Submission Criteria, and Sponsorship OpportunitiesSteven Becker, PhD, Health Science Administrator, National Eye Institute

ARVO gratefully acknowledges our Exhibitor Education Lounge Sponsors

EyeFind.org

ISER’s biennial meeting champions the advancement of inter-national eye research by uniting leading clinicians and vision researchers from around the world to share their expertise and experience. Be a part of one of the leading international platforms for the dissemination of cutting-edge knowledge, advances in eye research and treatment of ocular diseases!

#ISER2020 www.iserbiennialmeeting2020.org

SAVE THE

DATE!


Half-Page4-color

ARVOLearn

May 1 – 2, 2020Baltimore Convention Center

Baltimore, Md.

ARVO

ARVO.org/Imaging

ARVOLearn.org

ARVO’s New Option for Online Education


Daily Program

Time Session Title Location

8 – 10am 101 Approaches to restoring vision: Where are we now? [VN, AP, EY, GL, PH, RE, RC, VI]

East Ballroom A

102 A window on the soul: How systemic disease manifests in the eye [AP, EY, GL, RE, VN, GEN]

East Ballroom B

103 The potential and pitfalls of big data [CL, CO, GL, RE, MOI, LV]

East Ballroom C

10:15 – 11:45am

115 ARVO/Alcon Opening Keynote: How cells export proteins and RNA — applications to the treatment of disease

ARVO Ballroom

12noon – 12:45pm

116 Proctor Award and Lecture ARVO Ballroom

1– 2:30pm 117 New perspectives on sub-RPE deposit formation: discussing clinical and molecular progress — SIG [BI, RE, RC]

East 1

118 Protection, Correction, Regeneration: Are combination therapies in the future for Inherited Retinal Degenerations? — SIG [RE, GEN, LV]

East 2/3

119 New ideas about metabolic interactions between photoreceptors and Müller cells — SIG [RC, BI, RE]

East 8&15

120 Diabetic Keratopathy: An Understudied Corneal Disease — SIG [CO]

East 11/12

121 Tear film, inflammation and the nervous system—the three pillars of dry eye disease resulting in symptoms of discomfort — SIG [CO, IM]

East Ballroom A

122 Biomechanical Injury and Inflammatory Signaling in the Eye — SIG [VN, BI, GL, IM, PH, RC, VN, GEN]

East Ballroom B

123 Findings of the International Myopia Institute White Paper Reports — SIG [CL, AP, GEN]

East Ballroom C

123a Functional Imaging Technologies for Regenerative Medicine

West 211

124 Grant writing: Early career funding opportunities

West 217-219

125 Win-win collaborations between academia and industry

West 220

126 The importance of animal research in the bench to bedside pipeline

West 221/222

127 Low Vision Group — The effects of mesopic light levels on vision and functional activities [LV]

West 223/224

128 China-ARVO networking forum West 301

Sunday, April 28■■■Symposia, minisymposia, Keynote, lectures, workshop/SIGs

Symposia and minisymposia highlighted in boldface


Daily Program


Sunday, April 28■■■■Symposia, minisymposia, Keynote, lectures, workshop/SIGs

3 – 4:45pm 147 Uveal Melanoma [AP] East 1

148 Retina [PH] East 2/3

149 Emerging AMD Therapeutics [RE] East 8&15

150 Novel Pathogenic Mechanisms in Diabetic Retinopathy [RC]

East 11/12

151 Myeloid and Innate Immunology of the Retina [IM, AP]

East Ballroom A

152 New and emerging clinical trials endpoints — Minisymposium [RE, CL, GL, RE, RC, VI, GEN, MOI]

East Ballroom B

153 Omics and systems biology approaches for profiling ocular tissues in health and disease [BI]

East Ballroom C

154 Photoreceptors [VN] West 212-214

155 Cataract Surgery, Epidemiology and Clinical Outcomes [LE]

West 217-219

156 Healthcare Delivery [CL] West 220

157 Amblyopia and Visual Plasticity [EY] West 221/222

158 Advanced Imaging of Retinal Structure and Function in Disease [VI]

West 223/224

159 Epstein Award Session [GL] ARVO Ballroom

160 Emerging gene-driven therapies for anterior segment disease — Minisymposium [CO, BI, GL]

Harbour Ballroom


Visit the Gift Shop in ARVO Central to pick up the children’s t-shirt


Time Session Title Board #

Daily Program

Poster board numbers correspond to poster location in Exhibit Hall; A = Poster Area A and B = Poster Area B.

Sunday, April 28 ■■Posters

8 – 9:45am 104 Physiology/Pharmacology [PH] A0091 - A0124

105 AMD screening, risk factors, and conse-quences [CL]

A0125 - A0146

106 AMD anti-VEGF I [RE] A0253 - A0285

107 AMD anti-VEGF II [RE] A0287 - A0320

108 Image Processing and Interpretation [MOI, CL]

A0549 - A0591

109 Animal Imaging [MOI] A0592 - A0617

110 Amblyopia: Mechanisms and Associations [EY]

A0618 - A0636

111 Strabismus: Surgical management and outcomes [EY]

A0637 - A0650

112 Anti-inflammatory agents,antibiotics and antivirals [PH]

B0361 - B0380

113 Dry Eye [CO] B0401 - B0450

114 Keratokonus and corneal crosslinking [CO]

B0504 - B0546

1 – 2:45pm 129 AMD therapies (excluding anti-VEGF) [RE]

A0232 - A0252

130 Gene variants and regulation of ocular genes expression in health and disease [BI]

A0367 - A0420

131 Retinal Degeneration: Animal Models [RC, LV, RE ]

A0421 - A0458

132 Cataract Surgery I [LE, RE] A0459 - A0508

133 Eye Movements and Nystagmus [EY] A0651 - A0671

134 Inner Retinal Circuits [VN] B0001 - B0019

135 Outer Retinal Function [VN] B0020 - B0050

136 Aberrations, Ocular Optics, and Retinal Image Quality [VI]

B0067 - B0090

137 Neuroprotection [GL] B0091 - B0124

138 Neurodegeneration [GL] B0125 - B0161

139 Laser Therapy [GL] B0162 - B0187

140 Clinical Melanoma. Therapy and Complications [AP, CL, MOI]

B0188 - B0206

141 Melanoma: Immunotherapy, Genomics, New Strategies [AP]

B0207 - B0240




Daily Program

Sunday, April 28 ■■Posters

1 – 2:45pmcontinued

142 Mechanistic and translational studies of retinal degeneration and uveitis [IM]

B0241 - B0300

143 Clinical and epidemiological aspects of infection [IM]

B0301 - B0360

144 Corneal Immunology [CO, RC] B0381 - B0400

145 Corneal Epithelium [CO] B0451 - B0482

146 Corneal neovascularization [CO] B0483 - B0503

3 – 4:45pm 161 Visual Impairment - Impact on Daily Activities [LV]

A0001 - A0022

162 Diabetic eye disease [CL] A0023 - A0066

163 Cataractogenesis, Prevention, and Treatment [LE]

A0067 - A0090

164 AMD clinical research I [RE] A0147 - A0190

165 AMD clinical research II [RE] A0191 - A0231

166 AMD Pathogenic Mechanisms [RC, RE] A0321 - A0350

167 From Modeling to Potential Therapies [RC]

A0351 - A0366

168 OCT - New Biomarkers and Technical Improvements [MOI]

A0509 - A0548

169 Color. Adaptation and Sensitivity [VI] B0051 - B0066

5 – 6pm All Posters

Get your

ARVO gear at the

gift shop in ARVO

Central


Daily Program


7 – 8am 201 NAEVR Defense-Related Vision Research Opportunities

West 109/110

8:15 – 10am

202 Advances in Retinoblastoma and Radiation Retinopathy [AP]

East 1

203 Gene therapy and delivery [PH] East 2/3

204 Miscellaneous Maculopathies [RE] East 8&15

205 AMD Pathobiology and New Models [RC] East 11/12

206 Adaptive and Innate Immunity in Ocular Health and Disease [IM]

East Ballroom A

207 AMD Imaging I [RE] East Ballroom B

208 Frontiers in membrane dynamics and cellular communication: Impact on vision and disease mechanisms — Minisymposium [BI, AP, GL, IM, PH, RE, RC, VN, GEN]

East Ballroom C

209 Corneal Cell and Molecular Biology [CO] West 211

210 Circadian rhythms and photoreceptors [VN] West 212-214

211 Cataractogenesis and Cataract Treatment [LE] West 217-219

212 Impact of Visual Impairment [CL] West 220

213 Systemic Disorders: Basic and Translational Studies [EY]

West 221/222

214 Accommodation: Morphology and Mechanisms [VI]

West 223/224

215 Healthcare transformation with AI: Impact in glaucoma and ophthalmology — Minisymposium [GL, BI, CL, RE, VI]

ARVO Ballroom

216 Dry Eye I [CO] West 109/110

10:15 – 11am

202a AP Section Business Meeting East 1

203a PH Section Business Meeting East 2/3

205a RC Section Business Meeting East 11/12

206a IM Section Business Meeting East Ballroom A

207a RE Section Business Meeting East Ballroom B

208a BI Section Business Meeting East Ballroom C

209a CO Section Business Meeting West 211

210a VN Section Business Meeting West 212-214

211a LE Section Business Meeting West 217-219

212a CL Section Business Meeting West 220

213a EY Section Business Meeting West 221/222

214a VI Section Business Meeting West 223/224

215a GL Section Business Meeting ARVO Ballroom

Monday, April 29 ■■Papers, minisymposia, section business meetings



Daily Program


Monday, April 29 ■■Papers, minisymposia and workshops/SIGs

11:15am – 1pm

226 Drug delivery, drug and gene delivery system [PH]

East 2/3

227 Retinal Vascular Disease [RE] East 8&15

228 Retinal Bioenergetics and Metabolic Interactions [RC]

East 11/12

229 Translational immunology in AMD, uveitis and thyroid eye disease [IM]

East Ballroom A

230 Diabetic Retinopathy Therapeutics [RE] East Ballroom B

231 Molecular mechanisms of retinal function in health and disease [BI]

East Ballroom C

232 Ocular Surface Disease [CO] West 211

233 Of mice and men: Comparing primate and rodent retina — Minisymposium [VN, AP, RE, RC]

West 212-214

234 Mendelian Genetics and Animal Models of Retinal Disorder [GEN]

West 217-219

235 Quality of life and the patient experience [CL]

West 220

236 Strabismus and Nystagmus [EY] West 221/222

237 Advanced Imaging of Retinal Structure and Function in Healthy Eyes [VI]

West 223/224

238 New Ideas in Glaucoma [GL] ARVO Ballroom

1:15 – 2:45pm

253 Glia in blood-retina barrier disorders — SIG [RC, GL, IM]

East 1

254 Next generation sequencing for pathogen discovery, ready for prime time? — SIG [IM, RE]

East 2/3

255 Cellular and Molecular Imaging of the Retina in Health and Disease — SIG [RE, AP, BI, GL, IM, PH, RC, VI, VN, MOI]

East 8&15

256 Tear Biomarkers of Ocular Surface Diseases in the Clinic — SIG [CO]

East 11/12

257 Managing Patients with Diabetic Macular Edema, Diabetic Retinopathy, Neovascular and Non-Neovascular AMD, and Retinal Vein Occlusion: How Do We Best Utilize the Latest Data from Clinical Trials — SIG [RE, CL, CO, IM, PH, VI, VN, GEN, MOI]

East Ballroom A

258 Multidisciplinary Ophthalmic Imaging Group — OCT advances in vascular and functional imaging [MOI]

East Ballroom B

259 Aging as a factor in eye diseases — SIG [BI, CO, GL, LE, RE, RC, VN, LV]

East Ballroom C



Daily Program


Monday, April 29■■■■Papers, minisymposia workshops/SIGs, lectures

260 Members-in-Training career forum: Preparing for your future career NOW!

West 211

261 Getting published: The light and dark sides ...

West 212-214

262 Health disparities, social justice and vision research — SIG [CL, CO, EY, GL, GEN, LV]

West 217-219

263 Lipids in diverse functions and pathologies of the eye — SIG [BI, GL, IM, PH, RE, RC]

West 220

264 NIH-CSR peer review workshop West 221/222

265 VSS at ARVO — Vision after sight restoration

West 223/224

3 – 3:45pm

266 Friedenwald Award and Lecture ARVO Ballroom

4 – 5:45pm

267 Aqueous humor dynamics and IOP [PH] East 2/3

268 Imaging the Posterior Segment-Clinical [RE]

East 8&15

269 Emerging cell-based therapies to tackle retinal diseases — Minisymposium [RC, RE]

East 11/12

270 Deep learning for classification and segmentation [MOI]

East Ballroom A

271 AMD-clinical research [RE] East Ballroom B

272 Corneal surgery:non-refractive [CO] West 211

273 Corneal Tissue Engineering and Regenerative Medicine [CO]

West 212-214

274 Lens Cell Biology [LE] West 217-219

275 Visual Impairment and Multi-Morbidity [LV] West 221/222

276 Biomechanics [GL] ARVO Ballroom

277 Neuroprotection [GL] East Ballroom C

7:30 – 9pm

295 Diabetic Retinopathy Treatments: Clinically Relevant Results From the Diabetic Retinopathy Clinical Research Network — Special Session

West 211

296 New Clinical Trial Results in Retinal Vein Occlusion: SCORE2 and LEAVO Trials — Special Session

West 212-214

297 Changing What It Means To Be Blind: We're All in This Together — Special Session

West 217-219

298 New tools and techniques for functional and anatomical retinal circuit dissection — Special Session

West 223/224





Daily Program

Monday, April 29 ■■Posters

8:15 – 10am

217 Imaging Science and Vision Assessment [VI, RC, VN]

A0102 - A0116

218 Machine Learning I [MOI] A0117 - A0160

219 Machine Learning II [MOI] A0161 - A0205

220 Deep Learning & AI [RE] A0206 - A0225

221 Imaging: posterior segment, clinical [RE, LV, MOI, VI ]

A0302 - A0360

222 Glaucoma Genetics [GEN] A0481 - A0507

223 Retinal Vascular Biology [RC] B0265 - B0277

224 Retinal Angiogenesis and ROP [RC] B0278 - B0301

225 Metabolic and Oxidative Control of Retinal Homeostasis and Diseases [RC, RE]

B0302 - B0338

11:15am – 1pm

239 Accommodation, Binocular Function, TBI [VI]

A0056 - A0083

240 Visual Impairment - Measures of Visual Function [LV, CL]

A0084 - A0101

241 OCT - Clinical Applications I [MOI] A0226 - A0262

242 OCT - Clinical Applications II [MOI] A0263 - A0301

243 RPE Biology [RC, RE] A0436 - A0463

244 RPE: Potential Therapies [RC, RE] A0464 - A0480

245 Glaucoma risk factors, progression, and management [CL]

A0508 - A0551

246 Vitreoretinal interface disease [RE] B0019 - B0038

247 Endophthalmitis: clinical [RE] B0039 - B0059

248 Cataract Surgery II [LE] B0339 - B0374

249 Posterior Capsular Opacification [LE] B0375 - B0384

250 Cornea and lens [PH, VI] B0385 - B0400

251 Corneal imaging and topography [CO, CL]

B0401 - B0448

252 Corneal Endothelium I [CO] B0449 - B0483

4 – 5:45pm 278 Optic Neuropathy [EY] A0001 - A0021

279 Multiple Sclerosis and the Eye [EY] A0022 - A0034

280 Idiopathic Intracranial Hypertension, Dementia and Neurodegerative Disorders [EY]

A0035 - A0055

281 Retinoblastoma [AP] A0361 - A0380



Daily Program


4 – 5:45pm continued

282 Biochemistry and Molecular Biology of the Retina [BI]

A0381 - A0435

283 Clinical Studies [GL] A0552 - A0568

284 IOP Measurement [GL] A0569 - A0601

285 Visual Fields, Psychophysics, and Electrophysiology [GL, RC]

A0602 - A0654

286 Advances in Human Electrophysiology [VN]

A0655 - A0674

287 Ocular Trauma [CL] B0001 - B0018

288 Fundamentals of ocular infection 1 [IM] B0060 - B0084

289 Retinal Vascular Diseases II [RE] B0085 - B0127

290 Diabetic Macular Edema Clinical Research [RE]

B0128 - B0179

291 Biochemistry and molecular mechanisms of diabetic retinopathy [BI]

B0180 - B0212

292 Diabetic Retinopathy: Pathogenic Mechanisms [RC, RE]

B0213 - B0249

293 New Therapeutic Avenues in Diabetic Retinopathy [RC]

B0250 - B0264

294 Corneal Dry Eye Clinical II Epidemiology [CO]

B0484 - B0525


Monday, April 29 ■■Posters

For the latest program informationThis ARVO Annual Meeting program information is up to date as of April 5, 2019. For the latest changes to any program or session, download the ARVO 2019 mobile app or visit the Online Planner at ARVO.org/AM/Program.


Daily Program


Tuesday, April 30 ■■Papers, minisymposia, general business meeting


7 – 8:30am

301 Diabetes and its Ocular Complications — SIG [RE, CL, CO, GL, GEN, MOI]

East 1

302 Cutting funding requirements of third world researchers by 3D-printers, drone slit-lamps and AIRBNB-style equipment sharing — SIG [RE]

East 8&15

303 OCT Guided and Robotically Enabled Ophthalmic Surgery — SIG [MOI, CO, GL, RE]

East 11/12

304 The New face of (presumed) Intraocular Tuberculosis — SIG [IM]

West 212-214

305 Selective autophagy: a new therapeutic target for retinal diseases —SIG [ RC, BI, PH, RE, GEN]

West 217-219

306 Patient Engagement in Ophthalmology Research— SIG [CL, AP, BI, CO, EY, GL, IM, LE, PH, RE, RC, VI, VN, GEN, LV, MOI]

West 220

307 Metamorphopsia – an update on diagnostic methods, treatment, and evaluation of novel instruments and questionnaires — SIG [LV, RE, VI, VN]

West 221/222

308 Hyperreflective intraretinal spots (foci) in macular diseases: from bench to bedside — SIG [RE, RC, GEN, MOI]

West 223/224

309 Breakfast with the experts Harbour Ballroom

8:45 – 10:30am

310 Non-Melanoma Tumors: Genetics and Therapeutics [AP, RC]

East 1

311 Diabetic retinopathy [PH] East 2/3

312 Macular edema and neuroprotection-translational studies [RE]

East 8&15

313 Microglia and Innate Immunity [RC] East 11/12

314 Diabetic Retinopathy: Clinical Imaging [RE] East Ballroom B

315 Gene variants in major ocular diseases [BI] East Ballroom C

316 Dry Eye II [CO] West 211

317 Laser Therapy [GL, LE] West 212-214

318 Glaucoma Genetics Development with advanced technology & large datasets [GEN]

West 217-219

319 Aging with Vision Loss: Understanding the aging consequences of visual impairment — Minisymposium [CL]

West 220

320 Clinical outcomes and visual quality with retinal prosthetic vision restoration — Minisymposium [VI, EY, VN, LV]

West 223/224

321 Neurodegeneration [GL] ARVO Ballroom


Daily Program


Tuesday, April 30 ■■■Business meeting, papers, minisymposia, workshops/SIGs


8:45 – 10:30amcontinued

322 Visual Fields, Psychophysics, and Electrophysiology [GL]

East Ballroom A

10:45 – 11:30am

339 General Business Meeting West 211

11:45am – 1:30pm

340 Retina/RPE New drugs, Mechnisms of action, and Toxicility [PH]

East 2/3

341 Update on endophthalmitis [RE] East 8&15

342 Retinal Angiogenesis and Related Mechanisms in Vascular Biology [RC]

East 11/12

343 Innate immune memory and the eye — Minisymposium [IM, AP, CO, RE]

East Ballroom A

344 AMD Translational studies [RE] East Ballroom B

345 Highlights of OCT angiography [MOI] East Ballroom C

346 Lacrimal gland biology in homeostasis, disease, and repair — Minisymposium [CO]

West 211

347 Unresolved issues in myopia — Minisymposium [AP, BI, CL, PH, RE, VI, VN]

West 212-214

348 Lens Development [LE] West 217-219

349 Visual Training and Rehabilitation [LV] West 221/222

1:45 – 2:30pm

367 Weisenfeld Award and Lecture ARVO Ballroom

2:45 – 4:30pm

368 Retinal Development [RC] East 8&15

369 RPE Biology in Health and Disease [RC] East 11/12

370 Uveitis clinical epidemiology and therapeutics [IM]

East Ballroom A

371 DME Therapies and Outcomes [RE] East Ballroom B

372 Retinal degeneration: molecular disease mechanisms [BI]

East Ballroom C

373 Corneal endothelium and Fuchs corneal dystrophy [CO]

West 211

374 Ganglion cells and beyond [VN] West 212-214

375 Contact lens [CO] West 217-219

376 Myopia: Behavior and interventions [CL] West 220

377 Mechanisms and biomechanics of traumatic retinal hemorrhage in children — Minisymposium [EY, RE]

West 221/222

378 Vision assessment and modeling in health, and with impairment [VI]

West 223/224


Daily Program


Tuesday, April 30 ■■Papers, MIT poster awards and lectures

Happening Tonight ...MIT Outstanding Poster CompetitionTuesday, April 29, 4:15 – 5:45pm, Exhibit Hall

MIT First Authors of the top five scored poster abstracts from each Scientific Section and Cross-sectional Group will participate in the MIT Outstanding Poster Award Competition. One award recipient from each Scientific Section and Cross-sectional Group will be selected by the MIT Committee. Award recipients will be selected based on how well a poster displays the abstract’s research and on how effectively the MIT First Author discusses the research with the judges and with meeting participants.

All meeting participants are invited to view the competing posters and presentations.


2:45 – 4:30pmcontinued

379 Clinical Studies [GL] ARVO Ballroom

380 Structure-Function Relationships [GL] Harbour Ballroom

4:15 – 5:45pm

390 MIT Outstanding Poster Award Competition West Exhibit Hall

5:45 – 6:45pm

392 ARVO/Champalimaud Award Lecture ARVO Ballroom



Daily Program


Tuesday, April 30 ■■Posters

8:45 – 10:30am

323 Stem Cells and Retinal Organoids: Disease modeling [RC]

A0033 - A0049

324 Stem Cell based Approaches for Transplantation and Therapies [RC]

A0050 - A0066

325 Gene Therapy and Delivery [PH] A0083 - A0113

326 Retina genetics [GEN, CL] A0210 - A0236

327 AMD [GEN, LV] A0237 - A0254

328 AMD Translational Studies [RE, LE] A0255 - A0281

329 OCTA in AMD/DR/Glaucoma/Ischemia [MOI]

A0342 - A0393

330 OCTA in Healthy/Aging Eyes [MOI] A0394 - A0410

331 OCTA - Experimental Applications and Technical Improvements [MOI]

A0411 - A0441

332 Animal Models for Visual Disease and Restoration [VN]

A0490 - A0514

333 Pediatric eye disease [CL] B0041 - B0059

334 Genetics and Light dependent mechanisms in myopia [AP]

B0190 - B0210

335 Lens Physiology and Accommodation [LE, MOI]

B0211 - B0228

336 Aqueous humor Dynamics and IOP [PH] B0355 - B0376

337 Corneal Epithelium Wound Repair and Healing [CO]

B0377 - B0407

338 Corneal neuropathy: Diabetic and other [CO]

B0476 - B0486

11:45am – 1:30pm

350 Stem Cells and Retinal Organoids: Development [RC, CL, GL]

A0001 - A0032

351 Drug delivery, drug and gene delivery system, implant delivery [PH]

A0114 - A0154

352 Gene therapy for ocular disorders [BI] A0156 - A0197

353 Genome, chromatin structure and functional genomics [BI]

A0198 - A0209

354 AMD Imaging [RE, VN] A0282 - A0341

355 Uveitis and scleritis - clinical therapeutics and checkpoint inhibitors [IM]

A0540 - A0576

356 Non-Melanoma, Non-Retinoblastoma Intraocular Pathology & Retinopathy [AP, CL, CO, LV, RE, VN ]

A0577 - A0594

357 Tumors: Eyelids, Orbit, Ocular Surface, Conjunctiva, and Ocular Adnexa [AP, CO, EY]

A0595 - A0627




Daily Program

Tuesday, April 30 ■■Posters

11:45am – 1:30pmcontinued

358 Neuro-ophthalmology: Genetics and Investigational modalities [EY]

B0001 - B0019

359 Pediatric Ophthalmology [EY] B0020 - B0041

360 Consequences of vision impairment [CL] B0060 - B0071

361 DME anti-VEGF I [RE] B0148 - B0178

362 Retinal Laser Therapeutic Applications and Innovations [RE]

B0179 - B0189

363 IOLs: Calculations, Vision, Implantation, Multifocals [VI]

B0229 - B0274

364 Surgery and Wound Healing I [GL] B0275 - B0314

365 Pharmacologic Interventions and Cellular Mechanisms [GL, RE]

B0315 - B0354

366 Corneal Endothelium II [CO] B0487 - B0517

2:45 – 4:30pm

381 Retina/RPE transplantation and Stem Cell [RE, LV]

A0067 - A0082

382 Retinal disease epidemiology [CL] A0442- A0475

383 Retinal Degenerations - Cilia and Ciliopathies [RC]

A0476 - A0489

384 Retinal Microglia and Neuroinflammation [RC, GL]

A0515 - A0539

385 Visual Impairment - Assistive Devices and Rehabilitation [LV]

B0072 - B0103

386 Retinal Vascular Diseases I [RE] B0104 - B0147

387 Corneal Tissue Engineering and Regenerative Medicine [CO]

B0408 - B0465

388 Corneal Development and Cell Differentiation [CO]

B0466 - B0475

389 Tear film, Lacrimal and Meibomian Glands [CO, EY]

B0518 - B0557

4:45 – 5:45pm

All Posters


Daily Program


Wednesday, May 1 ■■Papers and minisymposia


8:15 – 10am

401 P2X7 receptor: One target for inflammatory responses in different ocular diseases — Minisymposium [PH, CO, IM, RE, RC]

East 2/3

402 Retinal Degeneration [RC] East 8&15

403 Repurposing drugs for the treatment of retinal diseases — Minisymposium [RC, BI, RE]

East 11/12

404 AMD Imaging II [RE] East Ballroom B

405 Gene editing & new cell-based and animal models for ocular disease [BI]

East Ballroom C

406 Corneal imaging and topography [CO] West 211

407 ERG: Advances, Disease and Injury [VN] West 212-214

408 GWAS & Beyond: Epigenetics and Functional Characterization [GEN]

West 217-219

409 Epidemiology of Corneal Disease [CL] West 220

410 Visual Impairment- Impact on Driving and Mobility [LV]

West 221/222

411 Refraction, Biometry, and Myopia [VI] West 223/224

412 Ocular Blood Flow [GL, RC] ARVO Ballroom

413 Corneal Neuropathy and Neovascularization [CO]

Harbour Ballroom

10:15am – 12noon

432 Advanced imaging technologies [MOI] East 1

433 Blood Flow [PH] East 2/3

434 Retinopathy of Prematurity [RE] East 8&15

435 Stem Cells and Organoids [RC] East 11/12

436 Precision through measurement: Biomarkers in health and disease — Minisymposium [IM, RE, VN]

East Ballroom A

437 Diabetic Retinopathy-Screening and Clinical Imaging [RE]

East Ballroom B

438 Corneal biomechanics, keratoconus and crosslinking [CO]

West 211

439 Inner Retinal Function [VN] West 212-214

440 Lens Biochemistry [LE] West 217-219

441 Retinal disease screening and risk factors [CL]

West 220

442 Optic Neuropathy [EY] West 221/222

443 Myopia Progression and Control: Animal and Clinical Studies [AP]

West 223/224


Daily Program


10:15am – 12nooncontinued

444 Imaging [GL] ARVO Ballroom

445 Corneal Epithelium in Health and Disease [CO]

Harbour Ballroom

12:15 – 1:45pm

457 Eye and Brain - the interrelationship and pathology (Second Edition) —SIG [VN, EY, GL, IM, RE, MOI]

East 1

458 Excellence in sight: enhancing the methodological rigor of clinical research to inform eye care practice and future research — SIG [CL, CO, GL, LE, RE]

East 2/3

459 Integrating Robotics into Ophthalmic Surgery — SIG [RE]

East 8&15

460 Retinal Ganglion Cell Differentiation from Pluripotent Stem Cells: Applications for Studying Development, Modeling Retinal Degeneration, and as a Vehicle for Cellular Replacement — SIG [RC, GL, RE, VN]

East 11/12

461 Choriocapillaris Imaging with OCT Angiography — SIG [MOI, GL, RE]

East Ballroom A

462 Genetics Group — Spotlight on retinal ciliopathy from genetics to mechanism [GEN]

East Ballroom B

463 Developing Eye Drops in Ophthalmology: Practical Considerations for Smooth Translation to the Clinic — SIG [GL, AP, IM, LE, PH, RE, RC]

East Ballroom C

464 Scientists as entrepreneurs (or how to apply your science to business)

West 211

465 How do I tell m(e)y(e) story? Why effective communication is needed now more than ever to increase research funding

West 212-214

466 Clinician-scientist forum: How to become a successful clinician-scientist

West 217-219

467 The role of the human microbiome in ocular disease — SIG [IM, RE, GEN]

West 220

468 Overcoming the challenges of international collaboration in ocular research

West 221/222

469 Ethical challenges and solutions for CRISPR treatment in human eye disorders

West 223/224

470 Advances and Challenges in Utilization of Artificial intelligence in Ophthalmology Research and Clinical Practice — SIG [RE, CO, GL, MOI]

Harbour Ballroom

Wednesday, May 1 ■■Papers, minisymposia, lectures and workshops/SIGs



Daily Program



Wednesday, May 1 ■■■Papers, minisymposia, lectures, SIGs and special sessions

2 – 2:45pm

471 Cogan Award and Lecture ARVO Ballroom

3 – 4:45pm

472 Retinitis Pigmentosa-Clinical [RE] East 8&15

473 Neuroprotection [RC] East 11/12

474 Ocular surface infection and inflammation [IM]

East Ballroom A

475 AMD clinical trials [RE] East Ballroom B

476 Advanced therapies for ocular disease [BI] East Ballroom C

477 Dry eye clinical [CO] West 211

478 Trabecular Meshwork and Ciliary Body [GL] West 212-214

479 Physiological biochemistry of the lens — Minisymposium [LE]

West 217-219

480 Genetic Epidemiology [CL] West 220

481 Imaging in Neuro-ophthalmic Disorders [EY]

West 221/222

482 The choroid in ocular physiology, pathology and myopia [AP]

West 223/224

483 Surgery and Wound Healing [GL] ARVO Ballroom

484 Corneal Stroma Wound Healing and Repair [CO]

Harbour Ballroom

6:15 – 7:45pm

498 Focal vs global: Is Keratoconus pathology driven by focal corneal tissue changes or is it a global corneal defect influenced by systemic factors? — SIG [CO, BI, GEN, MOI]

East 1

499 Fluorescence lifetime imaging ophthalmoscopy from bench to bedside — SIG [IM, RE]

East 2/3

499a New perspectives on MIGS — SIG [GL] East 8&15

499b Using, fluid biopsies, for decision-making in personalized medicine in ophthalmology — SIG [CO, AP, GL, IM, RE, RC, GEN]

East 11/12

499d Pathogenesis of TB-associated uveitis: current status and future directions — SIG [IM, AP, PH, RE]

East Ballroom B

499e Wnt Signalling and regenerative medicine for retinal vascular disease — SIG [RE]

East Ballroom C

499f Military Relevant Priorities and Strategies for Injury Diagnostics and Treatments — Special Session

West 211

499g The Role of the Tie2 Pathway in Ocular Disease — Special Session

West 212/214




Daily Program

Wednesday, May 1 ■■■Posters

8:15 – 10am

414 Lens Development [LE] A0001 - A0014

415 Anatomical changes during ocular morphogenesis and disease [AP]

A0015 - A0045

416 Structure, function and optics in physiological and pathological myopia [AP]

A0046 - A0089

417 Peripheral Vision, Perimetry and Cortical Function [VI]

A0101 - A0113

418 Muller Cells in Health and Disease [RC, GL]

A0278 - A0293

419 Retinal Trauma, PVR and Mesenchymal Transition [RC]

A0294 - A0306

420 Amblyopia: Vision Screening and Epidemiology [EY]

A0307 - A0319

421 Strabismus: Diagnosis and Evaluation [EY] A0320 - A0336

422 Prevalence of vision impairment [CL] A0337 - A0351

423 Patient perspectives and reported outcomes [CL]

A0352 - A0366

424 Retinitis pigmentosa (clinical) I [RE] A0405 - A0431

425 Retinitis pigmentosa (clinical) II [RE] A0432 - A0457

426 OCTA in Ocular, Cerebral and Systemic Diseases/Disorders [MOI, RC]

A0514 - A0562

427 Adaptive Optics [MOI] A0563 - A0598

428 Fundamentals of ocular infection 2 [IM] B0108 - B0143

429 Corneal Stroma and Keratocytes [CO] B0175 - B0186

430 Corneal Stroma and Keratocytes [CO] B0187 - B0215

431 Microbiome, Ocular Surface Diseases [CO, VN]

B0254 - B0302

10:15am–12noon

446 Refractive Error. Ocular Biometry and Biomechanics [VI]

A0090 - A0100

447 Retinal Ganglion Cells and Optic Neuropathies [RC]

A0164 - A0183

448 Neuroprotection [RC] A0184 - A0210

449 Biochemical and molecular mechanisms of age-related macular degeneration [BI, LV]

A0211 - A0242

450 Retinal disease: molecular mechanisms and gene editing [BI, LV]

A0243 - A0277

451 Visual Impairment and Patient Reported Outcomes [LV]

A0367 - A0380

452 Retinal Prostheses [RE] A0381 - A0404



Daily Program


Wednesday, May 1 ■■■Posters

453 Macular Diseases Excluding AMD [RE, RC] A0458 - A0513

454 Cornea surgery: refractive [CO] B0144 - B0174

455 Corneal Cell and Molecular Biology [CO] B0216 - B0253

456 Trabecular Meshwork and Ciliary Body [GL] B0522 - B0568

3 – 4:45pm 485 ipRGCs and Circadian Rhythms [VN] A0114 - A0128

486 Ganglion cells and Beyond [VN, VI] A0129 - A0163

487 Screening and Risk Factors in Diabetic Retinopathy [RE, VN]

B0001 - B0016

488 Diabetic Retinopathy Imaging [RE, RC] B0017 - B0048

489 Diabetic retinapathy, cytokines and growth factors [PH]

B0049 - B0071

490 AMD and Antiangiogenic agents [PH] B0072 - B0107

491 Cornea and diabetes-related disorders [GEN]

B0303 - B0322

492 Healthcare Delivery [CL] B0323 - B0374

493 Medical education, training, and EHR implementation [CL]

B0375 - B0403

494 Imaging I [GL] B0404 - B0453

495 Imaging II [GL] B0454 - B0504

496 Ocular Blood Flow [GL] B0505 - B0521


Happening Tonight ...

ARVO Classical Concert Wed., May 1, 8–10pmVancouver Convention Centre | West 301

Performed by multi-talented ARVO members. Relax and enjoy the music.

ARVO Karaoke*Wed., May 1, 9pm–12midnight Blackbird Public House | 905 Dunsumir St.

Admission includes one drink. Cash bar and light snacks available. You must be 21 years or older to attend this event.

*Ticket required. Tickets available on Sat. at Registration, and Sun. – Wed. at ARVO Central.


Daily Program


Thursday, May 2 ■■Symposia, papers and SIGs


8 – 10am 501 The gut-eye axis: Emerging roles of the microbiome in ocular immunity and diseases [RC, IM, RE, CL, CO, BI]

West 212-214

502 The single cell revolution: Novel insights and applications for single cell RNA sequencing in eye research [IM, AP, BI, CO, PH, RC, VN, GEN]

West 217-219

10:15am – 12noon

528 Mechanistic analysis of ocular morphogenesis, growth and disease [AP]

East 1

529 AMD and Antiangiogenic agents [PH] East 2/3

530 Advances in Retinal Gene Therapy and Stem Cells [RE]

East 8&15

531 Biology of Retinal Neurons [RC] East 11/12

532 Ocular microbiology and vaccines [IM] East Ballroom A

533 Retinal Surgery and PVR [RE] East Ballroom B

534 Biochemistry and molecular biology of diabetic retinopathy [BI]

East Ballroom C

535 Corneal surgery- refractive [CO] West 211

536 Visual Diseases and Protection [VN] West 212-214

537 Posterior Capsular Opacification [LE] West 217-219

538 Myopia prevalence and progression [CL] West 220

539 Brain and the Eye [EY] West 221/222

540 Intraocular Lenses and Presbyopia Correction [VI]

West 223/224

541 Pharmacological Interventions and Cellular Interventions [GL]

ARVO Ballroom

12:15 – 1:45pm

552 The implications of immune response in ocular gene therapy — SIG [RE, CL, IM, PH]

East 1

553 Re-Engineering Clinical Perimetry — SIG [GL, RE, VI, VN, LV]

East 8&15

554 Exploring Controversial Issues in BEST1-related Retinal Disease — SIG [RC, RE]

East Ballroom A

555 Optical Coherence Tomographic Angiography of the Eye — SIG [MOI, GL, RE]

East Ballroom B

556 EVER/ARVO workshop: The breadcrumb trail in glaucoma: From biology to the patient

West 211

557 Lipids and Eye Diseases- where should we focus? — SIG [BI, RC]

West 212-214


Daily Program


Thursday, May 2 ■■Keynote, lecture and workshops

558 Emerging Biological Functions of Non-canonical Photodetection — SIG [VN, AP, BI, RE, RC, GEN]

West 217-219

559 Are there alternatives to in vivo models in eye research? — SIG [GL, BI, IM, PH, RE, GEN]

West 220

560 Addressing global blindness through international research collaborations — Next frontier for 2020

West 221/222

561 Chinese Ophthalmology Society (COS) workshop: Cell biology and stem cells

West 223/224

562 NEI grants Workshop: New NIH regulations concerning human subject and animal research

Harbour Ballroom

3:15 – 4:15pm

564 Beckman-Argyros Award in Vision Research

ARVO Ballroom

4:30 – 6pm

565 ARVO/Alcon Closing Keynote: Models of translational science to span innovation gaps in academia

ARVO Ballroom

www.worldglaucomacongress.org

9th WORLD GLAUCOMA CONGRESSMARCH 24 - 27, 2021 KYOTO, JAPAN

SAVE THE DATE!




Daily Program

Thursday, May 2 ■ Posters

8 – 9:45am 503 Glaucoma: biochemistry and molecular biology, genomics and proteomics [BI]

A0001 - A0030

504 Proteomics, lipidomics, metabolomics and systems biology [BI]

A0031 - A0043

505 Lens Biochemistry and Cell Biology [LE] A0044 - A0062

506 Retina/RPE new drugs, mechanism of action, and toxicity [PH]

A0099 - A0119

507 Blood flow, Ischemia/reperfusion, hypoxia and oxidative stress [PH]

A0120 - A0140

508 Vitreoretinal Surgery, Novel Techniques and Clinical Applications [RE]

A0191 - A0250

509 Proliferative Vitreoretinopathy- Translational Studies [RE]

A0251 - A0261

510 Myopia and Refractive Error [CL] A0314 - A0358

511 Molecular mechanisms and anatomical changes in experimental myopia [AP, CL]

A0359 - A0395

512 Vision Assessment & Performance. Aging. Driving [VI, CL, LV, PH]

A0396 - A0442

513 Visual Disease Models and Restoration: Humans [VN]

A0443 - A0461

514 Animal Electrophysiology [VN] A0462 - A0475

515 Retinal Cell Biology [RC] A0476 - A0503

516 Retinal Development [RC] A0504 - A0529

517 Photoreceptor Cell & Developmental Biology [RC]

A0530 - A0549

518 Functional Genomics Characterization and animal models [GEN, LE, LV, RE ]

A0550 - A0573

519 Functional and Molecular Imaging [MOI] A0574 - A0584a

520 Multidisciplinary Imaging Technologies and Applications [MOI, GEN, RC ]

A0585 - A0631

521 Structure/Function Relationships [GL, RE]

B0001 - B0033

522 Biomechanics [GL] B0034 - B0069

523 Orbit and Thyroid eye Disease [EY] B0184 - B0203

524 Eyelid and Lacrimal System [EY] B0204 - B0225

525 Conjunctival Cell Biology, Disease and Surgery [CO, AP]

B0227 - B0252

526 Corneal surgery-non refractive [CO] B0323 - B0376

527 Contact lens [CO] B0414 - B0469



Daily Program


Thursday, May 2 ■ Posters

10:15am –12noon

542 Cataract, Cornea, and Ocular Surface Disease [CL]

A0063 - A0098

543 Retinopathy of Prematurity, Detection and Clinical [RE]

A0141 - A0167

544 Diabetic Retinopathy and Surgery [RE] A0168 - A0190

545 Retinal Detachment, Trauma and Repair [RE, BI, CO, RC]

A0262 - A0313

546 Surgery and Wound Healing II [GL] B0070 - B0111

547 Uveitis / ocular inflammatory disease: Epidemiology, clinical characteristics and QoL [IM]

B0112 - B0158

548 Non-infectious anterior segment / orbital inflammation and allergy [IM]

B0159 - B0183

549 Cornea Dry Eye Clinical Treatment [CO] B0253 - B0284

550 Cornea Dry Eye Clinical I Diagnostics [CO, MOI]

B0285 - B0322

551 Corneal biomechanics [CO] B0377 - B0413


Visit the

gift shop in

ARVO Central

located in the

Exhibit Hall


*

*

Ways to give• In ARVO Central in the Exhibit Hall• ARVOFoundation.org/Donate•Mobile app

Your gift brings young researchers to ARVO 2020in Baltimore

“Donate today and I’ll match your gift!”Your generous gift today will support travel awards for young scientists to attend next year’s Annual Meeting.

— Steve T. Charles, MD

CME/CPD Information


Statement of Need Ophthalmic researchers and physicians are many times unaware of and/or have limited exposure to the most recent research advances in vision and ophthalmology. This research continuously evolves toward enhancing the general understanding of the eye and visual systems, which gives rise to new pre-clinical treatment options, and revised standards of practice. Exposure to this new information is a critical first step in enhancing the understanding of basic eye functions and vision disease processes.

Target Audience The educational design of this activity addresses the needs of basic researchers, clinician-scientists, ophthalmologists, ophthalmology residents, optometrists, post-doctoral fellows, graduate students, PhD candidates, medical students and research assistants/associates involved in the treatment of patients with eye and vision diseases and disorders.

Educational Objectives After participating in this CME activity, participants should be able to:

• Discuss the results of basic and clinical ophthalmology investigations and vision research underway, relevant to my area of interest or practice.

• Describe new models and methods being used by researchers andpractitioners in eye and vision science.

• Cite ways in which new research data and methods may influencemy research and/or practice.

• Discuss prospective advancements in eye and vision researchand/or practice.

Physician Accreditation Statement The Association for Research in Vision and Ophthalmology (ARVO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physician Credit Designation ARVO designates this live activity for a maximum of 29.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

International Attendees: The American Medical Association (AMA) has determined that physicians not licensed in the U.S. who participate in CME activities are eligible for AMA PRA Category 1 Credit™.

The following Annual Meeting session types are not certified as Continuing Medical Education (CME) and are not eligible for AMA PRA Category 1 Credit™: ALCON/Keynote series, Award lectures, Posters, SIGs, and Special sessions.

CME/CPD Information


American Board of Ophthalmology (ABO) Diplomates Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to satisfy the Lifelong Learning, Self-Assessment, Improvement in Medical Practice and/or Patient Safety requirements for the American Board of Ophthalmology’s Maintenance of Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting MOC credit.

The Annual Meeting qualifies for Lifelong Learning (Part II). Credits will be reported to the ABO via the ACCME in September each year.

ARVO does not solicit commercial support so learner data will not be shared with any entity other than the ACCME for the purpose of granting MOC credit. Attendees will be able to provide the required information for MOC credit tracking on the Overall Meeting Evaluating Form. By providing the required information, attendees will be giving ARVO permission to share their learner data with the ACCME.

Royal College of Physicians and Surgeons of Canada Fellows and Health Care Professionals participating in the Maintenance of Certification Program can record credits earned at the Annual Meeting toward Section 1: Group Learning Credits.

European Union of Medical Specialists (UEMS) CME/CPD Requirements European physicians can convert CME credit from the Annual Meeting to meet European Union of Medical Specialists (UEMS) CME/CPD requirements.

The American Medical Association has an agreement of mutual recognition of CME credits with the UEMS, the accreditation body for European countries. Physicians interested in converting AMA PRA Category 1 Credit™ to UEMS-European Accreditation Council for Continuing Medical Education CME credits (ECMECs) should contact the UEMS at [email protected].

Certificate of Participation ARVO is accredited to offer AMA PRA Category 1 Credits™ to physicians. All other participants in the CME program may receive a Certificate of Participation that documents the number of CME hours attended* by following the same instructions listed above and paying the CME credits and certificates fee. *Some accrediting agencies may award equivalent Continuing Education (CE) credit when presented with a Certificate of Participation from an activity that offered AMA PRA Category 1 Credit™. Check with your accrediting agency for information. Instructions to receive credit and/or certificates Attendees interested in claiming AMA PRA Category 1 Credits™ for attendance at the Annual Meeting must pay the CME credits and

CME/CPD Information


certificates fee. Payment is collected during the registration process by adding “CME credits and certificates” as a session. Attendees who do not register for CME before the conclusion of the meeting will not be able to claim and request credit. Attendees registered as guests are not eligible to receive CME credit.

CME registrants will receive an email from “ARVO 2019 CME” with credit claiming instructions prior to the start of the Annual Meeting or within two business days of your purchase (whichever is later). All requests for credit must be submitted no later than 11:59pm U.S. Eastern Time on Friday, Aug. 30, 2019.

Contact Us ARVO 1801 Rockville Pike, Suite 400 Rockville, Md. 20852, USA Email: [email protected], p. +1.240.221.2900

Certificate of Attendance Certificates of attendance are available free to all attendees. These certificates state that one has attended the Annual Meeting; but does not offer credit tracking. They will be available for pick-up onsite at the meeting registration desk and ARVO Central in the exhibit hall.

CME credits and certificate fee Advance Onsite MIT, Student Non-Member $59 $59 Member, Non-Member, Exhibitor (paid full-meeting access badge)

$79 $99

Exhibitor (complimentary full-meeting access badge only)

$89 $89

Disclaimer The Annual Meeting provides a forum for the open exchange and discussion of research results and scientific advancements in the field of ophthalmology; however, ARVO makes no representation or warranty as to the truth, originality, or accuracy of the information presented at the meeting or in materials distributed in connection with them. Nor are the views expressed by the individual speakers necessarily the views of ARVO. ARVO supports the ACCME’s policy on evidence-based content and encourages faculty to adhere to these standards when planning a presentation.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this meeting is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

CME/CPD Information


Disclaimer off-label use The Annual Meeting may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. ARVO does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Disclosure of conflicts of interest ARVO requires instructors, planners, managers and other individuals and their spouse/ partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ARVO for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

ARVO considers presenting authors, not co-authors, to be in control of the educational content. It is ARVO’s policy and traditional scientific publishing practice to acknowledge all people contributing to the research, regardless of CME control of the live presentation of that content. ARVO collects and publishes disclosures from all co-authors although they do not have control of the CME content.

Disclosure information for presenters will be provided within initial disclosure slides, prior to the start of their respective presentations.

Disclosure for all individuals involved in planning and managing this CME activity are listed here with their relevant disclosure information.

The planners and managers reported the following financial relationships or relationships to products or devices that they or their spouse/life partners have with commercial interests related to the content of this CME activity:

Annual Meeting Program Committee (AMPC) Chair: Justine R Smith, FRANZCO, PhD, FARVO; Nothing to disclose.

The following individuals on the AMPC reported financial relationships. Name Commercial interest (nature of the

relationship) Regan Scott Ashby, PhD Australian International Patent Application

PCT/AU2017/050310 relating to a treatment for myopia: (P)

CME/CPD Information


Name Commercial interest (nature of the relationship)

Alexandra Benavente-Perez, MCOptom, MS, PhD

Johnson and Johnson Vision: (F)

Nicole Ann Carnt, PhD, BOptom

CooperVision: (R); Alcon: (F)

Netan Choudhry, MD, FRCS(C)

Allergan: (C); Bayer: (C); Carl Zeis Meditec: (F); Topcon: (C); Optos PLC (C, R); Ellex: (R)

Allen C. Clermont, MS Kalvista Pharmaceuticals, Inc.: (C)

M. Francesca Cordeiro, MD, PhD

Allergan: (F,C,R); Visufarma: (F,C,R); DARC: (P); Dompe: (F,R); Santhera: (C,R); Annexon: (F,R); Thea: (F,R) Novartis: (F,R) Santen: (F,R); Heidelberg Engineering: (F, R)

Timothy W. Corson, PhD 62/664,601: (P); 62/664,584: (P); 62/628,093: (P); 15/889,464: (P); PCT/US2016/062851 (P); US 2016/0222388 A1: (P); US 2016/0060241 A1

Ross C. Ethier, PhD, FARVO

Camras Vision: (C); Equinox: (C)

Robert Finger, PhD Novartis: (F,C); Bayer: (C); Santhera: (C); RetinaImplant: (C)

Murray Fingeret Aerie: (C); Allergan: (C); Bausch + Lomb: (C); Carl Zeiss Meditec: (C,I); Diopsys: (C); Heidelberg Engineering: (C, I); Topcon: (C, I)

Thomas A. Fuchsluger, MD, PhD, FEBO, MSc

EVER: (P,S); Santen: (R); Ursapharm: (R); Alcon: (R)

Anat Galor, MD Allergan: (F); Shire: (C); Novaliq: (C)

Paul D. Gamlin, PhD, FARVO

Editas Medicine: (F); AGTC: (F); Lacerta Therapeutics: (F)

Brian C. Gilger, DVM, MS, Dipl. ACVO, Dipl. ABT, FARVO

Bedrock Therapeutics: (I, P)

Neena B. Haider, PhD Ocugen: (F,R,S): SPOUSE: Neurotech: (E)

Tatjana C. Jakobs, MD Springer Science & Business Media: (R); Santen Inc.:(R); Qiagen: (I); Biogen: (I); Merck: (I)

Yali Jia, PhD Optovue Inc.: (F, P)

Noriko Koizumi, MD, PhD Kowa Company Ltd.: (F,C); M’s Science Corporation: (F,C); Senju Pharmaceutical Co., Ltd.: (F,R); ActualEyes, Inc.: (R); Japan Innovative Therapeutics, Inc.: (F); Doshisha University: (P)

CME/CPD Information



Mineo Kondo, MD, PhD, FARVO

Senjyu: (C,F,R); Bayer: (C,R,); Alcon: (F,R); Hoya: (F); Nidek: (F,R); Novartis: (F,R); Otsuka: (F,R); Pfizer: (F,R); Santen: (F,R); Senju: (F,R); Sanofi: (R); Sanwa: (R)

Richard W. J. Lee, MRCS, MRCOphth, PhD

US Patent App. 15/106,411 - Conjugates for treating inflammatory disease and identification of patients likely to benefit from such treatment. (P)

Thomas W. Raasch, OD, PhD, FARVO

Lentechs, LLC.: (C)

Vasanth Rao, PhD Aerie: (C,I,P); Merck: (C,I,P); Teva: (C,I,P); Pfizer pharmaceutical: (C,I,P)

Tony Realini, MD, MPH New World Medical: (C); Ellex: (C); iStarMed: (C); Palvella: (C); Aerie: (C); Reichert: (C); IRIS: (C)

Richard Rosen, MD Opticology: (I); OD~OS: (C); Allergan: (C,F); Guardion Health: (C); Boehringer-Ingelheim: (C); CellView: (C); Diopsys: (C); Optovue: (C, P); Astellas: (C); Genentech-Roche: (F); Nano Retina: (C,F); Regeneron: (C); Zeavision: (C,F)

Nicole Ross, OD, MSc Genentech: (R)

Stephen R. Russell, MD IDx, LLC: (I); Spark Therapeutics, Inc.: (F,R); ProQR, Inc.: (F)

Daniel R. Saban, PhD Allergan: (F)

Ursula Schmidt-Erfurth, MD, FARVO

Boehringer: (C); Genentech: (C); Novartis: (C); Roche: (C)

Alan W. Stitt, PhD Oxurion: (F); Roche: (F); Elasmogen: (F)

Donny W. Suh, MD NIH, Pediatric Eye Disease Investigator Group (PEDIG): (F); University of Nebraska Medical Center Research Center: (F)

Shiva K. Swamynathan, PhD

9,731,014 (P): SPOUSE: (P)

Akitaka Tsujikawa, MD Pfizer: (F,R); Bayer: (F,R); Novartis: (F,R); Santen: (F,R); Senju: (F,R); Alcon: (F,R); AMO Japan: (F,R); Hoya: (F); Kowa: (F,R); Nidek: (R); Sanwa Kagaku: (R)

The following individuals on the AMPC committee reported no financial relationships. Mohamed H. Abdel-Rahman, MD, PhD; Audrey M. Bernstein, PhD; Claudio Bucolo, PhD, FARVO; Andrew Carkeet, MS, PhD; Colleen M. Cebulla, MD, PhD; Kevin Chan, PhD; Zia Chaudhuri, FRCS, MS; Stacey S. Choi, PhD; Elfride De Baere, MD, PhD; Cintia S. De Paiva, MD, PhD; Astra Dinculescu, PhD; Erika D. Eggers, PhD; James M. Fadool, PhD; Amani A. Fawzi, MD; Ulrike Grunert, PhD; Haiyan Gong, MD, PhD;

CME/CPD Information


Jennifer J. Hunter, PhD; Zi-Bing Jin, MD, PhD; Jan J. Kremers, PhD; Salil Anil Lachke, PhD; Ecosse L. Lamoureux, MSc, PhD; Hani Levkovitch-Verbin, MPA, MD; Yutao Liu, MD, PhD; Goldis Malek, PhD, FARVO; Mary E. Marquart, PhD; Lisa A. Ostrin, OD, PhD; Luminita I. Paraoan, PhD; Brian D. Perkins, PhD; Susanne Roosing, PhD; Magali Saint-Geniez, PhD; Kevin L. Schey, PhD; Bonnielin K. Swenor, MPH, PhD; Jingyun Wang; Walter Wittich, PhD, FAAO, CLVT; Joanne M. Wood, BSc, PhD; Takefumi Yamaguchi, MD; Xiaoying Zhu, OD, PhD, MD, MS

Continuing Medical Education Committee (CME) Chair: William J Foster, MD PhD FRCSC, Altasciences Clinical Research: (C); US Patent 9,050,171, Small diameter fragmatome for minimally traumatic retained lens fragments removal: (P)

The following individuals on the CME Committee reported financial relationships.


Anton B. Hommer, MD Santen: (R); Allergan: (R); Alcon: (R); Thea: (R)

Christina Y Weng, MD, MBA Allergan, Inc.: (C); Alimera Sciences, Inc.: (C)

The following individuals on the CME Committee reported no financial relationships. Helena Filipe, MD; Bruce Ira Gaynes, OD PharmD; Vivek Kumar Gupta, PhD; Ludwig M. Heindl, MD, PhD; Ines Cardoso Leal, MD; Jonathan H Lin, MD PhD; Jaime Tejedor, MD, PhD; Ann Sofia Skou Thomsen, MD; and Sarah Xin Zhang, MD.

The following activity managers have reported no financial relationships. Regina Borkoski; Gayle Claman, MS, CAE; Cathy Conley; Kathy Cox; and Lancey Cowan, JD, CAE

The following clinical content reviewer has reported no financial relationships. Lindsay Scott, PT, DPT, ATC

Category code: Specific financial interests F (Financial Support) Indicates financial support received from an ACCME-defined commercial interest, in the form of research funding, grants, research materials or in-kind services (e.g., protein sequencing).

I (Personal Financial Interest) Indicates you are an investor in a company or competing company, including an ACCME-defined commercial interest, other than through a mutual or retirement fund.

E (Employment) Indicates you are an employee of an ACCME-defined commercial interest.

CME/CPD Information


C (Consultant) Indicates you are a consultant for an ACCME-defined commercial interest.

P (Patent) Indicates you are an inventor/developer designated on a patent, patent application, copyright, or trade secret, whether or not the patent, copyright, etc. is presently licensed or otherwise commercialized, or could be in competition with the technology described.

R (Recipient) Indicates you have received gifts, honoraria, travel reimbursement, patent royalties, or any other financial compensation valued in any amount from an ACCME-defined commercial interest.

N (No Commercial Relationship) Indicates there is no commercial relationship relevant to the subject matter of the abstract/article/presentation.

S (non-remunerative) Indicates you have position(s) of influence such as officer, board member, trustee, spokesperson, etc.

CME/CPD Information


CONTINUING MEDICAL EDUCATION SESSIONSAll Annual Meeting sessions certified as Continuing Medical Education (CME) and eligible for AMA PRA Category 1 Credit™ are listed below with their associated faculty presenters. Presenters are listed in presentation order. For a complete list of all individuals involved with each research project, refer to the online planner or the mobile app.

The following Annual Meeting formats are not certified as Continuing Medical Education (CME) and are not eligible for AMA PRA Category 1 Credit™: ALCON/Keynote series, Award lectures, Posters, SIGs, and Special sessions.

Sunday, April 28: 8-10am Session Session title Location

102 A window on the soul: How systemic disease manifests in the eye Maya Koronyo-Hamaoui, Nicolas Cuenca, José E Capo-Aponte, Yang Sun, Colleen M Cebulla

East Ballroom B

103 The potential and pitfalls of big data Laura B Balzer, Michael F Chiang, Joshua D Stein, Christopher J Hammond, Anne L Coleman

East Ballroom C

Sunday, April 28: 1-2:30pm Session Session title Location

127 Low Vision Group - The effects of mesopic light levels on vision and functional activities Aaron Johnson, Lauren Ayton, Cynthia Owsley, Bonnielin Swenor, Ava Bittner

West 223/224

Sunday, April 28: 3-4:45pm Session Session title Location

147 Uveal Melanoma Prisca Bustamante, Matthew Field, Mohamed H Abdel-Rahman, Stephen S Phillips, John W Crabb, Niels J Brouwer, Stylianos Serghiou

East 1

148 Retina Husvinee Sundaramurthi, Nate Benner, Morven Cameron, Dorota L Stankowska, Hiroki Mieno, Kore Chan, Anmar Abdul-Rahman

East 2/3

149 Emerging AMD Therapeutics Daniel V Palanker, William R Freeman, Suruchi Bhardwaj Bhui, Nathan Steinle, Scott W Cousins, Francine F Behar-Cohen, Robert B Bhisitkul

East 8&15

CME/CPD Information


Session Session title Location

151 Myeloid and Innate Immunology of the Retina Samantha Dando, Chen Yu, Elisabeth Andriessen, Sofia Theodoropoulou, Matt Rutar, Cristhian J Ildefonso, Siddharth Narendran

East Ballroom A

152 New and emerging clinical trials endpoints – Minisymposium Srinivas R Sadda, Jacque L Duncan, Ursula Schmidt-Erfurth, Emily Y Chew, Donald C Hood, David Huang, Richard B Rosen

East Ballroom B

153 Omics and systems biology approaches for profiling ocular tissues in health and disease Ameera Mungale, Timothy Cherry, Vinay Swamy, Dan P Murphy, Sanjoy K Bhattacharya, Inez Oh, Ilhan Erkin Acar

East Ballroom C

154 Photoreceptors Michael Tri Hoang Do, Takahisa Furukawa, Trevor D Lamb, Marta Zuzic, Ching-Kang Jason Chen, Wei Li, Niklas Domdei

West 212-214

155 Cataract Surgery, Epidemiology and Clinical Outcomes Rachel Bishop, Harrison Dermer, Luca Schwarzenbacher, Chirag Shah, Yann Bouremel

West 217-219

156 Healthcare Delivery Hursuong Vongsachang, Shicheng Jin, Preeti Gupta, Sharon Ann Bentley, Alyssa Marie Kretz, Danielle Altman, Olivia Killeen

West 220

157 Amblyopia and Visual Plasticity Bin Zhang, Kimberly Meier, Simon Grant, Eileen E Birch, Jingyun Wang

West 221/222

158 Advanced Imaging of Retinal Structure and Function in Disease Andrew M Huang, Ethan Bensinger, Fenghua Wang, Stephen A Burns, Nicole M Putnam, Bianca Leonard, Allen M Y Cheong

West 223/224

160 Emerging gene-driven therapies for anterior segment disease – Minisymposium Alexander V Ljubimov, Abbot F Clark, Audrey M Bernstein, Rajiv R Mohan, Robert M Lavker, Tara C B Moore

Harbour Ballroom

CME/CPD Information


Monday, April 29: 8:15-10am Session Session title Location

202 Advances in Retinoblastoma and Radiation Retinopathy Hardeep Pal Singh, Rajesh C Rao, Anthony B Daniels, Sameh Gaballah, Zhao Xun Feng, Antonia M Joussen, Brittany Powell

East 1

203 Gene therapy and delivery Brian C Gilger, Michael James Gilhooley, Robert E MacLaren, Ryan F Boyd, Andrea Korecki

East 2/3

204 Miscellaneous Maculopathies Philipp L Mueller, Martin Gliem, Simone Tzaridis, Emily Y Chew, Hendrik P Scholl, Winston Lee, E.H. Henrike Runhart

East 8&15

205 AMD Pathobiology and New Models Natalie Wagner, Sunghee Estelle Park, Amol Sura, Robert F Mullins, Venkata Ramana Murthy Chavali, Andrea García Llorca, Sayan Ghosh

East 11/12

206 Adaptive and Innate Immunity in Ocular Health and Disease Holly Rose Chinnery, Sudha Neelam, De-Quan Li, Andrew W Taylor, Jessica Wei, Darren J Lee, Haihan Jiao

East Ballroom A

207 AMD Imaging I Claus von der Burchard, Ferdinand Georg Schlanitz, Antoine Rivail, Wolf-Dieter Vogl, Sebastian M Waldstein, Stuart Keel, Minsu Jang

East Ballroom B

208 Frontiers in membrane dynamics and cellular communication: Impact on vision and disease mechanisms – Minisymposium Vadim Y Arshavsky, Yoshikazu Imanishi, Kapil Bharti, Kirill A Martemyanov, Luminita I Paraoan, Abbot F Clark

East Ballroom C

209 Corneal Cell and Molecular Biology Justin Ma, Aurelie Dos Santos, Carla Sanchez Martinez, Mohammad Zuhair Mustafa, Han Peng, Tiago Andre da Silva Ramos, Trevor Williams

West 211

210 Circadian rhythms and photoreceptors Sara Patterson, Tiffany M Schmidt, Seunghoon Lee, Nairouz Farah, Norianne T Ingram, Shuo Zhang, Stuart C Mangel

West 212-214

CME/CPD Information



212 Impact of Visual Impairment Dean A VanNasdale, Jose Javier Estevez, Charumathi Sabanayagam, Lisa Keay, Dandan Diane Zheng, Asad Farooq Durrani, John Paul Bader

West 220

213 Systemic Disorders: Basic and Translational Studies Aida Sanchez-Bretano, Venu Talla, Oliver W Gramlich, Linda K McLoon, Zia Chaudhuri, Peter van Wijngaarden

West 221/222

216 Dry Eye I Richard Zhang, Lixing W Reneker, Stephen C Pflugfelder, Ashley Bascom, Nai-Wen Fan, Xin He, Helen P Makarenkova

Harbour Ballroom

Monday, April 29: 11:15am-1pm


226 Drug delivery, drug and gene delivery system Baruch D Kuppermann, Sven Schnichels, Lingyun Cheng, Anthoula Arta, Anne Zebitz Zebitz Eriksen, Vanessa Yanez, Michelle E McClements

East 2/3

227 Retinal Vascular Disease Gwenola Drouglazet, Salam Bachour, Martin Michl, Hee Eun Lee, Maria João Vieira, Sana Idrees

East 8&15

228 Retinal Bioenergetics and Metabolic Interactions Mo Wang, Vera L Bonilha, Jianhai Du, Qitao Zhang, John D Ash, Luis James Knight, Eric Weh

East 11/12

229 Translational immunology in AMD, uveitis and thyroid eye disease Chung-Jung Chiu, Florian Sennlaub, Kathryn L Pepple, Jerry Chien-Chieh Huang, Jay Siak, Svenja Ploehn, Sijie Fang

East Ballroom A

230 Diabetic Retinopathy Therapeutics Chirag Jhaveri, Rubbia Afridi, David S Boyer, Diana V Do, Mark W Johnson, Andreas Stahl

East Ballroom B

CME/CPD Information



231 Molecular mechanisms of retinal function in health and disease Philip Ruzycki, Theodore G Wensel, Jeremy M Sivak, Srinivas Rao Sripathi, Binxing Li, Thomas Ray, Katya Lobanova

East Ballroom C

232 Ocular Surface Disease Giulio Ferrari, Yoko Ogawa, Marlies Gijs, Sharon Dsouza, Carol Kaplan, Douglas Borchman, Eugene Osae

West 211

233 Of mice and men: Comparing primate and rodent retina – Minisymposium Ulrike Grunert, Yi-Rong Peng, Greg D Field, Machelle T Pardue, Jan J Kremers, Jens Duebel

West 212-214

234 Mendelian Genetics and Animal Models of Retinal Disorder Gavin Arno, Nieneke Wesseling, Pooja Biswas, Kaoru Fujinami, Douglas Vollrath, Gemma Marfany, Ala Moshiri

West 217-219

235 Quality of life and the patient experience Stefan Nickels, Jamie N T Enoch, Konrad Pesudovs, Lee Jones, Vijaya Gothwal, Nicole Ann Carnt, Bamini Gopinath

West 220

236 Strabismus and Nystagmus Mary Whitman, Samuel Adade, Richard W Hertle, Jonathan M Holmes, Krista R Kelly, Yuxi Zheng

West 221/222

237 Advanced Imaging of Retinal Structure and Function in Healthy Eyes Rigmor C Baraas, Jason Porter, Jenny Lorén Reiniger, Khang T Huynh, Furu Zhang, Ramkumar Sabesan, Kazuhiro Kurokawa

West 223/224

238 New Ideas in Glaucoma Donald C Hood, Michael Sullivan-Mee, Mingguang He, Thanadet Chuangsuwanich, Rory Murphy, Tave van Zyl, Sri Meghana Konda

ARVO Ballroom

Monday, April 29: 1:15-2:45pm


258 Multidisciplinary Ophthalmic Imaging Group - OCT advances in vascular and functional imaging Ruikang K Wang, Hao F Zhang, Yali Jia, James G Fujimoto, Marinko V Sarunic, Michael Pircher

East Ballroom B

CME/CPD Information


Monday, April 29: 4-5:45pm


267 Aqueous humor dynamics and IOP W Daniel Stamer, David L Swain, Michael H Elliott, Carol B Toris, Oleg Yarishkin, Ashok Sharma, Elfriede Friedmann

East 2/3

268 Imaging the Posterior Segment-Clinical Ian Han, Jennifer I Lim, Katie M Litts, Alison L Huckenpahler, Amir Sadeghipour, Imre Lengyel

East 8&15

269 Emerging cell-based therapies to tackle retinal diseases – Minisymposium David R Hyde, Susanna S Park, Amir H Kashani, Valeria Canto Soler, Rachael A Pearson

East 11/12

272 Corneal surgery:non-refractive Faraaz Khan, Andri K Riau, Steven A Greenstein, Pranita Sahay, Jennifer Rose-Nussbaumer, Sanjay V Patel, Klara Charlotte Borgardts

West 211

273 Corneal Tissue Engineering and Regenerative Medicine Yu Yoshinaga, James L Funderburgh, Sarah Tsurkan, Mengyuan Xie, Bruce Ksander, Vincent M Borderie, Miguel Gonzalez Andrades

West 212-214

274 Lens Cell Biology S Amer Riazuddin, M Joseph Costello, Yuki Sugiyama, Catherine Cheng, Vasanth Rao, Woo-Kuen Lo

West 217-219

275 Visual Impairment and Multi-Morbidity Jasmine Junge, Andrea Urqueta Alfaro, Aaron Johnson, Ruth M.A. Van Nispen, Ecosse Luc Lamoureux, Ken Kitayama

West 221/222

276 Biomechanics Rouzbeh Amini, Harry A Quigley, Yanhui Ma, Tasneem Putliwala Sharma, Katie Lucy, Mark R Lesk, Soledad Aguilar Munoa

ARVO Ballroom

277 Neuroprotection Margaret McDougal Runner, Julia Oswald, Liang Li, Mojdeh Abbasi, Amit K Patel, Anitha Krishnan, Meredith S Gregory-Ksander

Harbour Ballroom

CME/CPD Information


Tuesday, April 30: 8:45-10:30am Session Session title Location

311 Diabetic retinopathy Jurgen Sergeys, Colin R Green, Heidrun L Deissler, Konstantin Petrukhin, Xavier Guillonneau, Cristiano Pedrozo Vieira, Katrin Lorenz

East 2/3

312 Macular edema and neuroprotection-translational studies Zhongxiao Wang, Allen C Clermont, Tea Soon Park, Xiaohong Nancy Chen, Ellen Townes-Anderson, Alejandra Daruich

East 8&15

313 Microglia and Innate Immunity Xuan Du, Lian Zhao, Yvette Wooff, Eleftherios I Paschalis, Oliver Hugh Bell, Monica L Vetter, Sheri Peterson

East 11/12

315 Gene variants in major ocular diseases Dror Sharon, Kristof Van Schil, Cecile Delettre Cribaillet, Adrian Dockery, Mubeen Khan, Paul N Bishop, Mineo Ozaki

East Ballroom C

317 Laser Therapy David S Friedman, Rick Trevino, Murray A Johnstone, Jessica Minjy Kang, Richard Chitedze, Tony Realini, Lucas Bonafede

West 212-214

318 Glaucoma Genetics Development with advanced technology & large datasets Hannah Currant, Omar García Rodríguez, Ayub Qassim, Shi Song Rong, Subhabrata Chakrabarti, Terri L Young, Wesley Goar

West 217-219

319 Aging with Vision Loss: Understanding the aging consequences of visual impairment – Minisymposium Heather Whitson, David J Lee, Ellen E Freeman, Ecosse Luc Lamoureux, Alan R Morse

West 220

320 Clinical outcomes and visual quality with retinal prosthetic vision restoration – Minisymposium Richard H Kramer, Yossi Mandel, Eli Peli, E.J. Chichilnisky, Avi Caspi, Gislin Dagnelie

West 223/224

321 Neurodegeneration Louis R Pasquale, Markus H Kuehn, Milica Margeta, Hangjing Wu, Melissa Cooper, Yaeram Jeong, Bailey Hannon

ARVO Ballroom

CME/CPD Information



322 Visual Fields, Psychophysics, and Electrophysiology Mengyu Wang, Alessandro Rabiolo, Gian-Gabriel P Garcia, Jorryt Gerlof Tichelaar, David F Garway-Heath, Pete R Jones, Vickie Hoi Ying Wong

Harbour Ballroom

Tuesday, April 30: 11:45am-1:30pm


341 Update on endophthalmitis Varsha M Rathi, Adriaan Heineken, Scott D Walter, Cecilia S Lee, Lindsay Chun, Diana Laura

East 8&15

342 Retinal Angiogenesis and Related Mechanisms in Vascular Biology Ruth B Caldwell, Michelle LeBlanc, Nader Sheibani, Guei-Sheung Liu, Da Long, Xi Lu, Lingli Zhou

East 11/12

343 Innate immune memory and the eye – Minisymposium Homayon Ghiasi, Martine J Jager, Andrew W Taylor, Wai T Wong, Holly Lallman Rosenzweig

East Ballroom A

344 AMD Translational studies Jeremy Lavine, Santiago Delgado-Tirado, Yingbin Fu, Dimitra Skondra MD,PhD, Sook Hyun Chung, Céline Koster, Timothy W Olsen

East Ballroom B

345 Highlights of OCT angiography Oscar Carrasco-Zevallos, Qisheng You, Minhaj Nur Alam, Qinqin Zhang, Huiyuan Hou, Giovanni Gregori, Zihan Sun

East Ballroom C

346 Lacrimal gland biology in homeostasis, disease, and repair – Minisymposium Darlene A Dartt, Kazuo Tsubota, Austin K Mircheff, Sarah F Hamm-Alvarez, Masatoshi Hirayama, Helen P Makarenkova

West 211

347 Unresolved issues in myopia – Minisymposium Frank Schaeffel, Earl L Smith, David Troilo, Daniel Ian Flitcroft, William K Stell, Christine Frances Wildsoet, Ian George Morgan, Pei-Chang Wu, Debora L Nickla, Kathryn Saunders

West 212-214

CME/CPD Information



348 Lens Development Ales Cvekl, Rupalatha Maddala, Sandeep Aryal, Stephanie Padula, Anthony Sallese, Timothy F Plageman

West 217-219

349 Visual Training and Rehabilitation Natalie N Stepien-Bernabe, Rajkumar Nallour Raveendran, William H Seiple, Ahmed M Sayed, Zahide Pamir, Meghan J DeBenedictis

West 221/222

Tuesday, April 30: 2:45-4:30pm


368 Retinal Development Bernadett Bosze, Andrea S Viczian, Nicolas Lonfat, Clayton Santiago, Masaya Fukushima, Kayla Titialii, Robert Mackin

East 8&15

369 RPE Biology in Health and Disease Yini Wang, Goldis Malek, Thomas Ach, Anna G Figueroa, Lyndsay L Leach, Alyson Wolk, Kevin Eade

East 11/12

370 Uveitis clinical epidemiology and therapeutics Peizeng Yang, John H Kempen, Victor Llorens, Edmund Tsui, Muhammad Hassan, Glenn J Jaffe, Alessandro Invernizzi

East Ballroom A

372 Retinal degeneration: molecular disease mechanisms Weiyong Shen, Chi-Hsiu Liu, Zubair Ahmed, Alexander M Dizhoor, Valentina Cipriani, Liu Yang, Yuri V Sergeev

East Ballroom C

373 Corneal endothelium and Fuchs corneal dystrophy Wenlin Zhang, Marianne Fritz, Viridiana Kocaba, Keith H Baratz, Risako Nakagawa, Genta Nakayama, Vinod V Mootha

West 211

374 Ganglion cells and beyond Megan Lee Zipperer, Molis Yunzab, Vineeth Raghuram, Tyler Godat, Peter B Detwiler, Paul R Martin, Ming-fai Fong

West 212-214

375 Contact lens Simin Masoudi, W Gregory Sawyer, Gabriela Dieckmann, Angela Pitenis, Emiliano Teran, Ananya Datta, Katrina L Schmid

West 217-219

CME/CPD Information



376 Myopia: Behavior and interventions Jeremy A Guggenheim, Matthew Boswell, Ahmed F Shakarchi, Longbo Wen, Han Yu Zhang, Lap Ki Alex Ng

West 220

377 Mechanisms and biomechanics of traumatic retinal hemorrhage in children – Minisymposium Donny W Suh, Joanne N Wood, Gil Binenbaum, Alex V Levin, Donny W Suh, Brittany Coats

West 221/222

378 Vision assessment and modeling in health, and with impairment Angela M Brown, Katarzyna Komar, Zhong-Lin Lu, MiYoung Kwon, Gislin Dagnelie, Eli Peli, Steven Savage

West 223/224

379 Clinical Studies Jessica V Jasien, Tanuj Dada, C Gustavo De Moraes, Jibran Mohamed-Noriega, Brian McMillan, Joanne C Wen, Yvonne M Buys

ARVO Ballroom

380 Structure-Function Relationships Vahid Mohammadzadeh, Henry Nicholas Marshall, Giovanni Montesano, Ou Tan, Mohammad Norouzifard, Ji Won Bang, Raymond Najjar

Harbour Ballroom

Wednesday, May 1: 8:15-10am


401 P2X7 receptor: One target for inflammatory responses in different ocular diseases – Minisymposium Julie Sanderson, Claire H Mitchell, Erica L Fletcher, Claudio Bucolo, Vickery E Trinkaus-Randall, Darlene A Dartt

East 2/3

402 Retinal Degeneration Wei-Chieh Jerry Chiang, Hongwei Ma, Jingyu Yao, Rui Chen, Ayse Mine Genc, Mao Shengru, Brittni A Scruggs

East 8&15

403 Repurposing drugs for the treatment of retinal diseases – Minisymposium Breandan N Kennedy, Nawajes A Mandal, Aparna Lakkaraju, Benjamin J Kim, Alfred S Lewin, Brian S McKay

East 11/12

CME/CPD Information



405 Gene editing & new cell-based and animal models for ocular disease Koji M Nishiguchi, Fan Li, Uwe Wolfrum, Manel Llado Santaeularia, Maureen A McCall, Ivana Trapani, Alecia K Gross

East Ballroom C

406 Corneal imaging and topography Janelle Tong, Cristina Canavesi, Elias Pavlatos, Osama Ibrahim, Kiran Kumar Vupparaboina, Alessia Colonna, Amira M Eltony

West 211

407 ERG: Advances, Disease and Injury Gabriel Peinado, Mirella Telles Salgueiro Barboni, Rikard Frederiksen, Melanie R Lalonde, James D Akula, Fatima Abbas, Anna Brouwer

West 212-214

408 GWAS & Beyond: Epigenetics and Functional Characterization Anand Swaroop, Louise Frances Porter, Laura Lorés de Motta, Alison J Hardcastle, Hannah Webber, Nicholas Tolman, Ayellet Segre

West 217-219

409 Epidemiology of Corneal Disease Qinqin Liu, Vikram Paranjpe, Meraf Amde Wolle, Chris Bradley, Nakul Shekhawat

West 220

410 Visual Impairment- Impact on Driving and Mobility Garrett Swan, Joanne M Wood, Kierstyn Napier-Dovorany, Sagar Chapagain, Ursula White, Joseph Da

West 221/222

411 Refraction, Biometry, and Myopia Damien Gatinel, Victor Rodríguez-Lopez, Lene A Hagen, James A Kuchenbecker, Yifei Wu, Andrew Carkeet, Ashutosh Jnawali

West 223/224

412 Ocular Blood Flow Lutz E Pillunat, Ryuna Chang, Georgios Lazaridis, Tailoi Chan-Ling, Bryn Brazile, Jeremiah Kah Heng Lim, Lorenzo Sala

ARVO Ballroom

Wednesday, May 1: 10:15am-12pm


432 Advanced imaging technologies Seung Woo Hong, Mathieu KUNZI, Danielle J Harper, Hao F Zhang, Kamal Dhakal, Maximilian Pawloff, Kevin C Chan

East 1

CME/CPD Information



433 Blood Flow Ronald H Silverman, Antonio Longo, Leopold Schmetterer, Leo Puyo, Andres Guevara-Torres, Breanna Tracey

East 2/3

434 Retinopathy of Prematurity Sherina Thomas, Siva Balasubramanian, Xi Chen, Tianyu Liu, Sang Jin Kim, Rene Choi, Kellyn N Smith

East 8&15

435 Stem Cells and Organoids Jiansu Chen, Kevin Gregory-Evans, Heike Kroeger, Ruchira Singh, Brian G Ballios, Kirstin Brooke VanderWall, Donald J Zack

East 11/12

436 Precision through measurement: Biomarkers in health and disease – Minisymposium Sarah E Coupland, Darragh Duffy, Pearse Andrew Keane, Russell Foster

East Ballroom A

437 Diabetic Retinopathy-Screening and Clinical Imaging Siamak Shokrollahi, Paolo Sandico Silva, Julia Hafner, Thomas S Hwang, Jay M Stewart, Bianca S Gerendas, Felicia Widyaputri

East Ballroom B

438 Corneal biomechanics, keratoconus and crosslinking Elias Flockerzi, Jennifer J Ling, Cynthia J Roberts, Brecken Blackburn, Ananya Goyal, Dimitrios Karamichos, Yutao Liu

West 211

439 Inner Retinal Function Rachel Care, Steven H DeVries, Antonio F Ambrosio, Nazarul Hasan, Chase B Hellmer, Santhosh Sethuramanujam, Rong-Shan Yan

West 212-214

440 Lens Biochemistry Justin Parreno, Viviana M Berthoud, Jie Liu, Kulandaiappan Varadaraj, Kevin L Schey, Kirsten J Lampi

West 217-219

441 Retinal disease screening and risk factors Stine Byberg, Soufiane Ajana, Carol Yim-lui Cheung, Spencer D Fuller, Simon P Harding, Marion Ronit Munk, Benedicte MJ Merle

West 220

442 Optic Neuropathy Steven Roth, Patrick Yu-Wai-Man, Farzad Pakdel, Steven Laurie, Brandon Macias, Tonia S Rex

West 221/222

CME/CPD Information



444 Imaging Hongli Yang, Laura P Pardon, Haogang Zhu, Maria V Castanos, Brad Fortune, Max Colbert, Kai Gao

ARVO Ballroom

445 Corneal Epithelium in Health and Disease Chidambaranathan Gowri Priya, Adam Poe, Justin Courson, Vickery E Trinkaus-Randall, Nick Di Girolamo, David Myung, Alison M McDermott

Harbour Ballroom

Wednesday, May 1: 12:15-1:45pm


462 Genetics Group - Spotlight on retinal ciliopathy from genetics to mechanism Ronald Roepman, Erica Davis, Robert S Molday, Anand Swaroop

East Ballroom B

465 How do I tell m(e)y(e) story? - Why effective communication is needed now more than ever to increase research funding Lauren N Ayton, Gadi Wollstein, Stacy Pagos Haller, Maria B Grant, Hosam Ibrahim-Elzembely

West 212-214

468 Overcoming the challenges of international collaboration in ocular research Rupesh Vijay Agrawal, Carmen Ayuso, Richard W J Lee, Cristos Ifantides

West 221/222

469 Ethical challenges and solutions for CRISPR treatment in human eye disorders Budd Tucker, Stephen H Tsang, Tara C B Moore, Peter A Campochiaro

West 223/224

Wednesday, May 1: 3-4:45pm


472 Retinitis Pigmentosa-Clinical Michalis Georgiou, Moreno Menghini, Katharina G Foote, Kirk Stephenson, Ahmed M Hagag, Adam M Dubis, Tomas S Aleman

East 8&15

CME/CPD Information



473 Neuroprotection Ben Mead, Sean K Wang, Kimberly A Wong, Ayse Sahaboglu, Thomas Wubben, Jia Xie, Dragana Trifunovic

East 11/12

474 Ocular surface infection and inflammation Sandamali Amarasingha Ekanayaka, Ashley Behrens, Mohammad Sharifian Gh, Stephanie Wan, Shunbin Xu, David J Evans, Jaya Rajaiya

East Ballroom A

475 AMD clinical trials Atsuro Uchida, Srinivas R Sadda, Jennifer Joan Arnold, Haley D'Souza, David Callanan, Derek Kunimoto, Rishi P Singh

East Ballroom B

476 Advanced therapies for ocular disease Harry Otway Orlans, Alaknanda Mishra, Daniel Grigsby, Michael Berry, Patrizia Tornabene, Karina E Guziewicz, Keiko Miyadera

East Ballroom C

477 Dry eye clinical Mario Joseph Rojas, Abraham Solomon, Leslie Small, Cameron K Postnikoff, John D Sheppard, Pedram Hamrah, Marko Oydanich

West 211

478 Trabecular Meshwork and Ciliary Body Terete Borras, David Krizaj, Krishnakumar Kizhatil, Wei Zhu, C Ross Ethier, Jacques Alexander Bertrand, Gulab Zode

West 212-214

479 Physiological biochemistry of the lens – Minisymposium Paul J Donaldson, Stephen Barnes, Julie C Lim, Miduturu Srinivas, Xiaohua Gong

West 217-219

480 Genetic Epidemiology Ching-Yu Cheng, Robert Wojciechowski, Pirro G Hysi, Denis Plotnikov, Patrice Marie Hicks, Katie Williams, Mark James Simcoe

West 220

481 Imaging in Neuro-ophthalmic Disorders Heather Moss, Bill Morgan, Frank A Proudlock, Jui-Kai Wang, Zhanhan Tu, Aleid van de Kreeke

West 221/222

482 The choroid in ocular physiology, pathology and myopia Audra M. A. Shadforth, Falk Schroedl, Hosein Hoseini-Yazdi, Jody A Summers, Christin Hanke-Gogokhia, Xiao Yang, Sang A Kim

West 223/224

CME/CPD Information



483 Surgery and Wound Healing Cynthia Yu-Wai-Man, Ali Salimi, Giacinto Triolo, Chen Xin, Pouya Alaghband, Hari Jayaram, Yingna Liu

ARVO Ballroom

484 Corneal Stroma Wound Healing and Repair Tina B McKay, Hon Shing Ong, Rajiv R Mohan, Steven E Wilson, Edgar M Espana, Paola Bargagna-Mohan, Paramananda Saikia

Harbour Ballroom

Thursday, May 2: 8-10am


501 The gut-eye axis: Emerging roles of the microbiome in ocular immunity and diseases John Bienenstock, Rachel R Caspi, Mihaela G Gadjeva, Allen Taylor, Maria B Grant

West 212-214

502 The single cell revolution: Novel insights and applications for single cell RNA sequencing in eye research Donald J Zack, Seth Blackshaw, Enrique J Rodriguez-Boulan, Marie E Burns, Daniel R Saban, Ido Amit

West 217-219

Thursday, May 2: 10:15am-12pm


528 Mechanistic analysis of ocular morphogenesis, growth and disease Friedrich P Paulsen, Jiali Ru, Katie L Wagner, Sophie Lemmens, MAI SHUYI, Steven L Bernstein, Meysam Yazdankhah

East 1

530 Advances in Retinal Gene Therapy and Stem Cells Qin Wan, Ebrahim Aboualizadeh, Jordi Mones, Huber Vasconcelos Junior, Andrew Chen, Rachel M Huckfeldt, Eyal Banin

East 8&15

531 Biology of Retinal Neurons Shyam S Chaurasia, Géraldine Millet Puel, Robert J Johnston, Joseph Fogerty, Jakub Famulski, Joel B Miesfeld, Reyna I Martinez-De Luna

East 11/12

CME/CPD Information



532 Ocular microbiology and vaccines Md Huzzatul Mursalin, Abby Kroken, Robert M Q Shanks, Kati Tormanen, Derek J Royer, Jacob Beaver, Daniel J Carr

East Ballroom A

533 Retinal Surgery and PVR Annabel von Studnitz, Bing Liu, Joseph Arboleda-Velasquez, Hiroki Kaneko, Edward Casswell, Irina De la Huerta, Naryan Singh Sabherwal

East Ballroom B

534 Biochemistry and molecular biology of diabetic retinopathy Todd McLaughlin, yan shao, Michael D Dennis, Ward Fickweiler, Priyamvada M Pitale, Mandy Losiewicz, Jose Manuel Romero del Hombre

East Ballroom C

536 Visual Diseases and Protection Eric B Miller, Zhuo-Hua Pan, Rachael S Allen, Yvonne Ou, Crystal Sigulinsky, Asia Cahill, Christian Felix

West 212-214

537 Posterior Capsular Opacification Linda Musil, Daisy Shu, Mihyun Nam, Samuel Novo, Janice L Walker, Melinda K Duncan

West 217-219

541 Pharmacological Interventions and Cellular Interventions Andras M Komaromy, Ajay Kumar, Joseph Hanna, Pinkal D Patel, Ian F Pitha, Yuan Lei, MinHee Kim Ko

ARVO Ballroom

Thursday, May 2: 12:15-1:45pm

560 Addressing global blindness through international research collaborations – Next frontier for 2020 Gyan "John" Prakash, Janey L Wiggs, Pamela C Sieving, Takeshi Iwata, Paul N Baird, Calvin C P Pang, Sudha K Iyengar, Sinnakaruppan Mathavan, Sundaram Natarajan

West 221/222


Sunday Social at the Vancouver Aquarium*Sun., April 28, 7–10pm845 Avison Way

Always a popular event, this year’s Sunday Social features exhibits, animals, a dolphin and sea lion show and a 4-D movie experience. Ticket includes admission and two drinks.

Shuttles will run on a loop from the Convention Centre to the Aquarium starting at 6:30pm. The last shuttle will leave the aquarium at 10pm.

Student/Trainee SocialMon., April 29, 7:30–9pm Vancouver Convention Centre | Ballroom Foyer

All trainees attending the Meeting are invited to join us in honoring the 2019 Travel Grant Recipients. Come and mingle with your colleagues, make new acquaintances, and meet members of the ARVO Board of Trustees.

ARVO Classical Concert Wed., May 1, 8–10pmVancouver Convention Centre | West 301

The popular ARVO Classical Concert is performed by multi-talented ARVO members. Relax and enjoy

the music.

ARVO Karaoke*Wed., May 1, 9pm–12midnightBlackbird Public House905 Dunsumir St.

Show your vocal talents or cheer on your favorite performer at the ARVO karaoke night! Admission includes one drink. Cash bar and light snacks will also be available. You must be 21 years or older to attend this event. Visit Baltimore Welcomes ARVO 2020 Kick-Off ReceptionThurs., May 2, 2–3pmVancouver Convention Centre | Exhibit Hall

Join ARVO and Visit Baltimore as we look forward to the ARVO 2020 Annual Meeting, May 3–7.

ARVO Social Events Everyone is welcome!

* Admission ticket required. Tickets available Sat. on the first floor of Convention Centre in the West Building and Sun.– Wed. at ARVO Central.


Section Business Meetings

Monday, April 29, 10:15 – 11am

AP Section Business Meeting — East 11. Trustee’s Report of Status of Association2. ARVO Strategic Plan3. Annual Meeting Program Committee Chair’s Report4. Annual Meeting Program Committee Election Results5. Other Business

BI Section Business Meeting — East Ballroom C1. Trustee’s Report of Status of Association2. ARVO Strategic Plan3. Annual Meeting Program Committee Chair’s Report4. Annual Meeting Program Committee Election Results5. Other Business

CL Section Business Meeting — West 2201. Trustee’s Report of Status of Association2. ARVO Strategic Plan3. Annual Meeting Program Committee Chair’s Report4. Annual Meeting Program Committee Election Results5. Other Business

CO Section Business Meeting — West 2111. Trustees Report of Status of Association2. ARVO Strategic Plan3. Annual Meeting Program Committee Chairs Report4. Annual Meeting Program Committee Election Results5. Other Business

EY Section Business Meeting — West 221/2221. Trustees Report of Status of Association2. ARVO Strategic Plan3. Annual Meeting Program Committee Chairs Report4. Annual Meeting Program Committee Election Results5. Other Business

GL Section Business Meeting — ARVO Ballroom1. Trustee’s Report of Status of Association2. ARVO Strategic Plan 3. Annual Meeting Program Committee Chair’s Report 4. Annual Meeting Program Committee Election Results5. Other Business

IM Section Business Meeting — East Ballroom A1. Trustees Report of Status of Association2. ARVO Strategic Plan3. Annual Meeting Program Committee Chairs Report4. Annual Meeting Program Committee Election Results5. 2019 Trustee Election Results6. Cora Verhagen Award7. Dr. Raniyah Ramadan Foundation Award8. Mallinckrodt Uveitis Research Fellowship9. Other Business

Section Business Meetings


LE Section Business Meeting — West 217-2191. Trustees Report of Status of Association 2. ARVO Strategic Plan3. Presentation of the National Foundation for Eye Research 2019 Cataract

Research Award to Frank J. Lovicu, PhD and Catherine K. Cheng, PhD4. Annual Meeting Program Committee Chairs Report5. Annual Meeting Program Committee Election Results6. Other Business

PH Section Business Meeting — East 2/31. Trustees Report of Status of Association2. ARVO Strategic Plan3. Annual Meeting Program Committee Chairs Report4. Annual Meeting Program Committee Election Results5. PH Section Trustee nomination(s) update6. Other Business

RC Section Business Meeting — East 11/121. Trustees Report of Status of Association2. ARVO Strategic Plan3. Annual Meeting Program Committee Chairs Report4. Annual Meeting Program Committee Election Results5. 2019 Trustee Election Results6. Other Business East Ballroom A

RE Section Business Meeting — East Ballroom B1. Trustees Report of Status of the Association2. ARVO Strategic Plan3. Annual Meeting Program Committee Chairs Report4. Annual Meeting Program Committee Elections Results5. Trustees Report of Status of Association6. Other Business

VI Section Business Meeting — West 223/2241. Trustees Report of Status of Association2. ARVO Strategic Plan3. Annual Meeting Program Committee Chairs Report4. Annual Meeting Program Committee Election Results5. 2019 Trustee Election Results6. Other Business

VN Section Business Meeting — West 212-2141. Trustees Report of Status of Association2. ARVO Strategic Plan3. Annual Meeting Program Committee Chairs Report4. Annual Meeting Program Committee Election Results5. Other Business


Transportation

Airport Transportation There are several options to go between Vancouver Airport (YVR) and downtown:

Taxi — Taxi stands are located on Level 2 of YVR. Taxis operating from the airport are licensed, and will use a zoned fare rate that will depend on downtown destination. Average fare is $27 – $34.

SkyTrain — The rapid rail service linking YVR to downtown Vancouver and parts of Richmond leaves the airport station approximately every seven minutes during most times of the day. There are 16 stops along the line, with downtown stops including Yaletown, Vancouver City Centre and Waterfront. The trip from YVR to downtown Vancouver takes 26 minutes on a two zone fare of $4.20, plus the $5 Canada Line YVR AddFare.

Car Service/Limousine —Ride in style with a luxury sedan or limousine. Simply use YVR’s official licenced limousine company – no booking required. Average towncar is $35 – $140.

Other Transportation Options Nearly everything you need in Vancouver is within walking dis-tance or a short cab ride of the Vancouver Convention Centre. The Information Desk at the entrance of the West Building of the Vancouver Convention Centre has more information. Taxis (including accessible wheelchair taxis) are plentiful and can be hailed on the street, as well as found at designated stands, and called for pick-up.

Getting around Vancouver Buses & Sky Train — Vancouver’s busiest bus routes run from 5am to 1am. Many buses will transit through Granville Street, Burrard Street and Georgia Street. Vancouver’s SkyTrain is a completely automated light rapid transit system, offering fast, efficient service between downtown and Metro Vancouver’s suburbs. For Trip Planning tools visit www.translink.ca.


icoph.org/woc2020

RegisteR Now foR woC2020& MARK YOUR CALENDAR!

Bench to Bedside (B2B)May 1, 2020Baltimore, Md.

ARVO is introducing a new program to encourage and foster innovation amongst members.■■Unique one-day meeting geared towards

research innovators and venture capitalists■ Learn how to advance translational ideas to

clinically applied products■ Early-stage pipeline companies will share their

trials and tribulations of taking a new discovery to the market

ARVO.org/Meetings/Bench-To-Bedside

New in 2020


2020 Hotels

Reserve your ARVO 2020 hotel online before you go home!Hotel reservations for ARVO 2020 in Baltimore, Md., open on Sunday, April 28. All attendees are encouraged to book their hotel for the 2020 Annual Meeting before heading home.

Two ways to book: ■ Stop by the Visit Baltimore kiosk in ARVO Central ■ Reserve online at ARVO.org/HOTELS

Hotels are available in all price ranges and service levels, and your favorite hotel brands are represented.

Please note: ARVO cannot assume responsibility for rooms reserved at hotels outside the ARVO block (either at hotels not listed or booked directly with the hotels). Special requests (i.e., king-size bed, non-smoking) may be noted but cannot be guaranteed. If you require accessible accommodations, contact ARVO’s Housing Bureau with details.

ARVO.org/Hotels

Future ARVO Annual Meetings

May 3 – 7, 2020 Baltimore, Md.

May 2 – 6, 2021 San Francisco, Calif.

May 1 – 5, 2022

Denver, Colo.

April 23 – 27, 2023New Orleans, La.

May 5 – 9, 2024Seattle, Wash.

May 4 – 8, 2025Austin, Texas


2020 Hotels

Baltimore is excited to welcome back ARVO for its 2020 Annual Meeting. Stop by the Visit Baltimore booth in ARVO Central and to make your hotel reservation and learn more about the city.

The Oriole Bird and the Baltimore Hons will be on hand for photos. The Oriole Bird is the mascot for the Baltimore MLB baseball team, the Orioles. He will be at the booth on Monday and Tuesday. The Hons, made famous by Cafe Hon in the Hampden neighborhood of Baltimore are known for their 1950s beehive hairdos, bright printed dresses and outdated glasses. Referring to eveyone as “hon,” short for honey, the Hons will be at the booth on Wednesday and Thursday.

Visit Baltimore will have packets of the city’s legendary Old Bay spice used to season one of its favorite foods, the blue crab, as well as some caramel creams from Goetze Candy, a Baltimore confectionary company.

Drop off your business card for a chance to win a $100 gift card from Under Armour, whose headquarters is in Baltimore. The first 250 people to make a reservation in ARVO Central will receive a Visit Baltimore travel coffee mug!

Great photos, great giveaways! Visit Baltimore in ARVO Central


f Supported by memorial donations* Funding of grants for attendance at this conference was made possible in part by grant 2U13EY002143-40 from

NEI. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the DHHS; nor does mention by trade names, commercial practices or organization imply endorsement by the U.S. Government.

ARVO and the ARVO Foundation are grateful to the supporters of the following named travel grants:Travel grants supporters:

ARVO Foundation awards & fellowships■ Alcon Early Career Clinician-Scientist Research Awards■■ Dr. David L. Epstein Award (supported by the family of Dr. Epstein)■■ Genentech AMD Research Fellowships■■ Bert M. Glaser, MD Award for Innovative Research in Retina (supported by the family of Dr. Glaser)■■■Mallinckrodt Uveitis Research Fellowship■■ Oberdorfer Award for Low Vision Research (supported by The Lighthouse Guild)■■ Pfizer Ophthalmics Carl Camras Translational Research Awards■■ Publications grants■■ Roche Collaborative Research Fellowships■ Lewis Rudin Glaucoma Prize■■ Ludwig von Sallmann Clinician-Scientist Award

■ American Macular Degeneration Foundation Travel Grants

■ American Uveitis Society Travel Grant■ ARVO International Travel Grants■ ARVO Staff Travel Grants■ ARVO Foundation Travel Grants■ Elizabeth Anderson Travel Grantsf ■ Joanne G. Angle Travel Grantsf■ Grant Wood Balkema Memorial Travel

Grantf■ Robert B. Barlow, Jr. Travel Grantf■ IRCCS-Fondazione G. B. Bietti per lo

Studio e la Ricerca in Oftalmologia-ONLUS Travel Grants

■ BrightFocus Foundation Travel Grants■ Sek-Jin Chew Travel Grantf■ Ramon F. Dacheux II Memorial Travel

Grant^■ Marij and Paulus de Jong Travel Grant ■ M. Velma Dobson Memorial Travel

Grantf■ C. Stephen and Frances B. Foster

Foundation Travel Grant■ Qais Farjo, MD Memorial Travel

Grantsf ■ Foster Ocular Immunology Society

Travel Grants■ G. M. Jager Travel Grantf■ Murray and Jeanie Johnstone

Travel Grant■ Karamichos/Utheim Keratoconus Travel Grant

■ Knights Templar Eye Foundation Travel Grants

■ Sarla P. Kothary Memorial Travel Grantf

■ Kowa Travel Grant ■ Kreissig Travel Grant ■ Lens and Cataract Travel Grant ■ Lions Eye Institute for Transplant and

Research Travel Grants■ Friederike Mackensen Travel Grantf■ Gesine Mohn Travel Grantf■ National Eye Institute Travel Grants*■ Richard Newton Lolley Travel Grantf■ NIHR Moorfields Biomedical

Research Centre Travel Grants■ Ocular Immunology and Uveitis

Foundation Travel Grant■ Overseas Chinese Association for

Vision and Eye Research (OCAVER) Travel Grant

■ David R. Pepperberg Travel Grantsf ■ Reader’s Digest Partners for Sight

Foundation Travel Grants■ Retina Research Foundation/Joseph

M. and Eula C. Lawrence Travel Grants■ Societa Italiana Laser in Oftalmologia

Travel Grants■ Josh Wallman Travel Grantf■ Women in Eye and Vision Research

(WEAVR) Travel Grants■ Gerhard Zinser Memorial Travel

Grantf

ARVO Foundation Developing Country Eye Researcher Travel Fellowships■■■Alcon Foundation■■ARVO Foundation Annual Meeting donors■■■ARVO member donors■■University of Wisconsin — Madison■■■Women in Eye and Vision Research (WEAVR)

ARVO gratefully acknowledges the generous support for the 2019 Annual Meeting and its programs.

Outstanding Solutions For YourOcular Drug & Medical Device Development Projects

1989 100% 216 +70

BIOANALYSIS

FORMULATION

CLINICAL SERVICES

CONSULTING

MICRO-DISSECTION

SURGERY

BIOLOGY ASSAYS

PRODUCT APPROVALS

PAPERSOPHTHAFOUNDED

Booth 1002

PRECLINICAL SERVICES

IRIS-ARVO-10,16x21,59VF.indd 1 19/03/2019 14:17

Documents

Pocket Guide - ARVO